Earlier today, Moderna hosted its 2026 Analyst Day, providing updates on our business strategy, pipeline progress and future priorities.
Members of our executive team sat down to share additional insights into the key takeaways from Analyst Day and what’s ahead for Moderna.
Watch our latest IR Insights video below to hear more: www.modernatx.com/recapping-2026-analyst-day
Moderna
Moderna, Inc. ( mə-DUR-nə) (founded as ModeRNA Therapeutics, Inc.) is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern". More on Wikipedia
-
Moderna
@moderna_tx
-
Moderna
@moderna_tx
Today we outlined the next phase of growth at our 2026 Analyst Day, highlighting how more than a decade of investment in our mRNA platform has enabled the development of multiple modalities of mRNA medicines, each with the potential to create durable franchises.
We also provided updates on commercial growth, oncology pipeline progress, manufacturing readiness and mid-term financial objectives.
Read more: feeds.issuerdirect.com/news-release.html?newsid=869710447… -
Moderna
@moderna_tx
Today we announced a publication in @JAMANetworkOpen of results from a large real-world study evaluating the comparative effectiveness of mNEXSPIKE® (COVID-19 Vaccine, mRNA) and Comirnaty® (COVID-19 Vaccine, mRNA) among U.S. Veterans aged 65 years and older during the 2025-2026 respiratory virus season.
Read more: feeds.issuerdirect.com/news-release.html?newsid=635491801… -
Moderna
@moderna_tx
Earlier today, Moderna reported financial results for the third quarter of 2026. Jamey Mock, Chief Financial Officer, sat down for an episode of IR Insights to discuss our financial performance.
Watch the episode here: www.modernatx.com/third-quarter-2026-earnings -
Moderna
@moderna_tx
Today we reported financial results and provided business updates for the third quarter of 2026.
Read more: feeds.issuerdirect.com/news-release.html?newsid=702506253… -
Moderna
@moderna_tx
Today we announced that Health Canada has authorized mFLUSIVA® (Influenza mRNA vaccine; mRNA-1010) and mCOFLU® (Combined Influenza and COVID-19 mRNA vaccine; mRNA-1083) for adults 50 years of age and older.
Read more: feeds.issuerdirect.com/news-release.html?newsid=532017407… -
Moderna
@moderna_tx
Today we announced that mRNA-1469, our investigational mRNA vaccine candidate against Bundibugyo ebolavirus (BDBV), has been recommended to advance into a Phase 2/3 efficacy study in the Democratic Republic of the Congo (DRC), supported by encouraging preclinical and Phase 1 clinical data.
Read more: www.accessnewswire.com/newsroom/en/healthcare-and-pharmac… -
Moderna
@moderna_tx
Today we announced that initial clinical data from our ongoing Phase 1/2 study of mRNA-2808 have been selected for oral presentation at the 68th American Society of Hematology (ASH) Annual Meeting, taking place December 12–15, 2026, in New Orleans, Louisiana.
Read more: www.accessnewswire.com/newsroom/en/healthcare-and-pharmac…
#ash2026 -
Moderna
@moderna_tx
With our partners at @Merck, we announced detailed results from the Phase 3 INTerpath-001 trial evaluating intismeran autogene (mRNA-4157 or V940), an investigational individualized neoantigen therapy, in combination with pembrolizumab, in patients with completely resected stage IIB-IV melanoma.
Presented during a Presidential Symposium at the European Society for Medical Oncology (ESMO) Congress 2026, these findings offer important insights into the potential of individualized cancer treatment.
Read more: www.modernatx.com/recapping-the-phase-three-interpath-res… -
Moderna
@moderna_tx
Today we announced detailed positive results from the Phase 3 INTerpath-001 study evaluating intismeran autogene (mRNA-4157 or V940), an investigational mRNA-based individualized neoantigen therapy, in combination with KEYTRUDA® (pembrolizumab), @Merck's anti-PD-1 therapy, in patients with high-risk melanoma (stage IIB-IV) following complete resection.
These late-breaking results will be presented during a Presidential Symposium at the 2026 European Society for Medical Oncology (@myESMO) Congress.
Read more: feeds.issuerdirect.com/news-release.html?newsid=827762088… -
Moderna
@moderna_tx
Today, we announced the addition of a Chief Operating Officer role to support the growing scale and diversification of our company.
Juan Andres will return to Moderna as Chief Operating Officer, effective October 5, 2026. In this role, he will help drive focus, prioritization and execution across the Company while leading our manufacturing organization. Juan previously spent nearly six years at Moderna, serving in several leadership roles before retiring from the Company in 2023.
Jerh Collins, Ph.D., Chief Technical Operations and Quality Officer, has decided to retire from Moderna. Since joining in 2022, Jerh has helped evolve our manufacturing footprint for an endemic vaccine market, advance our capabilities in the UK, Canada and Australia, and establish the manufacturing model to support intismeran autogene, our investigational individualized neoantigen therapy.
We’re pleased to welcome Juan back to Moderna and grateful to Jerh for his leadership and contributions.
feeds.issuerdirect.com/news-release.html?newsid=779701875… -
Moderna
@moderna_tx
Today we announced that three abstracts on intismeran autogene, our investigational mRNA-based individualized neoantigen therapy, have been accepted for presentation at the European Society for Medical Oncology (@myESMO) Congress 2026, which will be held October 23–27 in Madrid, Spain.
Read more: feeds.issuerdirect.com/news-release.html?newsid=692094433…
#esmo26 -
Moderna
@moderna_tx
Read our latest press release: feeds.issuerdirect.com/news-release.html?newsid=884066742…
-
Moderna
@moderna_tx
Today we announced that the U.S. Food and Drug Administration has approved the supplemental Biologics License Applications for the 2026-2027 formulas for Spikevax® (COVID-19 Vaccine, mRNA) and mNEXSPIKE® (COVID-19 Vaccine, mRNA), containing the JN.1-lineage XFG subvariant of SARS-CoV-2 to help prevent COVID-19.
Read more: feeds.issuerdirect.com/news-release.html?newsid=539165846… -
Moderna
@moderna_tx
Read our latest press release: www.accessnewswire.com/newsroom/en/healthcare-and-pharmac…
-
Moderna
@moderna_tx
Along with our partners at @Merck, we announced positive results from the Phase 3 INTerpath-001 study of intismeran autogene, our investigational individualized neoantigen therapy, in combination with pembrolizumab as adjuvant treatment in patients with completely resected Stage IIB-IV melanoma. This marks the first and only combination regimen to demonstrate a clinically meaningful improvement over pembrolizumab alone, a current standard-of-care for these patients.
In our latest IR Insights, members of our executive team sat down to reflect on what this means: www.modernatx.com/ir-insights-phase-3-intesmeran -
Moderna
@moderna_tx
Moderna and @Merck today announced positive topline results from the Phase 3 INTerpath-001 trial evaluating adjuvant treatment with intismeran autogene, a novel investigational mRNA-based individualized neoantigen therapy jointly developed by Merck and Moderna, in combination with KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in patients with completely resected Stage IIB-IV melanoma.
Read more: -
Moderna
@moderna_tx
Today we announced that the U.S. Food and Drug Administration has approved mFLUSIVA® (mRNA-1010), a new vaccine against seasonal influenza, for use in all adults 50 years and older.
This approval follows unanimous recommendations from the FDA's Vaccines and Related Biological Products Advisory Committee supporting mFLUSIVA for adults 50 years of age and older.
Read more: feeds.issuerdirect.com/news-release.html?newsid=480191528… -
Moderna
@moderna_tx
Today we announced that following Health Canada’s authorization of the study, the first participants have been vaccinated in a Phase 1 clinical study in Canada evaluating mRNA-1469, our investigational mRNA vaccine being evaluated to prevent Bundibugyo ebolavirus disease.
Read more: feeds.issuerdirect.com/news-release.html?newsid=553132810… -
Moderna
@moderna_tx
Today we reported financial results and provided business updates for the second quarter of 2026.
Read more: feeds.issuerdirect.com/news-release.html?newsid=704402706… -
Moderna
@moderna_tx
Today we announced the dosing of the first U.S. participant in our Phase 1 study evaluating mRNA-4200, a tumor-targeted cancer antigen therapy candidate, in patients with advanced or metastatic solid tumors.
Read more: feeds.issuerdirect.com/news-release.html?newsid=601459687… -
Moderna
@moderna_tx
At Moderna, our Mission is to deliver the greatest possible impact to people through mRNA medicines. In pursuit of this, we remain focused on advancing our science, supporting our people, and delivering for patients, communities, and the environment.
Our latest Impacting Human Health Report reflects how we are continuing to turn scientific progress into meaningful impact while helping shape a healthier future for people around the world.
Read the full report: static.modernatx.com/pm/6cef78f8-8dad-4fc9-83d5-d2fbb7cff… -
Moderna
@moderna_tx
Today we announced the appointment of Michael McDonnell to our Board of Directors, effective July 8, 2026. Mr. McDonnell will also serve on the Board's Audit Committee.
Read more: feeds.issuerdirect.com/news-release.html?newsid=842958494… -
Moderna
@moderna_tx
Happy Fourth of July! 🇺🇸
-
Moderna
@moderna_tx
Yesterday, Moderna announced research and early development updates at our Science Day event.
Members of our executive team sat down to provide more insight into our strategy that balances near-term growth with long-term innovation. Watch our latest IR Insights video to learn more: www.modernatx.com/ir-insights-science-day -
Moderna
@moderna_tx
At our Science Day event, we shared how we're building Moderna for the next decade and beyond.
In his latest blog post, our CEO Stéphane Bancel outlines our three-horizon strategy—executing on today's commercial opportunities while advancing new modalities and investing in science, AI and platform innovation that will help shape the next generation of mRNA medicines.
Read more: www.modernatx.com/science-day -
Moderna
@moderna_tx
Today we announced research and early development updates at our Science Day event.
The updates include information on our strategic plan to become a diversified, multi-modality biotechnology company and balance near-term growth with long-term innovation.
Read more: -
Moderna
@moderna_tx
We recently received authorization from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for our Phase 1/2 clinical study evaluating mRNA-4194, an investigational mRNA-based vaccine for people with Lynch syndrome, an inherited condition that increases the risk of cancer.
David Berman, our Chief Development Officer, sat down for an episode of IR Insights to provide an overview of this innovative program and Moderna’s research in the cancer prevention vaccine space: www.modernatx.com/media-center/all-media/blogs/potential-… -
Moderna
@moderna_tx
Today, along with the University of Oxford, we announced that a Phase 1/2 study of mRNA-4194, our investigational cancer vaccine for Lynch syndrome, has received Medicines and Healthcare products Regulatory Agency (MHRA) authorization in the UK. The trial is part of a scientific collaboration between Moderna and the University of Oxford to advance a novel mRNA approach to cancer prevention.
Read more: feeds.issuerdirect.com/news-release.html?newsid=865250249… -
Moderna
@moderna_tx
Earlier today, Moderna and Merck presented 5-year follow-up data for intismeran autogene in combination with KEYTRUDA® (pembrolizumab) in patients with high-risk melanoma at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting.
Watch our latest IR Insights video below to hear more from our CEO Stéphane Bancel and Chief Development Officer David Berman about these results. www.modernatx.com/recapping-moderna-asco-oral-presentation
#asco2026 #asco26 -
Moderna
@moderna_tx
Today we announced detailed results from a planned five-year follow-up analysis of the Phase 2b randomized KEYNOTE-942/mRNA-4157-P201 study evaluating intismeran autogene (mRNA-4157 or V940), an investigational mRNA-based individualized neoantigen therapy, in combination with KEYTRUDA® (pembrolizumab), @Merck's anti-PD-1 therapy, in patients with high-risk melanoma (stage III/IV) following complete resection.
These data will be presented today at the 2026 American Society of Clinical Oncology (@ASCO) Annual Meeting (May 29-June 2) and published simultaneously in ASCO’s Journal of Clinical Oncology.
Read more: feeds.issuerdirect.com/news-release.html?newsid=895770254… -
Moderna
@moderna_tx
Today we announced an expanded collaboration with @CEPIvaccines (Coalition for Epidemic Preparedness Innovations) to advance the development of a potential vaccine against Bundibugyo ebolavirus, a cause of Ebola virus disease for which there are currently no licensed vaccines indicated.
Read more: feeds.issuerdirect.com/news-release.html?newsid=493480886… -
Moderna
@moderna_tx
Early detection matters when it comes to melanoma. The American Academy of Dermatology recommends regularly checking your skin — including areas that are easy to miss, like your scalp, back, palms, soles, and between your toes.
If you notice a mole or spot that looks different, changes, itches or bleeds, make an appointment with a board-certified dermatologist. Regular skin checks, sun protection, and avoiding tanning beds can all help support skin health. #melanomaawarenessmonth -
Moderna
@moderna_tx
Melanoma outcomes can improve significantly when the disease is identified in its earliest stages, with a 95% 5-year survival rate when caught early. Knowing your skin and paying attention to changes like new or evolving moles, spots, or bumps is important.
Regular skin self-checks, annual dermatology visits, sun protection, and avoiding tanning beds can all help reduce risk and support earlier identification of melanoma, when it may be easier to treat.
#melanomaawarenessmonth -
Moderna
@moderna_tx
We’re proud to be named #1 on @TIME's list of the World’s Most Impactful Companies.
Moderna was built on the belief that mRNA could change medicine—and that belief continues to drive us forward. Today, our pipeline spans infectious diseases, oncology and rare diseases, with continued research and innovation shaping what comes next.
As we continue to advance what's possible with mRNA, we remain focused on turning breakthrough science into real-world impact for patients, and delivering for people and communities around the globe.
Read more: feeds.issuerdirect.com/news-release.html?newsid=869861879… -
Moderna
@moderna_tx
Results were published in Clinical Infectious Diseases from a Phase 1/2 randomized, observer-blind study of our mRNA-1018 pandemic influenza vaccine candidates targeting H5 and H7 viruses, supporting continued development of mRNA-based pandemic influenza vaccines for preparedness.
academic.oup.com/cid/advance-article/doi/10.1093/cid/ciag… -
Moderna
@moderna_tx
Today we announced a publication in the New England Journal of Medicine (@NEJM) of the positive Phase 3 study results evaluating mRNA-1010, our vaccine candidate for seasonal influenza.
The peer-reviewed article summarizes the safety and efficacy data from our Phase 3 study (P304) evaluating the relative vaccine efficacy of mRNA-1010 against influenza illness compared to a licensed standard-dose seasonal influenza vaccine in adults aged 50 years and older.
Read more: feeds.issuerdirect.com/news-release.html?newsid=594241352… -
Moderna
@moderna_tx
Today, we reported financial results and provided business updates for the first quarter of 2026.
Read more: feeds.issuerdirect.com/news-release.html?newsid=745366252… -
Moderna
@moderna_tx
Today we announced that the first participants in the U.S. and UK have been dosed in a Phase 3 study of our investigational mRNA-based H5 pandemic influenza vaccine candidate, mRNA-1018. In December 2025, @CEPIvaccines and Moderna announced that CEPI will invest up to $54.3 million to help advance mRNA-1018 to licensure.
Read more: feeds.issuerdirect.com/news-release.html?newsid=775089864… -
Moderna
@moderna_tx
Today we announced that three abstracts on our investigational mRNA therapeutics have been accepted for presentation at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, which will be held May 29 – June 2 in Chicago, IL.
Read more about the presentation details: feeds.issuerdirect.com/news-release.html?newsid=786803891… -
Moderna
@moderna_tx
Today we announced that the European Commission (EC) has granted marketing authorization for mCOMBRIAX® (mRNA-1083), our mRNA combination vaccine for active immunization for the prevention of influenza disease and COVID-19 caused by SARS-CoV-2 in individuals 50 years of age and older.
Read more: feeds.issuerdirect.com/news-release.html?newsid=603757086… -
Moderna
@moderna_tx
Earlier today, we presented data from a Phase 1/2 study of mRNA-4359, an investigational cancer antigen therapy, at the American Association for Cancer Research (AACR) Annual Meeting in San Diego, CA, held from April 17-22, 2026.
Watch our latest IR Insights video with Dr. David Berman, Moderna’s new Chief Development Officer, to learn more about the presentation and Dr. Berman’s journey to Moderna. Watch here: www.modernatx.com/en-US/irinsights-recapping-moderna-mrna… -
Moderna
@moderna_tx
We announced today that we will present data from a Phase 1/2 study of mRNA-4359, an investigational cancer antigen therapy, at the American Association for Cancer Research (AACR) Annual Meeting in San Diego, CA, on April 17-22, 2026. The U.S. FDA has granted Fast Track designation for mRNA-4359 in combination with pembrolizumab for the treatment of checkpoint inhibitor refractory unresectable or metastatic melanoma with PD-L1+ (TPS≥1%).
Read more: feeds.issuerdirect.com/news-release.html?newsid=805407966… -
Moderna
@moderna_tx
We announced today that we will present late-breaking oral presentations on revaccination data for both mRNA-1010, our investigational seasonal influenza vaccine, and for mRESVIA® (mRNA-1345), our mRNA respiratory syncytial virus (RSV) vaccine, at the 2026 European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global Congress in Munich, Germany, on April 17-21, 2026.
Learn more: feeds.issuerdirect.com/news-release.html?newsid=676796879…
#escmidglobal2026 -
Moderna
@moderna_tx
Today we announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending marketing authorization in the European Union for mCOMBRIAX® (mRNA-1083), Moderna’s combination vaccine indicated for active immunization for the prevention of influenza and COVID-19 caused by SARS-CoV-2 in individuals 50 years of age and older.
Read more: feeds.issuerdirect.com/news-release.html?newsid=824575289…. -
Moderna
@moderna_tx
Today we announced that, in response to a prior Refusal-to-File letter, we engaged with the U.S. Food and Drug Administration (FDA) in a Type A meeting and proposed a revised regulatory approach for our investigational seasonal influenza vaccine candidate, mRNA-1010.
Read more: -
Moderna
@moderna_tx
Today we announced that the European Commission has granted marketing authorization for mNEXSPIKE® (mRNA-1283), a new COVID vaccine, for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals aged 12 years and older.
Read more: feeds.issuerdirect.com/news-release.html?newsid=820184517… -
Moderna
@moderna_tx
Today, we reported financial results and provided business updates for the fourth quarter of 2025.
Read more: feeds.issuerdirect.com/news-release.html?newsid=475759192… -
Moderna
@moderna_tx
Today we announced that the U.S. Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research (CBER) has notified Moderna that it will not initiate a review of the biologics license application (BLA) for our investigational influenza vaccine, mRNA-1010, and has issued a Refusal-to-File letter.
Read more: feeds.issuerdirect.com/news-release.html?newsid=734609061… -
Moderna
@moderna_tx
Today we announced that we have signed a Memorandum of Understanding for a long-term strategic agreement with the Mexican Government, Laboratorios de Biológicos y Reactivos de Mexico, and Laboratorios Liomont, to enhance Mexico’s health sovereignty and mRNA manufacturing resilience.
Learn more: feeds.issuerdirect.com/news-release.html?newsid=480639430… -
Moderna
@moderna_tx
Earlier today, we announced a strategic collaboration with Recordati to advance our investigational propionic acidemia (PA) therapy, mRNA-3927, through the final stages of clinical development and, upon approval, global commercialization.
Stéphane Bancel, CEO, sat down for an episode of IR Insights to give an overview of the partnership. Watch the episode here: www.modernatx.com/en-US/media-center/all-media/blogs/reco… -
Moderna
@moderna_tx
Today we announced a strategic collaboration with Recordati to advance our investigational propionic acidemia therapeutic, mRNA-3927, through the final stages of clinical development and, upon approval, global commercialization. Through this agreement, Moderna will continue to lead the clinical development of mRNA-3927 through approval and Recordati will lead commercialization.
Read more: feeds.issuerdirect.com/news-release.html?newsid=836194605… -
Moderna
@moderna_tx
Moderna and @Merck announced today median five-year follow-up data from the Phase 2b KEYNOTE-942/mRNA-4157-P201 study, evaluating intismeran autogene (mRNA-4157 or V940), an investigational mRNA-based individualized neoantigen therapy (INT), in combination with KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in patients with high-risk melanoma (stage III/IV) following complete resection.
Read more: feeds.issuerdirect.com/news-release.html?newsid=758554722… -
Moderna
@moderna_tx
This week, Moderna presented business and pipeline updates at the 44th Annual J.P. Morgan Healthcare Conference. Stéphane Bancel, CEO, and Jamey Mock, CFO, sat down for an episode of IR Insights to give an overview of key highlights from the presentation.
Watch the episode here: www.modernatx.com/en-US/media-center/all-media/blogs/upda…
#jpm2026 #jpm26 -
Moderna
@moderna_tx
Today we announced business updates and progress across our pipeline of mRNA medicines. Read more about the updates that will be provided during our presentation at the 44th Annual J.P. Morgan Healthcare Conference: feeds.issuerdirect.com/news-release.html?newsid=719359286…
#jpm2026 #jpm26 -
Moderna
@moderna_tx
Guided by our Mission to deliver the greatest possible impact to people through mRNA medicines, Moderna remained focused in 2025 on operational execution, scientific progress and disciplined financial management—navigating a difficult environment while strengthening our foundation for long-term growth.
With three approved commercial products, continued pipeline momentum across infectious diseases, oncology and rare diseases, an extraordinary team and a global manufacturing network, we are entering 2026 positioned to deliver the next era of growth and innovation in mRNA medicines.
Read more in our CEO Stéphane Bancel’s annual letter to shareholders: www.modernatx.com/media-center/all-media/blogs/moderna-20… -
Moderna
@moderna_tx
Today we provided an update on regulatory submissions for our investigational seasonal influenza vaccine, mRNA-1010, for adults aged 50 years and older. Moderna has filed for marketing authorization with the U.S. Food and Drug Administration, the European Medicines Agency, Health Canada, and the Therapeutic Goods Administration in Australia.
Read more: feeds.issuerdirect.com/news-release.html?newsid=658331284… -
Moderna
@moderna_tx
Today we announced that the @CEPIvaccines (Coalition for Epidemic Preparedness Innovations) will invest up to $54.3 million to support a pivotal Phase 3 clinical trial that aims to help advance our investigational mRNA-based H5 pandemic influenza vaccine candidate, mRNA-1018, to licensure.
Read more: feeds.issuerdirect.com/news-release.html?newsid=613029763… -
Moderna
@moderna_tx
Today we announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending marketing authorization of mNEXSPIKE® (mRNA-1283), a new COVID vaccine, for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals aged 12 years and older.
Following the CHMP's positive opinion, the European Commission will make a marketing authorization decision. Read more: feeds.issuerdirect.com/news-release.html?newsid=554567696… -
Moderna
@moderna_tx
In a study using data from the French National Health Data System, including 22.7 million vaccinated individuals and 5.9 million unvaccinated individuals aged 18-59 years, vaccinated individuals had a 74% lower risk of death from severe COVID-19 and no increased risk of all-cause mortality over a median follow-up of 45 months. Read the study: jamanetwork.com/journals/jamanetworkopen/fullarticle/2842305
-
Moderna
@moderna_tx
November is Lung Cancer Awareness Month — a moment to recognize the strength of those living with the disease and the urgent need for continued innovation in research.
For Keith Perry, a dedicated triathlete, a lung cancer diagnosis changed everything. Losing his left lung could have ended his active life but instead, it became the start of a new chapter defined by determination and hope.
🎥 Watch Keith’s full story: www.modernatx.com/en-US/media-center/all-media/blogs/lung…This media couldn't be displayed. See it on the original post. -
Moderna
@moderna_tx
Earlier today, we hosted our Analyst Day, which included presentations from management discussing our development and commercial strategy and key business considerations.
Members of our executive team sat down to provide a recap of the updates shared. Watch our latest IR Insights video to hear more: www.modernatx.com/media-center/all-media/blogs/analyst-da… -
Moderna
@moderna_tx
Today we announced program and financial updates at our Analyst Day event. The updates include mRNA pipeline progress and a three-year plan for strategic growth.
Read more: feeds.issuerdirect.com/news-release.html?newsid=575834570… -
Moderna
@moderna_tx
Today we announced the expansion of our U.S. manufacturing capabilities with the onshoring of Drug Product manufacturing to our existing Moderna Technology Center in Norwood, Massachusetts. Through this strategic onshoring, Moderna will now operate full end-to-end manufacturing for our mRNA medicines in the U.S.
Read more: feeds.issuerdirect.com/news-release.html?newsid=547788026… -
Moderna
@moderna_tx
Earlier today, Moderna reported financial results and provided business updates for the third quarter of 2025. Members of our executive team sat down to provide more insight into our financial performance and upcoming late-stage pipeline milestones.
Watch now: -
Moderna
@moderna_tx
Today, we reported financial results and provided business updates for the third quarter of 2025.
Read more: feeds.issuerdirect.com/news-release.html?newsid=494943064… -
Moderna
@moderna_tx
We are proud to be recognized on @biospace's Best Places to Work list of large employers for the fifth-year running! 🎉
This list highlights sought-after employers in life sciences based on community votes and ratings, with a focus on culture, career growth and development opportunities, leadership and innovation.
Learn more: www.biospace.com/best-places-to-work -
Moderna
@moderna_tx
Today we announced that the first patient has been dosed in a Phase 1/2 study of mRNA-2808, our investigational mRNA-based T-cell engager for participants with relapsed or refractory multiple myeloma (RRMM).
Read more: feeds.issuerdirect.com/news-release.html?newsid=869774820… -
Moderna
@moderna_tx
We’re proud to be named a @ScienceCareers Top Employer for the 11th consecutive year! 🏆
This recognition reflects our incredible teams across the globe who turn bold ideas into real-world impact—those who push the boundaries of what’s possible with mRNA science, technology and innovation. Thank you for the curiosity, passion and commitment you bring every day.
Learn more: feeds.issuerdirect.com/news-release.html?newsid=796168940…
#sctopemployers #bestworkplaces #sciencecareers #biopharmacareers -
Moderna
@moderna_tx
Today we announced data regarding two of our investigational influenza candidates will be presented at IDWeek 2025, October 19-22, 2025, in Atlanta, GA.
Read more: feeds.issuerdirect.com/news-release.html?newsid=840045114… -
Moderna
@moderna_tx
Today we announced that clinical, safety and translational data from our Phase 1/2 study evaluating mRNA-4359 in combination with pembrolizumab in checkpoint inhibitor-resistant/refractory (CPI-R/R) melanoma patients will be presented at the 2025 European Society for Medical Oncology (ESMO) Congress, October 17-21, 2025, in Berlin, Germany.
Read more: feeds.issuerdirect.com/news-release.html?newsid=582394335… -
Moderna
@moderna_tx
Today we announced that the Moderna Innovation and Technology Centre (MITC) at the Harwell Science and Innovation Campus in Oxfordshire, UK has officially opened. The MITC will now produce British-made mRNA respiratory vaccines for the UK public to support the National Health Service seasonal vaccination programs.
Learn more: feeds.issuerdirect.com/news-release.html?newsid=735052666… -
Moderna
@moderna_tx
Today we announced positive preliminary immunogenicity data for the 2025-2026 formula of mNEXSPIKE® (COVID-19 Vaccine, mRNA), which targets the LP.8.1 variant of SARS-CoV-2 to help prevent COVID-19. Learn more: feeds.issuerdirect.com/news-release.html?newsid=612597182….
-
Moderna
@moderna_tx
Today we announced that the first mRNA vaccines fully manufactured in Canada are being shipped to Canadian provinces and territories. This milestone advances Canada’s domestic vaccine production capacity and strengthens national health security. Read more: feeds.issuerdirect.com/news-release.html?newsid=775629382….
-
Moderna
@moderna_tx
Today we announced positive preliminary immunogenicity data for the 2025-2026 formula of Spikevax®, which targets the LP.8.1 variant of SARS-CoV-2 to help prevent COVID-19. Learn more: feeds.issuerdirect.com/news-release.html?newsid=451922399….
-
Moderna
@moderna_tx
We are immensely proud of the role we played in the historic achievements of Operation Warp Speed. COVID-19 vaccines helped end the pandemic, re-open economies and save millions of lives. mRNA, the same technology that helped turn the tide of a global pandemic, is now paving the way for breakthroughs in cancer, autoimmune and rare diseases.
To help ensure Americans have clear and accessible information, we will be compiling previously disclosed information here: investors.modernatx.com/moderna-recognizes-the-success-of… -
Moderna
@moderna_tx
Today we announced that five abstracts on our investigational mRNA therapeutics for rare diseases have been accepted for presentation at the 2025 International Congress of Inborn Errors of Metabolism (ICIEM), which will be held September 2-6, 2025, in Kyoto, Japan.
Read more: -
Moderna
@moderna_tx
👋💉 This week, Moderna employees hand-delivered the first shipment of our COVID-19 vaccines to a local pharmacy. We’re grateful to the pharmacies, healthcare professionals and partners who make vaccination possible in our communities.
-
Moderna
@moderna_tx
Today we announced that the U.S. FDA has approved the supplemental Biologics License Applications for the 2025-2026 formulas for Spikevax® and mNEXSPIKE®, targeting the LP.8.1 variant of SARS-CoV-2 to help prevent COVID-19.
Read more: feeds.issuerdirect.com/news-release.html?newsid=672924976… -
Moderna
@moderna_tx
Today we announced that Health Canada has authorized our updated COVID-19 mRNA vaccine, Spikevax®, targeting the SARS-CoV-2 LP.8.1 variant, for individuals aged six months and older. We are on track to deliver the updated vaccine in time for the 2025-2026 vaccination season.
Read more: feeds.issuerdirect.com/news-release.html?newsid=595182447… -
Moderna
@moderna_tx
Earlier today, Moderna reported financial results and provided business updates for the second quarter of 2025. Members of our executive team sat down to provide more insight into our financial performance and upcoming late-stage pipeline milestones.
Watch now: -
Moderna
@moderna_tx
Today, we reported financial results and provided business updates for the second quarter of 2025.
Read more: feeds.issuerdirect.com/news-release.html?newsid=467262580… -
Moderna
@moderna_tx
Today we announced that the UK Court of Appeal has upheld the validity of our EP’949 patent.
Read more: feeds.issuerdirect.com/news-release.html?newsid=747027435… -
Moderna
@moderna_tx
Today we announced that the European Commission has granted marketing authorization for the updated formulation of our COVID-19 vaccine Spikevax®, targeting the SARS-CoV-2 variant LP.8.1, for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals six months of age and older.
This marketing authorization follows the Positive Opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use.
Read more: feeds.issuerdirect.com/news-release.html?newsid=461970196… -
Moderna
@moderna_tx
Today we announced that three abstracts on our investigational mRNA therapeutics have been accepted for presentation at the 2025 European Society for Medical Oncology (ESMO) Congress, which will be held October 17-21, 2025, in Berlin, Germany.
Read more: feeds.issuerdirect.com/news-release.html?newsid=870193602… -
Moderna
@moderna_tx
Today we announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion recommending marketing authorization for an updated formulation of the COVID-19 vaccine Spikevax®, targeting the SARS-CoV-2 variant LP.8.1, for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals six months of age and older.
Read more: feeds.issuerdirect.com/news-release.html?newsid=790402382… -
Moderna
@moderna_tx
For Jagjit Ludu, joining Moderna meant the chance to think differently and connect science to people in new ways. From launching clinician-focused docu-series to building AI-powered tools for bite-sized learning, he’s reshaping how Medical Affairs engages and informs.
💡 “Being a changemaker means hearing ‘no’ and persisting,” Jagjit shares. His work is proof that creativity and science can move together—and make an impact.
Read more about Jagjit’s journey: www.modernatx.com/media-center/all-media/blogs/navigating… -
Moderna
@moderna_tx
We are proud to share the results of our mRNA-1283 Phase 3 trial in @TheLancetInfDis.
Read more: www.thelancet.com/journals/laninf/article/PIIS1473-3099(2… -
Moderna
@moderna_tx
Today we announced that the U.S. Food and Drug Administration has approved the supplemental Biologics License Application for Spikevax®, our COVID-19 vaccine, in children 6 months through 11 years of age who are at increased risk for COVID-19 disease. Our COVID-19 vaccine, mRNA-1273, was previously available for pediatric populations under Emergency Use Authorization.
Read more: investors.modernatx.com/news/news-details/2025/Moderna-Re… -
Moderna
@moderna_tx
Today we announced positive results from a Phase 3 efficacy study evaluating the relative vaccine efficacy against influenza illness of mRNA-1010, our seasonal influenza vaccine candidate, compared to a licensed standard-dose seasonal influenza vaccine in adults aged 50 years and older.
Read more: news.modernatx.com/news/news-details/2025/Moderna-Announc… -
Moderna
@moderna_tx
We announced today that the U.S. FDA has approved mRESVIA®, our respiratory syncytial virus (RSV) vaccine, for the prevention of lower respiratory tract disease caused by RSV in individuals 18–59 years of age who are at increased risk for disease. This approval expands the previous indication of mRESVIA, which was approved in May 2024 for adults aged 60 years and older.
Read more: investors.modernatx.com/news/news-details/2025/Moderna-Re… -
Moderna
@moderna_tx
mNEXSPIKE® (COVID-19 vaccine, mRNA) is now approved in the U.S., marking our third approved product. We are proud of our platform’s continued impact, and our relentless commitment to excellence.
Read more from our CEO Stéphane Bancel about this approval, and what’s next: -
Moderna
@moderna_tx
We announced today that the U.S. FDA has approved mNEXSPIKE®, a new vaccine against COVID-19, for use in all adults 65 and older, as well as individuals aged 12 years through 64 years of age with at least one underlying condition that puts them at high risk for severe outcomes from COVID-19.
Learn more: investors.modernatx.com/news/news-details/2025/Moderna-Re… -
Moderna
@moderna_tx
Today we announced an update on our investigational pandemic influenza program. Learn more: feeds.issuerdirect.com/news-release.html?newsid=569697948….
-
Moderna
@moderna_tx
Today we announced that we have submitted an application to the U.S. Food and Drug Administration for review of our Spikevax 2025-2026 formula, a COVID-19 vaccine targeting the SARS-CoV-2 variant LP.8.1. Read more: feeds.issuerdirect.com/news-release.html?newsid=857700893….
-
Moderna
@moderna_tx
Today we announced an update on our BLA submission for our combination vaccine against influenza and COVID-19. Read more: investors.modernatx.com/news/news-details/2025/Moderna-Pr…
-
Moderna
@moderna_tx
Today, on #clinicaltrialsday, we pause to thank the people who make progress in medicine possible.
To the participants who lend their time, trust and courage.
To the researchers who push the boundaries of science.
To the coordinators, nurses and support staff who keep it all running.
Your contributions help turn scientific discovery into real-world impact for patients.
Thank you for everything you do. -
Moderna
@moderna_tx
Earlier today, we reported financial results and provided business updates for the first quarter of 2025.
For the latest episode of our #irinsights series, members of our executive team sat down to provide more insight into our financial performance and upcoming late-stage pipeline milestones.
Watch the full video here: www.modernatx.com/en-US/media-center/all-media/blogs/firs… -
Moderna
@moderna_tx
Today, we reported financial results and provided business updates for the first quarter of 2025.
Read more: investors.modernatx.com/news/news-details/2025/Moderna-Re… -
Moderna
@moderna_tx
At Moderna, we recognize that human and planetary health are interconnected—and that we have a responsibility to grow in a way that protects the planet and minimizes our environmental impact.
To celebrate Earth Day, colleagues from our Cambridge, Massachusetts, office rolled up their sleeves to clean and care for the tree wells in the neighborhood surrounding our headquarters, contributing to a healthier environment in the community we call home.
This is just one way we’re putting our values into action. We recently achieved validation of our near-term and net-zero science-based targets by the Science Based Targets initiative (SBTi)—a major milestone in our journey to reach net-zero greenhouse gas emissions across our value chain by 2045.
Learn more about how we’re building a more sustainable future: www.modernatx.com/media-center/all-media/blogs/moderna-sb… -
Moderna
@moderna_tx
We announced today that Moderna will deliver twelve scientific presentations at the ESCMID Global Congress in Vienna, Austria, April 11–15, 2025.
This includes three oral presentations, one e-poster presentation, and eight poster presentations, highlighting the breadth of our research in respiratory and emerging infectious diseases. #escmidglobal2025
Learn more: investors.modernatx.com/news/news-details/2025/Moderna-to… -
Moderna
@moderna_tx
Have you ever wondered what happens when you're infected with a virus like the #flu, or SARS-CoV-2? How does it multiply and spread in your body?
Watch this video to learn how your own cellular machinery fuels the spread of viruses.
You can also head to Module 1 on our free 'mRNAs as Medicines' Coursera course to find out more about how viruses spread: www.coursera.org/learn/mrnas-as-medicines -
Moderna
@moderna_tx
We announced today that the Australian Therapeutic Goods Administration has granted approval for mRESVIA® (mRNA-1345), an mRNA respiratory syncytial virus (RSV) vaccine, to prevent lower respiratory tract disease caused by RSV infection in adults aged 60 years and older.
Read more: investors.modernatx.com/news/news-details/2025/Moderna-Re… -
Moderna
@moderna_tx
For Monika Kowalska, joining Moderna meant the chance to build something new and make an impact. From ensuring the accuracy of safety data to shaping a growing team, she’s driven by the opportunity to improve how things work.
💡 “Being a changemaker means seeing gaps, asking ‘why,’ reflecting, and figuring out how to make things better,” Monika shares.
Read more about Monika’s journey: www.modernatx.com/media-center/all-media/blogs/monika-bui… -
Moderna
@moderna_tx
This Women’s History Month, our Women’s ERG, WISDM, hosted a career panel featuring senior leaders in our research organization, including Rose Loughlin, EVP, Research, to discuss perseverance, discovery and success from the bench to the office.
WISDM plays a key role in fostering career development and leadership opportunities for women at Moderna, creating spaces for learning, connection and growth.
Join us in celebrating the women shaping the future of science and beyond. #womenshistorymonth #womeninstem -
Moderna
@moderna_tx
In 2024, we navigated a rapidly evolving healthcare ecosystem while making significant progress across our pipeline. With two approved mRNA medicines, a deep late-stage portfolio and cutting-edge digital innovations, we remain focused on delivering impact for patients. Through it all, our people—driven by a shared commitment to science and to each other—continued to push the boundaries of what’s possible.
Read our 2024 Annual Report to learn more: investors.modernatx.com/financials/annual-reports/default… -
Moderna
@moderna_tx
At #sxsw, an important conversation took the stage: how can companies, brands and the medical community bridge the growing communication gap between science and the public? In a world of information overload, making facts clear, engaging and trustworthy is more important than ever.
Catch the panel replay and read more here: www.modernatx.com/en-US/media-center/all-media/blogs/brid…
#sxsw2025 -
Moderna
@moderna_tx
We announced today that the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK has granted authorization for our respiratory syncytial virus (RSV) vaccine indicated for active immunization for the prevention of lower respiratory tract disease (LRTD) caused by RSV in adults 60 years of age and older.
Read more: investors.modernatx.com/news/news-details/2025/Moderna-Re…. -
Moderna
@moderna_tx
For Michelle Patel, joining Moderna was about taking the next step in her #career and finding the right place to drive meaningful change in medicine. It takes urgency, focus and the right team to transform #innovation into life-changing treatments.
💡 “I wanted to be at the precipice of changing the way we think about treating cancers, rare diseases and beyond,” Michelle shares.
Read more about Michelle’s role and the mission that is clear to her at Moderna: advance science, embrace risk and push medicine forward for patients who need it most: www.modernatx.com/media-center/all-media/blogs/why-michel…. -
Moderna
@moderna_tx
Viruses are not technically alive. Sounds surreal, right?
But how do they manage to replicate and spread despite lacking the machinery to survive on their own? See how it all works in this video, where we uncover the fascinating strategies viruses use to thrive.
For a deeper look, head to Module 1 on our free mRNAs as Medicines Coursera course to learn more about viruses: www.modernatx.com/en-US/power-of-mrna/science-of-mrna
#mrna101 #mrnascience #microlearning #innovationinmedicine #sciencesimplified #futureofhealthcare -
Moderna
@moderna_tx
🚀 Welcome, 1st Half 2025 Co-op Cohort! 🚀
We’re excited to welcome 60 talented students from 38 universities into our Co-op Program! Over the next five months, they will gain hands-on experience and contribute to impactful projects across Moderna.
Their journey kicked off with insightful speaker sessions covering our commitment to health equity, the science behind our platform and the impact of our Employee Resource Groups. We can’t wait to see the energy, ideas and innovation they bring!🎉 #modernacoop #earlycareer #campusrecruiting -
Moderna
@moderna_tx
Staying informed about the latest #covid19 vaccine recommendations is crucial for protecting yourself, especially if you're an older adult or have a weakened immune system. The CDC recommends that everyone 65 years and older, along with those who are moderately or severely immunocompromised, receive a second dose of the updated 2024-2025 COVID-19 vaccine six months after your first. Read more from Francesca Ceddia our Chief Medical Affairs Officer on the importance of this second dose: www.modernatx.com/en-US/media-center/all-media/blogs/seco…
-
Moderna
@moderna_tx
Earlier today, we reported financial results and provided business updates for the fourth quarter and fiscal year 2024.
Members of our executive team sat down in latest episode of our #irinsights series to provide more insight into our financial performance and upcoming late-stage pipeline milestones. www.modernatx.com/media-center/all-media/blogs/fiscal-yea… -
Moderna
@moderna_tx
Today, we reported financial results and provided business updates for the fourth quarter and fiscal year 2024.
Read more: investors.modernatx.com/news/news-details/2025/Moderna-Re… -
Moderna
@moderna_tx
Introducing mRNAs as Medicines, a micro-learning video series that explores the fascinating world of #mrna science—how it works, why it’s groundbreaking and how it has the potential to shape a new era of medicine.
Think of it as your backstage pass to understanding everything from protein science to vaccine innovations. For a deeper look, head to our free Coursera course or keep an eye out for the next episode in our series. Learn more: www.modernatx.com/en-US/power-of-mrna/science-of-mrna
#mrna101 #mrnascience #microlearning #innovationinmedicine #sciencesimplified #futureofhealthcare -
Moderna
@moderna_tx
This #blackhistorymonth, we sat down with Jameka Hill, our Head of Clinical Trial Health Equity, to discuss why #inclusivity in research is a scientific imperative. From breaking barriers to building trust, Jameka shares how Moderna is working to help ensure that the medicines of tomorrow reflect the broader population today. Read the full Q&A here: www.modernatx.com/media-center/all-media/blogs/q-a-with-j…
-
Moderna
@moderna_tx
Today, on #internationaldayofwomenandgirlsinscience, we’re proud to highlight the incredible work of Joanna Prieto, founder of @GeekGirlsLatam, a nonprofit dedicated to empowering women and girls in Latin America to thrive in STEM.
Through our partnership with @Ashoka, the Moderna Charitable Foundation is supporting visionary leaders like Joanna, who are breaking barriers, fostering innovation and ensuring more young women have the opportunity to lead in science and technology.
In a conversation with Clara Fernandez de Castro, our Sr. Director of ESG Strategy , Joanna shared her inspiring journey—from receiving her first computer at age nine, to pioneering remote learning and building a movement that champions women in #stem.
💡 Read the full interview to learn more: www.modernatx.com/media-center/all-media/blogs/empowering… -
Moderna
@moderna_tx
Rare diseases are often difficult to diagnose and treat, with many causing life-threatening complications and lacking treatment options. Learn more in our mini guide, including how #mrna could potentially treat rare diseases. #rarediseaseday
-
Moderna
@moderna_tx
On the heels of #worldcancerday, we wanted to tell you more about how fighting #cancer could look very different in the future. Each person’s cancer is unique, and we are researching ways to customize treatment to the individual, versus a one-size-fits-all approach. By combining the power of the #mrna platform with technological advances, we hope to develop precise, individualized treatments that empower the body’s immune system to recognize and destroy cancer cells. Learn more ⬇
-
Moderna
@moderna_tx
This #worldcancerday, as we recognize the profound impact of #cancer, this year’s theme #unitedbyunique reminds us that cancer care must be as individualized as the patients it serves.
Hear from our Chief Legal Officer, Shannon Thyme Klinger on what this day means to her and how it calls us to reimagine how we can make a difference, for individuals and for entire communities: www.modernatx.com/en-US/media-center/all-media/blogs/worl… -
Moderna
@moderna_tx
We’re excited to welcome Amy Mahery as our new SVP and Chief Marketing Officer at Moderna!
A seasoned biopharma leader with 20+ years of experience, Amy has led commercial strategies across global portfolios in large pharma and biotech, most recently as Chief Commercial Officer at Roivant Sciences.
We’re thrilled to have her on board as we continue to build for 2025 and beyond. Welcome, Amy! -
Moderna
@moderna_tx
The countdown is on to this year’s #rarediseaseday—just 28 days away! This month, join us in raising awareness for the 300 million people worldwide living with a #raredisease.
Moderna
@moderna_tx
Learn more about rare diseases, the people they impact and how to get involved at rarediseaseday.org. 💜
-
Moderna
@moderna_tx
Our science-based targets have been validated by @sciencetargets (SBTi) , marking a milestone in our journey to #sustainability. Our commitments include:
✅ 90% reduction in Scope 1 & 2 emissions by 2030.
✅ Net-zero across all scopes by 2045.
✅ Engaging 85% of suppliers to set science-based targets by 2028.
We work to integrate sustainability into everything we do—designing energy-efficient sites, conserving natural resources and decarbonizing our value chain. 🌍
Read more from Deb Donovan our SVP of Environment, Health and Safety: www.modernatx.com/en-US/media-center/all-media/blogs/mode… -
Moderna
@moderna_tx
Hear from @MariaTeresa, Co-founder & CEO of @votolatino on how #latino adults are more likely than other racial or ethnic groups to report COVID-19 symptoms lasting three months or longer. However, many Latinos face an uphill battle when seeking treatment, with patients reporting their concerns being dismissed by healthcare providers. Maria and others warn that there’s an urgent need for culturally sensitive care and greater awareness of Long #covid as a disease. Read more: www.modernatx.com/en-US/media-center/all-media/blogs/stro…
-
Moderna
@moderna_tx
Today we announced that @EC_HERA has awarded Moderna a tender for the supply of our #mrna #covid-19 vaccine in the European Union, Norway and North Macedonia. Under the resulting agreement, 17 participating countries can access the vaccine for up to four years. Read more:
-
Moderna
@moderna_tx
As of December 2024, the U.S. has seen a worrying surge in #norovirus outbreaks, with the highest levels reported for this time of year since 2012. In order to understand the burden of Norovirus, and why #mrna technology has the potential to be an important tool for combating it, it’s important to look at how it spreads and evolves. Read more from Dr. Doran Fink our Clinical Therapeutic Area Head for Gastrointestinal and Bacterial Pathogens on the burden and challenges that come with Norovirus: www.modernatx.com/en-US/media-center/all-media/blogs/unde…
-
Moderna
@moderna_tx
“We believe at Moderna that it’s not just technology that drives progress and change, it’s people using technology. We truly believe that everyone at Moderna should be empowered to transform their work and their jobs with the power of AI.”
🎧 Listen to The @coursera Podcast for more from our Chief Learning Officer, Molly Nagler as she shares how curiosity and #innovation fuel learning at Moderna, from #ai-driven training to closing #stem skills gaps: podcasts.apple.com/nz/podcast/building-a-culture-of-curio… -
Moderna
@moderna_tx
Today we announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the development of mRNA-based pandemic influenza vaccines. The award was made through the Rapid Response Partnership Vehicle (RRPV) Consortium with funding from the Biomedical Advanced Research and Development Authority (BARDA), part of the HHS Administration for Strategic Preparedness and Response (ASPR). Read more: investors.modernatx.com/news/news-details/2025/Moderna-An…
-
Moderna
@moderna_tx
Winter brings an increase in respiratory illnesses like #covid19, #rsv and #flu, posing serious risks, especially for older adults and those with weakened immune systems. Vaccination remains the most effective way to reduce severe illness and protect your community. Read more from our Chief Medical Affairs Officer, Francesca Ceddia, on how #vaccination and preventive habits can lead to a healthier winter: www.modernatx.com/en-US/media-center/all-media/blogs/stay…
-
Moderna
@moderna_tx
As we step into 2025, it’s important to be proactive and informed about our health. From preventative measures to healthy habits, taking charge of our physical and mental well-being sets the stage for the year ahead. Our Senior Director of Medical Affairs, Rachel Kennedy, shares four recommendations for #healthyliving: www.modernatx.com/media-center/all-media/blogs/4-ways-to-…
-
Moderna
@moderna_tx
Earlier today, Moderna presented an update on our business and pipeline of #mrna development programs at the 43rd Annual J.P. Morgan Healthcare Conference.
Members of our executive team sat down in the latest episode of #irinsights to give an overview of key highlights from the presentation. Watch the episode: www.modernatx.com/media-center/all-media/blogs/updates-43… -
Moderna
@moderna_tx
Today we announced business updates and progress across our pipeline of #mrna medicines. Read more about the updates that will be provided during our presentation at the 43rd Annual J.P. Morgan Healthcare Conference: news.modernatx.com/news/news-details/2025/Moderna-Provide…
-
Moderna
@moderna_tx
This #nationalpharmacistsday, we recognize the vital role pharmacists play in keeping our communities healthy.
Mitchel Rothholz, Pharmacist and Consultant to the Pharmacy Profession, shares his perspectives on how pharmacists are much more than medication experts—they’re trusted healthcare advocates and integral members of every patient’s care team. From administering vaccines to managing chronic conditions and serving as a first point of care in underserved areas, pharmacists are at the forefront of #publichealth. modernatx.com/en-US/media-center/all-media/blogs/celebrat… -
Moderna
@moderna_tx
We're proud to announce that we've received the Equality 100 Award for earning a top score on @HRC's 2025 Corporate Equality Index.
This recognition highlights our dedication to advancing LGBTQ+ workplace equality through inclusive policies and practices. At Moderna, we celebrate the diversity of our workforce and remain committed to building a culture where everyone feels a true sense of belonging. Learn more at: www.hrc.org/cei -
Moderna
@moderna_tx
Our unwavering commitment to our Mission to deliver the greatest possible impact to people through #mrna medicines has always served as our guiding force. In a relatively short time, we have grown our portfolio to two approved medicines, seven candidates in Phase 3 trials and a total of 45 programs in our development pipeline.
We are confident that with our industry-leading mRNA platform, technology, resources and team, we are well-positioned to execute our strategy and continue building a future where Moderna leads in healthcare innovation, delivering on our Mission for patients in 2025 and beyond.
Read more in our CEO Stéphane Bancel’s annual letter to shareholders: www.modernatx.com/en-US/media-center/all-media/blogs/mode… -
Moderna
@moderna_tx
The magic of every new beginning starts with you! Wishing you a happy and healthy beginning to 2025. Happy New Year!
-
Moderna
@moderna_tx
Wishing you a joyful holiday season from all of us at #teammoderna! May your days be filled with warmth, celebration and time spent with those who matter most. Stay safe, stay well and enjoy this special time of year.
-
Moderna
@moderna_tx
Long COVID is reshaping the workforce—sidelining employees, reducing productivity and driving up healthcare costs. But employers can be part of the solution by encouraging employees to stay protected with updated vaccines, hosting workplace vaccine clinics for added convenience, or creating policies that support employees managing Long COVID.
Read more from Mary Bausch-Jurken, our Director of Global Medical Affairs, Infectious Diseases: www.modernatx.com/media-center/all-media/blogs/Long-COVID… -
Moderna
@moderna_tx
If you had COVID in September or earlier during this year’s summer surge, you should still get an updated vaccine – and now’s the perfect time! The CDC recommends waiting 3 months after symptoms or a positive test before getting your updated #covid19 #vaccine.
Protect yourself and your loved ones – find a vaccine near you: foryouandthem.com -
Moderna
@moderna_tx
We were proud to celebrate the opening of Australia’s first large-scale mRNA manufacturing facility at Monash University’s Technology Precinct in Clayton, Victoria. The facility positions Australia as one of the only countries globally with end-to-end #mrna vaccine capabilities and represents a critical step in strengthening the nation’s health resilience and ensuring rapid response capabilities. Read more from our Site Head, Emma Harrington: www.modernatx.com/en-US/media-center/all-media/blogs/mRNA…
-
Moderna
@moderna_tx
The holiday season is once again upon us, and people are planning reunions with loved ones, inviting family and friends to celebrations and booking travel. One addition to the holiday prep list: please consider getting your updated COVID-19 vaccine to help keep loved ones safe! What might be a run-of-the-mill respiratory illness for you and your kids could be severe for aging parents. Read more: www.modernatx.com/en-US/media-center/all-media/blogs/keep…
-
Moderna
@moderna_tx
Why did our Head of Development, Oncology and Therapeutics, Kyle Holen, choose to join Moderna? As a medical oncologist, he recognized the transformative potential of #mrna technology to reimagine cancer therapeutics, offering a more personalized approach to care.
Moderna
@moderna_tx
Hear his insights on the future of cancer treatment alongside other experts at @BostonGlobe's recent #futureofmedicine event ⬇ sponsored.bostonglobe.com/moderna/watch-future-of-medicin…
-
Moderna
@moderna_tx
Immunization against the flu, COVID-19, and RSV remains the best way to prevent hospitalizations, long-term health impacts, and death from those viruses.
Moderna
@moderna_tx
Healthcare providers are patients’ most trusted source for health information. Here are some tips from James Mansi, our VP of Medical Affairs on navigating vaccine season with patients: www.modernatx.com/media-center/all-media/blogs/Helping-Yo…
-
Moderna
@moderna_tx
If you had COVID in September or earlier this year, you should still get an updated #vaccine this fall – and now’s the perfect time!
The CDC recommends waiting 3 months after symptoms or a positive test before getting your updated #covid19 vaccine. Find a vaccine near you: -
Moderna
@moderna_tx
This Thanksgiving, we want to thank everyone who has been part of the Moderna journey and to highlight the many ways they make what we do possible.
Happy #thanksgiving! We are grateful for you! -
Moderna
@moderna_tx
Cancer impacts so many of us and much is still unknown, but advances in #mrna technology are unlocking a new era of individualized #medicine.
Moderna
@moderna_tx
Learn more from the @BostonGlobe how we are exploring this groundbreaking approach to potentially transform cancer care ⬇
sponsored.bostonglobe.com/moderna/cancer-care-mrna/ -
Moderna
@moderna_tx
Last season, COVID-19 was still putting more people in the hospital than the flu. In fact, cumulative hospitalization rate for #covid was almost 2.4 times than that for #flu.
An updated vaccine can help protect you and your loved ones – find a vaccine near you: -
Moderna
@moderna_tx
Congratulations to our Chief Brand Officer Kate Cronin on being inducted into the 2024 #prweekhalloffame! 🎉
From leading communications for Moderna to shaping the company’s global brand during one of the most critical times in public health, Kate has played a pivotal role in amplifying Moderna’s story and advocating around the promise of #mrna science for patients.
PRWeekUS
@PRWeekUS
A heartfelt congratulations to Kate Cronin on her induction into the 2024 PRWeek Hall of Fame! As @moderna_tx's chief brand officer, Kate has championed the transformative potential of mRNA science while elevating the company’s global brand. #prweekhalloffame
-
Moderna
@moderna_tx
Exciting times at The @BostonGlobe's Future of Medicine event last week! We were thrilled to have our Chief Medical Officer, Jacqueline Miller, kick off a powerful panel on the next generation of vaccines.
Kyle Holen, our Head of Development for Oncology and Therapeutics, joined forces with experts from @DanaFarber and @bethisraellahey for an inspiring discussion on the future of #cancer care.
A big thank you to @hannah_reports from the @BosBizJournal for moderating the panel. Together, we’re exploring groundbreaking advancements that could shape the future of healthcare!
#futureofmedicine #vaccineinnovation -
Moderna
@moderna_tx
📢 We’re thrilled to welcome Brian Gladsden to Moderna in a new role as the head of Commercial Platforms. Brian will join our Commercial Leadership Team and brings more than 25 years of experience in the biopharmaceutical industry.
Most recently he served as CEO of Mosaic Therapeutics, and before that led Worldwide Commercial & Portfolio Strategy for Novartis Oncology. His experience spans global launches across the U.S., Asia Pacific and Europe, and he has successfully led country operations in Japan, Australia, Korea and Austria.
Welcome, Brian! -
Moderna
@moderna_tx
Congratulations to our Chief Information Officer Brad Miller for being named to the 2024 #forbescio Next List! 🎉
Moderna
@moderna_tx
This prestigious recognition highlights Brad’s innovative leadership in advancing Moderna's mission. By deeply integrating technology into the company's DNA, we are using AI to scale and maximize our impact on #patients.
Read more about this recognition ⬇ www.forbes.com/sites/richardnieva/2024/11/19/the-forbes-c… -
Moderna
@moderna_tx
The fall respiratory virus season significantly increases pharmacies' workloads, particularly with the heightened demand for #vaccinations – which places an immense pressure on pharmacy teams.
Moderna
@moderna_tx
Read more from Justin Scholl, a pharmacist in Northwestern Pennsylvania, about some of the challenges and opportunities pharmacists face during this demanding season, along with tips to help pharmacies navigate it effectively ⬇️www.modernatx.com/en-US/media-center/all-media/blogs/a-ph…
-
Moderna
@moderna_tx
For the third consecutive year, we were a Health Equity sponsor of #hlthusa. A key highlight included a fireside chat with Hamilton Bennett, our Senior Director of Vaccine Access and Partnerships and Dr. Nicole Lurie, @CEPIvaccines's Executive Director for Preparedness and Response. The conversation highlighted how partnerships are key to building systems, processes, and innovations for effective, equitable pandemic responses.
Read more about our presence at the event: www.modernatx.com/en-US/media-center/all-media/blogs/high… -
Moderna
@moderna_tx
We are thrilled to announce the expansion of our Executive Committee! 🎉
Rose Loughlin, Ph.D., has been promoted to the newly created position of Executive Vice President, Research. In her role, Rose will lead our Research organization, focusing on driving our investment in pioneering science and expanding our innovative pipeline of #vaccines and #therapeutics.
Jacqueline Miller, M.D., has been promoted to Chief Medical Officer, and will lead our Development organization across vaccines and therapeutics.
Congratulations to Jackie and Rose on their promotions!
Moderna
@moderna_tx
We are excited to also announce expanded roles of two current members of our Executive Committee! 🎊
Stephen Hoge, M.D., our President, will expand his role to include oversight of the Commercial organization, responsible for strategy across the full product lifecycle from Research and Development, through Medical Affairs and Commercial.
Tracey Franklin, our Chief Human Resources Officer, will expand her role to become the Chief People and Digital Technology Officer. The expansion of her role emphasizes the vital integration of people, culture and digital #innovation.
Congratulations to Stephen and Tracey! -
Moderna
@moderna_tx
We are proud to be ranked #1 on @biospace's Best Places to Work list of large employers for the fourth year running! 🎉
This list highlights sought-after employers in life sciences, based on community votes and ratings, focusing on culture, leadership, career growth, and innovation.
Learn more: investors.modernatx.com/news/news-details/2024/Moderna-To…
#bestplacestowork #topworkplace -
Moderna
@moderna_tx
"Whether it’s leading a team, managing complex security threats, or making critical decisions in high-stakes environments, the lessons I learned during my service have been invaluable. I am continually reminded that service doesn’t stop when you leave the military—it’s a lifelong commitment to making a difference wherever you are.”
This #veteransday, Dean Geribo, our VP of Global Corporate Security and a United States Marine Corps veteran, leads us in honoring the courage, sacrifice, and commitment of those who have served our country.
Read more from Dean who also serves as the Executive Sponsor of our Employee Resource Group, mVETS: www.modernatx.com/media-center/all-media/blogs/reflecting… -
Moderna
@moderna_tx
For #worldimmunizationday, we’re reflecting on centuries of scientific innovations in #vaccines and looking ahead to an even brighter future fueled by innovative technologies that allow for greater speed and scale of development. 🌎
Moderna
@moderna_tx
Join us in a look back at vaccines throughout history: www.modernatx.com/en-US/media-center/all-media/blogs/Worl…
-
Moderna
@moderna_tx
Whether it’s a phone notification, an old-fashioned paper planner, or something else, make sure you set a reminder to get your updated #covid19 #vaccine.
If you had COVID in August or earlier during the summer surge, you should get an updated vaccine this month!
Protect yourself and your loved ones – find a vaccine near you: foryouandthem.com -
Moderna
@moderna_tx
Our commitment to learning fuels our innovation every day. This mindset is especially important as we celebrate #nationalstemday, which serves as a powerful reminder of the role education plays in shaping the future.
From our mRNAs as Medicines course on @coursera to partnerships with organizations like Science Club for Girls, we hope to make #stem education more accessible. 🔬🧪✨
Read more from our Chief Learning Officer, Molly Nagler: www.modernatx.com/en-US/media-center/all-media/blogs/Cele… -
Moderna
@moderna_tx
We announced today that Health Canada has approved mRESVIA™ (Respiratory Syncytial Virus mRNA vaccine) for Adults Aged 60 Years and Older.
Learn more: investors.modernatx.com/news/news-details/2024/Moderna-Re… -
Moderna
@moderna_tx
Earlier today, we reported financial results and provided business updates for the third quarter of 2024.
For the latest episode of our #irinsights series, members of our executive team sat down to provide more insight into our financial performance and upcoming late-stage pipeline milestones.
Watch the full video here: www.modernatx.com/en-US/media-center/all-media/blogs/thir… -
Moderna
@moderna_tx
Today, we reported financial results and provided business updates for the third quarter of 2024.
Read more: investors.modernatx.com/news/news-details/2024/Moderna-Re… -
Moderna
@moderna_tx
Join us at the Boston @globeevents first annual Future of Medicine event on Nov. 13 to hear from Kyle Holen, our Head of Development, Oncology and Therapeutics who will be joined by Patrick Ott of @DanaFarber Cancer Institute and Jacalyn Rosenblatt of @BIDMChealth to discuss precision approaches shaping the future of cancer care.
Learn more: futureofmedicine2024.splashthat.com
Boston Globe Events
@globeevents
Experts are optimistic about a new frontier in cancer research with the ability to attack cancer with more precision. On Nov. 13, hear from industry leaders including @moderna_tx who are investigating approaches to shape the future of cancer care. RSVP: futureofmedicine2024.splashthat.com/social
-
Moderna
@moderna_tx
We're implementing AI use cases across our entire value chain—from research to commercialization—to accelerate help advance the development of #mrna medicines.
Moderna
@moderna_tx
Discover how we’re leveraging generative AI and large language models to empower our employees and unlock innovative treatments. Read more from @FortuneMagazine: brand-studio.fortune.com/moderna/how-Moderna-is-reimagini…
-
Moderna
@moderna_tx
Over the summer, the U.S. experienced one of the biggest #covid19 waves in the past two years.
In its updated guidance, the CDC recommends that people who recently had a COVID-19 infection should consider waiting up to three months from your first symptoms or, if the infection was asymptomatic, a positive test, to get their updated COVID-19 vaccine.
So if you had COVID in August or earlier, you should get an updated vaccine this month!
Learn more: www.modernatx.com/media-center/all-media/blogs/it-may-be-… -
Moderna
@moderna_tx
Vampires and latent #viruses might have more in common than you think! 👀😶
This #halloween, watch to learn more about these scary viruses and how they work. 👻🦇 -
Moderna
@moderna_tx
Our Canadian manufacturing site, a 100,000-square-foot drug substance manufacturing facility located just outside Montreal in Laval, recently reached a major milestone — receiving a Drug Establishment License (DEL) from Health Canada.
Moderna
@moderna_tx
This certification allows us to manufacture drug substances on Canadian soil and positions Laval as the first Moderna site outside of the United States to achieve this authorization.
Read more about our Laval facility: www.modernatx.com/en-US/media-center/all-media/blogs/a-mi… -
Moderna
@moderna_tx
Merck and Moderna announced today the initiation of the Phase 3 trial evaluating V940 (mRNA-4157), an investigational individualized neoantigen therapy (INT), in Combination with KEYTRUDA® (pembrolizumab) after neoadjuvant KEYTRUDA and chemotherapy in patients with certain types of non-small cell lung cancer (NSCLC).
Read more: investors.modernatx.com/news/news-details/2024/Merck-and-… -
Moderna
@moderna_tx
If you had COVID in June or July during the recent summer surge, you should still get an updated vaccine this fall – and now’s the perfect time! The CDC recommends waiting 3 months after symptoms or a positive test before getting your updated #covid19 vaccine.
Moderna
@moderna_tx
Read more: www.modernatx.com/en-US/media-center/all-media/blogs/COVI…
-
Moderna
@moderna_tx
We are honored to be named a Science Careers Top Employer for the 10th consecutive year! 🏆🎉
This milestone is not just an accolade—it reflects the passion, dedication, and innovation that our people bring to work each day.
Learn more about the recognition here: www.modernatx.com/en-US/media-center/all-media/blogs/scie…
#sctopemployers -
Moderna
@moderna_tx
📢 Andrew’s panel starts shortly – join him on the Gallery stage @HLTHEVENT!
Moderna
@moderna_tx
We're back at @HLTHEVENT! Stop by the Impact Stage on Oct. 21st to hear our Senior Director of Vaccine Access and Partnerships Hamilton Bennett discuss accelerating #vaccine development, and the Gallery Stage on Oct. 22nd to hear our Executive Director of AI Engineering Andrew Giessel discuss AI’s role in pharmaceutical research.
#hlth2024 #hlthusa
www.hlth.com/2024event/agenda -
Moderna
@moderna_tx
📢 Hamilton’s panel starts shortly – join her on the Impact stage @HLTHEVENT!
Moderna
@moderna_tx
We're back at @HLTHEVENT! Stop by the Impact Stage on Oct. 21st to hear our Senior Director of Vaccine Access and Partnerships Hamilton Bennett discuss accelerating #vaccine development, and the Gallery Stage on Oct. 22nd to hear our Executive Director of AI Engineering Andrew Giessel discuss AI’s role in pharmaceutical research.
#hlth2024 #hlthusa
www.hlth.com/2024event/agenda -
Moderna
@moderna_tx
#icymi: During the summer surge, if you had COVID in July or earlier - now’s the perfect time to get your updated #vaccine! The CDC recommends waiting 3 months after symptoms or a positive test before getting your updated #covid19 vaccine.
Protect yourself and your loved ones – find a vaccine near you: foryouandthem.com -
Moderna
@moderna_tx
We're back at @HLTHEVENT! Stop by the Impact Stage on Oct. 21st to hear our Senior Director of Vaccine Access and Partnerships Hamilton Bennett discuss accelerating #vaccine development, and the Gallery Stage on Oct. 22nd to hear our Executive Director of AI Engineering Andrew Giessel discuss AI’s role in pharmaceutical research.
#hlth2024 #hlthusa
www.hlth.com/2024event/agenda -
Moderna
@moderna_tx
Today is the start of @IDWeekmtg 2024, one of the leading infectious disease conferences in the world. Every year, Moderna looks forward to several days of learning, engaging with infectious disease scientists and experts, and collaborating with leaders in the infectious disease field.
Learn more about our presentations at #idweek2024: www.modernatx.com/en-US/media-center/all-media/blogs/id-w… -
Moderna
@moderna_tx
School is in full swing, the leaves are turning, and the Halloween candy has hit the shelves. But as the weather cools down, the risk of getting sick is rising – and not just for our kids with the exposure that comes from school. What might be a run-of-the-mill respiratory illness for you and your kids could be severe for your aging parents.
Learn more about how you can help keep your loved ones safe, healthy, and able to enjoy time with family during the upcoming holidays: www.modernatx.com/media-center/all-media/blogs/keeping-yo… -
Moderna
@moderna_tx
Respiratory syncytial virus, or RSV, is a respiratory virus so widespread that most children will have been infected with it by the age of two. As a common and highly contagious seasonal virus, RSV is a leading cause of lower respiratory tract infections and can also be dangerous for high-risk adults and those over the age of 60.
This #rsvawarenessmonth, make sure you have the tools and information you need to keep yourself and your community safe: www.modernatx.com/media-center/all-media/blogs/RSV-awaren… -
Moderna
@moderna_tx
As we reflect on #worldmentalhealthday, it’s important to acknowledge the profound impact of #longcovid on mental well-being. Francesca Ceddia's latest blog delves into how Long COVID adds new layers to mental health challenges—affecting millions worldwide.
With over 26% of people experiencing serious limitations in daily life, and 41% reporting depression months after infection, we must prioritize awareness, support, and solutions.
Read more on the intersection of Long COVID and mental health here: www.modernatx.com/media-center/all-media/blogs/mental-hea… -
Moderna
@moderna_tx
Did you have COVID in June or July during the recent summer surge? If so, now’s the perfect time to get your updated #vaccine! The CDC recommends waiting 3 months after symptoms or a positive test before getting your updated #covid19 vaccine.
Read more: www.modernatx.com/en-US/media-center/all-media/blogs/COVI… -
Moderna
@moderna_tx
In March 2024, the CDC updated its recommendations for protecting yourself and others from respiratory viruses like COVID-19, flu, and RSV.
Updates to recommendations were made due to changes in the numbers of hospitalizations and deaths from COVID-19, coupled with the increased availability of tools to combat COVID, flu and RSV.
Here’s the latest guidance and what you need to know: www.modernatx.com/en-US/media-center/all-media/blogs/cdc-… -
Moderna
@moderna_tx
Congratulations to our CEO, Stéphane Bancel, on his formal induction into the @theNAEng Class of 2024!
As one of the highest honors in the field, Stéphane was recognized for his distinguished contributions to engineering and the development and manufacturing of pharmaceutical products, including the COVID-19 vaccine.
#nae2024 -
Moderna
@moderna_tx
We announced today that Abbas Hussain, former Chief Executive Officer of Vifor Pharma, will join Moderna’s Board of Directors, effective October 2, 2024.
Learn more: news.modernatx.com/news/news-details/2024/Abbas-Hussain-J… -
Moderna
@moderna_tx
It's October 1st – which means if you had COVID in July or earlier during the summer surge, now is the time to get your updated #covid19 vaccine!
The CDC recommends waiting 3 months after symptoms or a positive test before getting your updated #covid19 vaccine.
Protect yourself and your loved ones – find a vaccine near you: foryouandthem.com -
Moderna
@moderna_tx
Moderna and Cenra Healthcare announced today that the companies have entered into a joint agreement regarding the co-promotion of Moderna’s mRNA respiratory vaccine portfolio in Taiwan, including Moderna’s COVID-19 vaccine.
Under the agreement, Moderna will manufacture and distribute its mRNA respiratory vaccines. Cenra Healthcare will engage in promotion and execute medical education activities to ensure broad access to Moderna’s mRNA respiratory portfolio across Taiwan.
Learn more: investors.modernatx.com/news/news-details/2024/Moderna-an… -
Moderna
@moderna_tx
We announced today that the first participant in the U.S. has been dosed in the Nova 301 Trial, a pivotal Phase 3 randomized clinical trial evaluating the efficacy, safety, and immunogenicity of an investigational norovirus vaccine, mRNA-1403. Global recruitment for the Nova 301 trial has also begun.
Read more: investors.modernatx.com/news/news-details/2024/Moderna-An… -
Moderna
@moderna_tx
Long COVID, particularly in children, has remained largely under the radar. Pediatric #longcovid involves lingering symptoms that can severely impact a child’s daily life, which we see first-hand in our work with Long COVID Families.
Read more from Megan Carmilani, Founder & President of @LongCovidFam, about how we can help support affected children and their families: www.modernatx.com/media-center/all-media/blogs/stigma-of-… -
Moderna
@moderna_tx
#icymi: If you had COVID in June during the summer surge, now’s the perfect time to get your updated #vaccine!
The CDC recommends waiting 3 months after symptoms or a positive test before getting your updated #covid19 vaccine.
Read more: www.modernatx.com/media-center/all-media/blogs/COVID-19-s… -
Moderna
@moderna_tx
Last week, our CIO Brad Miller participated in a panel with Colleen Aubrey and Emily Capodilupo at the @FastCompany Innovation Festival to discuss the transformative role #ai is playing in shaping the future of our industries.
Read Brad's key takeaways from the panel at #fcfestival: www.modernatx.com/media-center/all-media/blogs/fast-compa… -
Moderna
@moderna_tx
Today, on World Cancer Research Day, we recognize the critical importance and impact of cancer research.
Research shows that nearly 40% of men and women will be diagnosed with cancer at some point in their lifetimes and that cancer is among the leading causes of death worldwide, underscoring the need for continued investment in research to improve treatments and care for patients and their families.
Read more about our commitment to cancer research: www.modernatx.com/media-center/all-media/blogs/modernas-c… -
Moderna
@moderna_tx
This September, we recognize #newbornscreening Awareness Month, highlighting the critical role of newborn screening in identifying and treating conditions that can severely impact a child’s long-term health and survival.
Learn more about the need for increased screening for #cytomegalovirus, the most common infectious cause of birth defects and developmental disabilities in the U.S.: www.modernatx.com/en-US/media-center/all-media/blogs/newb… -
Moderna
@moderna_tx
The #covid19 pandemic taught us that infectious diseases do not respect borders, and onshore supply chains are critical to getting vaccines and therapeutics to people when global supplies are tight.
Learn more about our efforts to build resilience in the UK, with localized #mrna manufacturing for enhanced pandemic preparedness: www.modernatx.com/media-center/all-media/blogs/building-r… -
Moderna
@moderna_tx
Did you have COVID during the recent summer surge? The CDC recommends waiting 3 months after symptoms or a positive test before getting your updated #covid19 vaccine.
If you had COVID in June, now’s the perfect time to get your updated #vaccine! Protect yourself and your loved ones – find a vaccine near you: foryouandthem.com. -
Moderna
@moderna_tx
We announced today that Health Canada has authorized our updated #covid19 #vaccine, targeting the KP.2 sub-lineage of SARS-CoV-2.
Learn more: investors.modernatx.com/news/news-details/2024/Moderna-Re… -
Moderna
@moderna_tx
As we close out #esmo24, we're grateful for the invaluable interactions with the scientific community that help drive our multipronged approach to advancing oncology care.
Our hope is that #mrna technology has the potential to transform #cancer treatment by individualizing therapies to align with each patient’s unique mutation fingerprint. It offers potential opportunities to impact immunomodulation, address cancer targets, and enable novel therapies.
Stay tuned as we seek to transform patient outcomes and continue to push the boundaries of what's possible in cancer treatment.
#oncologyinnovation #cancerresearch -
Moderna
@moderna_tx
The start of the school year is a time of coming together with new teachers and old friends. Unfortunately, it also brings unwelcome infections - which can spread to the family members our children love.
It's crucial to take steps to protect your kids from #covid19 so they can start the year healthy.
Here is what to keep in mind as students head back to school: www.modernatx.com/media-center/all-media/blogs/COVID-is-s… -
Moderna
@moderna_tx
The next wave of AI innovation is here – but how do you know if you are ready for it?
Our CIO Brad Miller will sit down with Colleen Aubrey from @awscloud and Emily Capodilupo from @WHOOP at @FastCompany Innovation Festival this week to discuss the bold approaches they are taking to weave AI into the fabric of their business.
Join us at the Forum Stage this Wednesday, September 18th: events.fastcompany.com/innovationfestival24
#fcfestival #fcif10 -
Moderna
@moderna_tx
Join us at #esmo24 as we advance #mrna technology in immuno-oncology.
Our pipeline reflects Moderna’s commitment to researching and developing mRNA-based cancer therapies. We aim to develop a range of treatments for many cancer types using diverse strategies, all enabled by the flexibility of our mRNA platform.
We believe mRNA has the potential to transform cancer care. Explore the possibilities with us at #esmo2024 in Barcelona at booth #613. Together, we can bring new hope to patients through the power of mRNA. -
Moderna
@moderna_tx
At our annual R&D Day yesterday, we announced program and financial updates demonstrating progress and strategic prioritization of its mRNA pipeline.
For the latest episode of our #irinsights series, Our CEO Stéphane Bancel, President Stephen Hoge and CFO Jamey Mock sat down to discuss their focus on delivering 10 new products to patients, pacing R&D investment, and building the Company’s commercial business.
Watch the full video here: www.modernatx.com/en-US/media-center/all-media/blogs/stra… -
Moderna
@moderna_tx
Over the past three years, Moderna’s robust pipeline has achieved milestones across multiple late-stage clinical trials, and its early-stage portfolio has produced proof-of-concept data with multiple candidates ready for pivotal studies.
From developing treatments for unmet needs, to addressing global health threats - we're here to fight the big, intimidating, impossible-to-change problems.
We're here to change #medicine.
#thischangeseverything -
Moderna
@moderna_tx
We announced today program and financial updates demonstrating progress and strategic prioritization of our mRNA pipeline at our annual R&D Day event.
The updates include data readouts in our respiratory vaccine portfolio and a revised financial framework.
Read more: investors.modernatx.com/news/news-details/2024/Moderna-RD… -
Moderna
@moderna_tx
We announced today that Swissmedic has granted full marketing authorization for the use of our updated #covid19 #vaccine in Switzerland targeting the SARS-CoV-2 variant JN.1.
In Switzerland, COVID-19 vaccination is recommended in autumn for persons at an increased risk of developing a severe case of the illness. -
Moderna
@moderna_tx
We announced today that our manufacturing facility in Laval, Quebec, has been granted a Drug Establishment License (DEL) from Health Canada. This certification affirms the facility’s compliance with rigorous safety and quality standards, authorizing it to produce drug substance.
This key milestone enables our Canadian manufacturing site to become fully operational, bringing the company closer to ensuring a reliable and onshore supply of #mrna #vaccines within Canada.
Learn more: investors.modernatx.com/news/news-details/2024/Modernas-C… -
Moderna
@moderna_tx
We announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion recommending marketing authorization for an updated formulation of our COVID-19 mRNA vaccine, targeting the SARS-CoV-2 variant JN.1.
Learn more: -
Moderna
@moderna_tx
We are likely to encounter the #covid19 virus again as we enter another respiratory virus season, and the gravity of your next COVID-19 episode depends on a variety of factors.
Moderna
@moderna_tx
Here are key things to keep in mind about repeat COVID infections as we approach the fall and winter months ⬇ www.usatoday.com/story/news/health/2024/08/23/covid-repea…
-
Moderna
@moderna_tx
We announced today that the Medicines and Healthcare products Regulatory Agency (MHRA) has authorized our updated COVID-19 vaccine targeting the JN.1 variant of SARS-CoV-2.
Following the MHRA decision, doses will be available for eligible groups as part of the NHS autumn vaccination program, which is prioritized for use in people at greatest risk of serious illness from COVID-19.
Read more: investors.modernatx.com/news/news-details/2024/Moderna-Re… -
Moderna
@moderna_tx
Economists estimate that #longcovid has forced around one million Americans out of the labor force, and it is most prevalent among Americans in their prime working years.
Moderna
@moderna_tx
Studies show that COVID vaccines reduce the risk of Long COVID by up to 70% — underscoring the importance of CDC’s recommendation to stay up to date with COVID vaccinations.
Learn more about this public health crisis: www.wsj.com/health/wellness/long-covid-knocked-a-million-… -
Moderna
@moderna_tx
Vaccines play a vital role in public health. Data from the @WHO show that vaccines prevent an estimated 3.5 to 5 million deaths each year from 20 different diseases.
This National Immunization Awareness Month, read more about the vaccines you need to protect yourself this fall, and how you can help protect yourself and your community from some of the most common respiratory illnesses this winter ⬇
www.modernatx.com/en-US/media-center/all-media/blogs/vacc… -
Moderna
@moderna_tx
We’re excited to announce the launch of our new awareness campaign, “Do It For You & Them.” This initiative is part of our broader efforts to educate the public about the ongoing risks of COVID-19 and its continued impact on daily life.
With COVID-19 infection rates still elevated across the country, staying up to date on your COVID-19 vaccination is one of the best ways to protect yourself and your loved ones.
Updated vaccines are now available — find one near you today: foryouandthem.comThis media couldn't be displayed. See it on the original post. -
Moderna
@moderna_tx
COVID-19 remains a significant health risk and is the leading cause of respiratory illness-related hospitalization.
According to the CDC, people over 65 are at least three times more likely to be hospitalized due to #covid19 than the #flu, and at least seven times more likely than #rsv.
Moderna
@moderna_tx
Staying up to date on your COVID-19 vaccination is one of the best ways to protect yourself and your loved ones.
Updated vaccines are now available —find one near you today ➡ www.foryouandthem.com -
Moderna
@moderna_tx
We announced today that the European Commission has granted marketing authorization for our mRNA respiratory syncytial virus (RSV) vaccine.
The marketing authorization follows the Positive Opinion from the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP).
Read more: investors.modernatx.com/news/news-details/2024/Moderna-Re… -
Moderna
@moderna_tx
We announced today that we have received approval from the Ministry of Health, Labour and Welfare (MHLW) in Japan for a partial change application for an updated formulation of our COVID-19 mRNA vaccine targeting the SARS-CoV-2 variant JN.1.
Read more: investors.modernatx.com/news/news-details/2024/Ministry-o… -
Moderna
@moderna_tx
Earlier today, we announced that the FDA had approved Moderna’s updated #covid19 vaccine for this fall for individuals 12 years of age and older.
This approval is timely, as COVID-19 remains a significant health risk and is the leading cause of respiratory illness-related hospitalization, regardless of age or health condition.
Moderna
@moderna_tx
Read more about this milestone, and what lies ahead, from our CEO Stéphane Bancel: modernatx.com/en-US/media-center/all-media/blogs/FDA-appr…
-
Moderna
@moderna_tx
We announced today that the FDA has approved the supplemental Biologics License Application (sBLA) for Spikevax® (2024-2025 formula) for individuals 12 years and above.
Emergency Use Authorization (EUA) for Moderna’s COVID-19 Vaccine (2024-2025 formula) was also granted for individuals 6 months through 11 years of age.
Learn more: investors.modernatx.com/news/news-details/2024/Moderna-Re… -
Moderna
@moderna_tx
Based on wastewater trends, the US is in the midst of a significant #covid19 wave, with viral activity levels in wastewater the highest they’ve been for a summer surge since July 2022.
Moderna
@moderna_tx
In its updated guidance, the CDC notes that people who recently had a COVID-19 infection may consider waiting up to 3 months from symptom onset or a positive test to get their updated COVID-19 vaccine.
Moderna
@moderna_tx
In other words, if you recently had COVID, you should still plan to get an updated vaccine this fall.
Learn more: www.cnn.com/2024/08/16/health/covid-largest-summer-wave/i… -
Moderna
@moderna_tx
Long COVID affects the health and quality of life of millions of people across the globe, costing economies billions of dollars in reduced productivity of employees and an overall drop in the work force.
Moderna
@moderna_tx
Learn more about #longcovid, how it affects the body, and what lies ahead ⬇
www.pbs.org/newshour/health/scientists-are-piecing-togeth… -
Moderna
@moderna_tx
It may seem like many people you know have had COVID this summer, and the data backs it up — 44 out of 50 U.S. states are currently experiencing "high" or "very high" levels of #covid19, according to the CDC.
Moderna
@moderna_tx
If you had COVID this summer, the CDC recommends that you should still get an updated #vaccine this fall, once three months have passed since your infection.
Learn more: www.modernatx.com/en-US/media-center/all-media/blogs/COVI… -
Moderna
@moderna_tx
Today, we are proud to announce the launch of mRNAs as Medicines, a free course on @coursera offering a comprehensive overview of #mrna science, how it represents a new era of medicine, and its power to positively impact human health.
An estimated 3.5 million STEM jobs will need to be filled in the U.S. by 2025, and we are committed to helping ensure that people have access to the knowledge they need to leverage emerging technologies.
Learn more, and get started: www.modernatx.com/media-center/all-media/blogs/mRNA-as-me… -
Moderna
@moderna_tx
Today we announced a partnership with @coursera to launch mRNAs as Medicines, a three-module course designed by experts at Moderna that offers a comprehensive understanding of mRNA medicines, how they work and their potential applications.
mRNAs as Medicines is available for free to individuals who register as Coursera users.
Learn more: investors.modernatx.com/news/news-details/2024/Moderna-an… -
Moderna
@moderna_tx
We are proud to be recognized by the @BosBizJournal for the second year in a row as one of the most charitable companies in Massachusetts!
Moderna
@moderna_tx
We are honored to receive this recognition and are committed to extending our societal impact through the Moderna Charitable Foundation, which seeks to be a full partner in the pursuit of health and education equity.
www.bizjournals.com/boston/news/2024/07/16/bbj-most-chari… -
Moderna
@moderna_tx
According to a @NatureMedicine report, about 400 million people worldwide have been afflicted with #longcovid, and the worldwide economic cost — from factors like healthcare and patients unable to return to work — is about $1 trillion each year or about 1% of the global economy.
Moderna
@moderna_tx
Learn more ⬇ www.nytimes.com/2024/08/09/health/long-covid-world.html
-
Moderna
@moderna_tx
A recent study published in @TheLancet Psychiatry showed that some patients still had mild to severe cognitive and psychiatric outcomes up to 3 years after being hospitalized with acute SARS-CoV-2 during the first months of the pandemic.
Learn more ⬇ www.medpagetoday.com/neurology/longcovid/111401 -
Moderna
@moderna_tx
Age remains the strongest risk factor for severe #covid19 outcomes, with risk of severe outcomes increasing markedly with increasing age, and substantially at ages >65 years.
Learn more: www.modernatx.com/en-US/media-center/all-media/blogs/covi… -
Moderna
@moderna_tx
Curiosity is the spark that ignites our passion for change. It's what compels our Digital team to venture beyond the expected, to question the status quo, and to envision a future that others have yet to imagine.
In our latest video, meet members of our Digital team who are driving our technology roadmap across the organization, with the ultimate goal of transforming patients' lives. 👩🏽💻👨🏽💻
www.modernatx.com/en-US/media-center/all-media/blogs/mode…This media couldn't be displayed. See it on the original post. -
Moderna
@moderna_tx
Long COVID is a new disease, and can present in a lot of different ways - but the lack of a consensus definition has led to patients being met with skepticism, delays in care and difficulty in obtaining the support they need.
Moderna
@moderna_tx
A newly published definition for #longcovid, written and published recently by a @theNASEM committee, might help get patients the care they require.
Learn more ⬇ www.ctinsider.com/connecticut/article/ct-long-covid-defin… -
Moderna
@moderna_tx
Last week, we partnered with Washington @PostLive on an event titled, “Long COVID: Where Things Stand,” which spotlighted the causes, prevalence and long-term impacts of #longcovid on communities and the workforce four years since the start of the global COVID-19 pandemic.
This media couldn't be displayed. See it on the original post.
Moderna
@moderna_tx
The event brought together top researchers, government leaders, advocates, and patients to discuss the latest research on Long COVID, its prevalence, and its wide-ranging impact on businesses, the economy, and the lives of millions of Americans.
Read more about the event: -
Moderna
@moderna_tx
In our latest #irinsights video, our Chief Financial Officer Jamey Mock sat down to provide more insight into our financial performance, challenging market dynamics, and our focus for the second half of the year.
Watch the full video: www.modernatx.com/en-US/media-center/all-media/blogs/reca…This media couldn't be displayed. See it on the original post. -
Moderna
@moderna_tx
Today, we reported financial results and provided business updates for the second quarter of 2024.
Read more: investors.modernatx.com/news/news-details/2024/Moderna-Re… -
Moderna
@moderna_tx
📣 We're thrilled to share that we made the first shipment our #rsv #vaccine yesterday!
A monumental moment for Moderna, this marks our evolution into a multi-product company, and is a testament to #teammoderna's incredible dedication and unwavering commitment to patients. -
Moderna
@moderna_tx
In every age group, even a mild #covid19 infection may trigger a lasting set of problems – but for some people with certain risk factors — pregnancy, chronic conditions or a compromised immune system — an infection may bring serious illness.
Moderna
@moderna_tx
Here's what you need to know about vaccination against COVID-19 this fall: www.nytimes.com/article/long-covid-vaccine.html
-
Moderna
@moderna_tx
Respiratory syncytial virus, or RSV, is a highly contagious seasonal respiratory virus and a leading cause of lower respiratory tract infections, causing between 6,000 to 10,000 deaths each year amongst adults 65 years and older in the United States.
Learn more about RSV, how you can help prevent it's spread, and new recommendations for RSV vaccinations from the CDC’s Advisory Committee on Immunization Practices: www.modernatx.com/media-center/all-media/blogs/RSV-what-y… -
Moderna
@moderna_tx
📢 This week we sponsored a Washington @PostLive event focusing on the public health challenge of #longcovid. This crucial conversation brought together policymakers, medical researchers, and patients to explore the causes, prevalence, and long-term impacts of this condition.
Moderna
@moderna_tx
Thank you to @zalaly, Dr. Linda Sprague Martinez, @exceedhergrasp1, @chiluvs1, @NYCHealthCommr, and Rachel Beale for their invaluable contributions and commitment to understanding and combatting Long COVID. Together, we can make a difference!
-
Moderna reposted
Washington Post Live
@PostLive
.@chiluvs1 tells @akjohnson1922, "With long covid ... you don't know what's happening with your body ... But you do know that something is wrong with your body ... It took me becoming my best advocate for myself, for people to start taking my symptoms seriously."
This media couldn't be displayed. See it on the original post. -
Moderna reposted
Washington Post Live
@PostLive
.@zalaly tells @akjohnson1922, "We've learned that long covid can affect nearly everyone ... Long covid is not only brain fog and fatigue ... but it can literally affect nearly every organ system. It can lead to brain problems, strokes, heart failure, new onset diabetes."
This media couldn't be displayed. See it on the original post. -
Moderna
@moderna_tx
This event starts shortly! Tune in virtually at 9:00 am ET for a live conversation on the looming public health challenge of Long COVID ⬇
Moderna
@moderna_tx
Join leading policymakers, medical researchers and patient advocates tomorrow at 9:00 am ET for a live conversation about the causes, prevalence and long-term impacts of #longcovid ⬇
www.washingtonpost.com/washington-post-live/2024/07/25/lo… -
Moderna
@moderna_tx
Long COVID presents a growing public health challenge worldwide, and is having a major impact on the productivity of health systems and the wider workforce - with severe cases potentially costing the economy $200 billion in lost annual wages in the US alone.
Moderna
@moderna_tx
Join leading policymakers, medical researchers and patient advocates tomorrow at 9:00 am ET for a live conversation about the causes, prevalence and long-term impacts of #longcovid ⬇
www.washingtonpost.com/washington-post-live/2024/07/25/lo… -
Moderna
@moderna_tx
A large new study in @NEJM shows that among people in the U.S. infected during the first two years of the pandemic, the percentage of vaccinated individuals who developed #longcovid was significantly lower than that of unvaccinated individuals.
Moderna
@moderna_tx
This study provides some of the strongest evidence yet that #vaccines reduce the risk of developing Long COVID.
Learn more: www.nytimes.com/2024/07/17/health/long-covid-vaccines.html -
Moderna
@moderna_tx
We announced today that David M. Rubenstein, Co-Founder and Co-Chairman of The Carlyle Group, will join Moderna’s Board of Directors, effective August 5, 2024.
Learn more: investors.modernatx.com/news/news-details/2024/David-Rube… -
Moderna
@moderna_tx
We are proud to have earned a top score on the Disability Equality Index and recognized as a #bestplacetowork24 for #disabilityinclusion for the 3rd year in a row! 🏆
Our commitment to diversity and inclusion starts with belonging, which we see as essential for our people to thrive at Moderna. Thank you @DisabilityIN for the recognition, and for driving disability inclusion and accessible innovation for all. -
Moderna
@moderna_tx
#mrna technology has gained significant attention, particularly in the realm of vaccine development. But what exactly is mRNA, and why does it hold such potential in modern #medicine?
Read our latest blog to learn more about the basics of mRNA, how it functions within our bodies, and its role in the development of vaccines: www.modernatx.com/media-center/all-media/blogs/mrna-expla… -
Moderna
@moderna_tx
COVID-19 continues to cause a more significant burden than #influenza in the U.S.
Moderna
@moderna_tx
For both diseases, hospitalizations and deaths tend to follow peaks during the traditional winter viral respiratory season, however, influenza typically drops below endemic levels at certain points, while #covid19 is responsible for significant burden throughout the year.
Moderna
@moderna_tx
Learn more: www.modernatx.com/media-center/all-media/blogs/covid-19-a…
-
Moderna
@moderna_tx
#longcovid is a complex chronic condition caused by a COVID-19 infection, that can manifest as potentially hundreds of symptoms in many different body systems.
Moderna
@moderna_tx
Some health effects of Long COVID, such as chronic fatigue and cognitive impairment (sometimes referred to as brain fog), can affect a person’s ability to work or attend school for an extended period of time.
Moderna
@moderna_tx
Learn more about Long COVID in a new report from @theNASEM: www.nationalacademies.org/news/2024/06/new-report-reviews…
-
Moderna
@moderna_tx
Moderna and Mitsubishi Tanabe Pharma Corporation today announced that the companies have entered into a joint agreement regarding the co-promotion of Moderna’s mRNA respiratory vaccine portfolio in Japan, including Moderna’s COVID-19 vaccine.
Learn more: feeds.issuerdirect.com/news-release.html?newsid=552199725…. -
Moderna
@moderna_tx
Happy #fourthofjuly from all of us at Moderna! We hope you enjoy a fun, safe, and healthy celebration with your loved ones. #independenceday
-
Moderna
@moderna_tx
Last week, we celebrated the official opening of our global headquarters in Cambridge, MA - a purpose-built space intended to fuel our next chapter of discovery.
Thank you to all of the dignitaries, partners, community members, and employees who joined us in celebrating this momentous occasion.
Read more: www.modernatx.com/media-center/all-media/blogs/new-global… -
Moderna
@moderna_tx
We announced today a project award through the Rapid Response Partnership Vehicle (RRPV) to accelerate the development of mRNA-based pandemic #influenza #vaccines.
The RRPV is a Consortium funded by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS).
Learn more: investors.modernatx.com/news/news-details/2024/Moderna-Re… -
Moderna
@moderna_tx
We announced today that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of marketing authorization in the European Union for mRNA-1345, an mRNA respiratory syncytial virus (RSV) vaccine.
#rsv is a highly contagious seasonal respiratory #virus and a leading cause of lower respiratory tract infections and pneumonia. It causes a particularly high burden of disease in infants and older adults. In the European Union, RSV is estimated to cause approximately 160,000 hospital admissions in adults each year, with 92% of these admissions occurring in adults aged 65 and over.
Learn more: investors.modernatx.com/news/news-details/2024/EMA-Commit… -
Moderna
@moderna_tx
Today marks a monumental day for Moderna as we officially celebrate the opening of our state-of-the-art global headquarters in Cambridge, Massachusetts! This new space serves as a central hub, fostering connections among our employees and the community. 🎉🍾
Our cutting-edge 460,000-square-foot facility showcases our dedication to science, sustainability, and innovation – and is designed with exceptional energy efficiency, featuring everything from solar panels to geothermal wells.
We were thrilled to have @MassGovernor Healey, @MassLtGov Driscoll and many other distinguished leaders, partners, and community members from across the state join us for the ribbon-cutting ceremony alongside #teammoderna. Join us in celebrating this milestone! -
Moderna
@moderna_tx
Long COVID affects an estimated 17.8 million people in the US, with severe cases potentially costing the economy $200 billion in lost wages annually.
Moderna
@moderna_tx
Recognizing the significant disparities in disease outcomes, especially for Black communities, we partnered with @TeamWellnessCtr and people.health to organize and analyze patient data through innovative mobile CT scanning clinics.
Moderna
@moderna_tx
Learn more about our collaborative efforts to understand the impact of #longcovid on underserved communities: www.bloomberg.com/news/newsletters/2024-06-19/long-covid-…
-
Moderna
@moderna_tx
The lack of a clear and consistent definition for #longcovid presents challenges for patients, clinicians, researchers, and policy makers.
Based on findings reported in existing literature, as well as expert input, a @theNASEM committee developed a consensus definition ⬇ -
Moderna
@moderna_tx
As we advance our platform and continue to make progress in profoundly impacting human health, we recognize that building the best version of Moderna requires increasing trust with stakeholders, protecting the health of the planet, and deeply caring for our employees and communities.
Learn more about the progress we’ve made over the last few years in our third annual Environmental, Social and Governance (ESG) Report – a milestone that underscores our commitment to transparency, stakeholder engagement and integrating ESG priorities into the heart of our operations.
www.modernatx.com/media-center/all-media/blogs/moderna-20…This media couldn't be displayed. See it on the original post. -
Moderna
@moderna_tx
Cytomegalovirus (CMV) is the most common infectious cause of birth defects in the U.S. - but it's impact is uneven across different racial and ethnic groups. For instance, the rate of congenital #cmv infection is significantly higher in Black infants as compared to other populations.
This disparity highlights the importance of ensuring that our clinical trials reflect the diverse communities we serve, so that people of all backgrounds have access to the promising medicines of tomorrow.
Learn more about the approaches we are taking to increase the inclusiveness of our scientific research: www.modernatx.com/en-US/media-center/all-media/blogs/mark…
#cmvawarenessmonth -
Moderna
@moderna_tx
Bipartisan legislation was recently introduced in both the United States Senate and House to enhance early detection and research for congenital #cytomegalovirus (#ccmv)!
Moderna
@moderna_tx
The Stop CMV Act, introduced in the Senate by Senators Richard Blumenthal, Chris Murphy, and Roger Marshall, and in the House by Representatives Mike Lawler and Greg Landsman, authorizes funding to support hospitals and healthcare providers with cCMV screening, and creates grant programs to fund CMV testing, improve cCMV data collection, and support education and training on cCMV.
Moderna
@moderna_tx
Furthermore, it also promotes @NIH research focused on screening techniques, diagnostics, prevention, vaccines, and treatments for CMV.
Learn more about the bill: lawler.house.gov/news/documentsingle.aspx?DocumentID=1432
#cmvawarenessmonth #stopcmv -
Moderna
@moderna_tx
"If the pediatrician or the OB would have said, hey, be careful of this - we might be in a different situation."
Michelle and Joe Longo's third child was not tested for #cytomegalovirus (CMV) at birth and was discharged, despite exhibiting warning signs of the disease, including failing a newborn hearing screening. After persistent hearing problems, and seeking the opinion of multiple healthcare professionals, their son was diagnosed with congenital CMV at four months old.
Learn more about their story: www.modernatx.com/en-US/media-center/all-media/blogs/cmv-…
#cmvawarenessmonth #stopcmv -
Moderna
@moderna_tx
We announced today that our Phase 3 trial of mRNA-1283, an investigational next-generation COVID-19 vaccine, has met its primary efficacy endpoint.
Learn more: investors.modernatx.com/news/news-details/2024/Moderna-An… -
Moderna
@moderna_tx
A group of experts from across medical disciplines under @theNASEM released a report today proposing a consensus definition for #longcovid. The report includes important evidence and supporting data, details on different manifestations of the disease and recommendations for adoption and implementation of the guidance.
Long COVID has profound medical, social, and economic consequences worldwide, and a consensus in definition will help promote consistency in diagnosis, aid awareness efforts, harmonize research and recognize and support patients as they navigate the complexities of living with the disease.
Read more ⬇
National Academies
@theNASEM
The lack of a clear and consistent definition for #longcovid presents challenges for patients, clinicians, #publichealth practitioners, researchers, and policymakers.
Read our new report on an evidence-based Long COVID definition: www.nationalacademies.org/news/federal-government-clinici… -
Moderna
@moderna_tx
There is a need for innovative approaches to protect our most vulnerable against diseases like #covid19 and #flu, as well as a potential opportunity to redefine the burden of respiratory season and advance public health. A combination vaccine that could provide dual protection in a single shot has the potential to encourage more widespread vaccination uptake while also reducing the burden of acute respiratory disease on health systems.
Learn more about the potential impact of combination vaccines on public health: www.modernatx.com/en-US/media-center/all-media/blogs/impa… -
Moderna
@moderna_tx
We announced today that our Phase 3 trial of mRNA-1083, an investigational combination #vaccine against #influenza and #covid19, has met its primary endpoints.
mRNA-1083 comprises components of mRNA-1010, Moderna’s vaccine candidate for seasonal influenza, and mRNA-1283, Moderna’s next-generation COVID-19 vaccine candidate.
Read more: investors.modernatx.com/news/news-details/2024/Moderna-An… -
Moderna
@moderna_tx
In a 2022 survey, 3.4 percent of U.S. adults and 1.3 percent children reported they were experiencing #longcovid symptoms.
A new report from @theNASEM presents findings about Long COVID diagnosis, symptoms, and impact on daily function — including that Long COVID can cause more than 200 symptoms, and can impair an individual’s ability to work or attend school for six months to two years or more after COVID-19 infection.
Read the full report ⬇
National Academies
@theNASEM
Many individuals infected with the virus that causes #covid19 have continued to experience lingering symptoms for months or even years following infection, a condition often referred to as #longcovid.
Learn more about Long COVID from our new report: www.nationalacademies.org/news/new-report-reviews-evidenc…
Moderna
@moderna_tx
Join @NASEM_Health on June 11th as they release a definition of #longcovid to promote consistency in diagnosis, care, and research ⬇
NASEM Health
@NASEM_Health
Join us on 6/11 for the public release webinar of our new report proposing the 2024 NASEM #longcovid Definition to promote consistency in diagnosis, aid awareness efforts, help patients access appropriate care, & harmonize research. Register here: www.nationalacademies.org/projects/HMD-HSP-23-01/event/42882
-
Moderna
@moderna_tx
We announced today that we have submitted an application to the U.S. FDA for review of our updated COVID-19 vaccine formula, targeting the SARS-CoV-2 variant JN.1.
The submission is based on guidance from the U.S. FDA, which advised that COVID-19 vaccines should be updated to a monovalent JN.1 composition for the 2024-2025 season.
Read more: investors.modernatx.com/news/news-details/2024/Moderna-Fi… -
Moderna
@moderna_tx
Every year, 8,000 children in the U.S. develop lasting health issues due to #cytomegalovirus (#cmv), including hearing loss, developmental delays, and seizures. Raising awareness about CMV is crucial to reducing its spread.
By practicing basic hygiene habits, which are already part of our daily routines, we can help protect ourselves and our families.
Stay informed and help us spread the word. Learn more: nowiknowcmv.com
#cmvawarenessmonth #stopcmv #nowiknowcmv -
Moderna
@moderna_tx
We recently published our inaugural annual #covid19 report, which provides an overview of the evolving landscape of COVID-19, and discusses its comparative burden of disease as compared to influenza (flu).
Moderna
@moderna_tx
With the continued evolution of the virus, and potential for more virulent variants, the reports explores potential barriers to and solutions for improving COVID-19 protection for future seasons.
Read more about the report here: www.modernatx.com/en-US/media-center/all-media/blogs/covi… -
Moderna
@moderna_tx
We announced today that our investigational therapeutic for methylmalonic acidemia, mRNA-3705, was selected by the U.S. FDA for the Support for Clinical Trials Advancing Rare Disease Therapeutics (START) pilot program.
Methylmalonic acidemia (MMA) is a rare, life-threatening, inherited metabolic disorder that is most commonly (approximately 60% of cases) caused by a deficiency in the mitochondrial enzyme MUT.
Read more: investors.modernatx.com/news/news-details/2024/Modernas-I… -
Moderna
@moderna_tx
That’s a wrap – thank you @ASCO!
During #asco2024, we presented data on mRNA-4157 (V940), our investigational individualized neoantigen therapy, which is being evaluated in a comprehensive development program with our partner @Merck.
We have initiated Phase 3 studies in patients with high-risk #melanoma and non-small cell lung cancer, in addition to Phase 2 studies in patients with renal cell carcinoma and urothelial carcinoma and a Phase 2/3 study for cutaneous squamous cell #carcinoma.
The future of #cancer treatment is evolving, and #mrna is at the forefront. Together, we can revolutionize oncology. -
Moderna
@moderna_tx
A recent study highlights the widespread impact of #cytomegalovirus (#cmv), demonstrating that modeled seroprevalence estimates increased with age and were higher in females than males. By young adulthood, about half of US and a quarter of Canadian women have been exposed to CMV, underscoring the vital importance of awareness and prevention especially since CMV is the leading infectious cause of birth defects.
Understanding CMV’s impact is crucial for developing better public health policies, screening programs, and potential vaccines that can make a real difference in people's lives.
📚 Dive into the full study to learn more about the study's findings and their implications: onlinelibrary.wiley.com/doi/10.1002/jmv.29525
#cmvawarenessmonth #stopcmv #publichealth -
Moderna
@moderna_tx
We believe #mrna technology has the potential to revolutionize #cancer treatment by enhancing the immune system's capacity to identify and eradicate cancer cells through specific T-cell responses.
One approach is tailoring therapy to each patient’s unique cancer mutational fingerprint. Our investigational individualized neoantigen therapy is the most advanced mRNA candidate in our pipeline.
This investigational mRNA therapy, mRNA-4157 (V940), is designed to train and activate anti-tumor T-cell responses by targeting a unique set of cancer-specific mutations called neoantigens, which the immune system recognizes as foreign.
Learn more ⬇This media couldn't be displayed. See it on the original post. -
Moderna
@moderna_tx
Moderna and @Merck today announced that mRNA-4157 (V940), an investigational individualized neoantigen therapy, in combination with KEYTRUDA, Merck’s anti-PD-1 therapy, demonstrated sustained improvement in recurrence-free survival and distant metastasis-free survival compared with KEYTRUDA alone in patients with high-risk stage III/IV melanoma following complete resection.
These data are being presented for the first time today during a rapid oral abstract session at the 2024 @ASCO Annual Meeting (abstract hashtag#LBA9512).
Learn more: investors.modernatx.com/news/news-details/2024/Moderna--M… -
Moderna
@moderna_tx
June is CMV Awareness Month! Did you know that #cytomegalovirus (CMV) remains the leading infectious cause of birth defects in the United States?
Join us this month as we share the latest information about #cmv, including how to identify it, ways to help protect yourself and your family, patient stories, and research developments. Stay informed and help spread the word! Learn more at nowiknowcmv.com.
#cmvawarenessmonth #stopcmv #nowiknowcmv -
Moderna
@moderna_tx
Join us at @ASCO as we advance #mrna technology in immuno-oncology. We are leveraging mRNA's adaptability to develop a broad portfolio of investigational #cancer therapies across multiple tumor types.
Our pipeline includes individualized approaches designed to harness each patient's immune system to identify and kill cancer cells.
We believe mRNA has the potential to transform cancer care and outcomes. Come explore the possibilities with us at #asco24 in Chicago at booth #13153. Together, we can bring new hope to patients through the power of mRNA. -
Moderna
@moderna_tx
Our vision is to revolutionize #oncology through the power of #mrna. We are delivering on the promise of mRNA science to create a new generation of transformative medicines for patients with #cancer.
Our pipeline in oncology showcases a multi-pronged approach. mRNA technology may provide an opportunity to tailor treatment to an individual patient in addition to being leveraged to address targets more widely expressed on many cancers.
Leveraging over ten years of expertise in mRNA, strategic collaborations, groundbreaking research, and the agility of artificial intelligence, we continue to strengthen our portfolio and increase our potential to improve treatment options for patients with cancer. Find out more about our work in oncology ⬇ -
Moderna
@moderna_tx
#icymi: Earlier today, we announced today that the U.S. FDA has approved mRESVIA® (Respiratory Syncytial Virus Vaccine). The approval was granted under a breakthrough therapy designation and marks the second approved #mrna product from Moderna.
Learn more: -
Moderna
@moderna_tx
There are different types of #viruses, and scientists and researchers have grouped them into categories — like family and genus — based on similar features, like size, shape and the type of #genetic material they carry.
In our first blog in the 'Virology 101' series, learn more about a few types of viruses and how they work: www.modernatx.com/en-US/media-center/all-media/blogs/type… -
Moderna
@moderna_tx
A recent publication in @NatureComms reports that vaccinated individuals are less likely to experience #longcovid symptoms.
Researchers analyzed data from over 323,000 people across the U.S., finding that those with two doses of a COVID #vaccine had a significantly lower rate of post-COVID conditions.
Moderna
@moderna_tx
The study underscores the importance of vaccination in mitigating long-term effects, and follows a push by many lawmakers to enhance research and support for Long COVID.
Learn more ⬇ thehill.com/policy/healthcare/4682325-vaccines-lower-risk… -
Moderna
@moderna_tx
To mark Mental Health Awareness Month, Jerh Collins, Chief Technical Operations and Quality Officer, sat down with Jeff Stohlberg, Director of Benefits, for a conversation about prioritizing well-being in his professional journey and taking time to recharge in our daily lives.
#mham2024This media couldn't be displayed. See it on the original post. -
Moderna
@moderna_tx
We announced today that three abstracts on mRNA-4157 (V940), an investigational #mrna individualized neoantigen therapy, have been accepted for presentation at the 2024 @ASCO Annual Meeting, which will be held May 31 – June 4 in Chicago, IL.
Read more: investors.modernatx.com/news/news-details/2024/Moderna-An… -
Moderna
@moderna_tx
Skin cancer is the most common form of cancer, affecting one in five Americans in their lifetimes. The deadliest form of skin cancer, #melanoma, is much less common, but still leads to approximately 300,000 new cases annually.
This Melanoma and #skincancerawarenessmonth, we’re highlighting the three things you need to know to help protect yourself and your loved ones: www.modernatx.com/en-US/media-center/all-media/blogs/thre… -
Moderna
@moderna_tx
On #clinicaltrialsday, we're sharing a message from @stacy_hurt, a cancer survivor and mom to a child with a ultra-rare chromosomal disorder.
We extend our heartfelt gratitude to clinical trials organizations, the dedicated individuals working there, and participants worldwide. You help bring hope to patients, and it is because of you that we're able to evaluate new treatments, advance research, and deliver the greatest possible impact to human #health.
#ctd2024This media couldn't be displayed. See it on the original post. -
Moderna
@moderna_tx
Four years on, #covid19 remains a worse killer than Flu. A new US study published in @JAMA_current showed that last winter, patients hospitalized for COVID had a 35% higher risk of dying within 30 days than influenza patients.
Learn more ⬇ www.bloomberg.com/news/articles/2024-05-15/four-years-on-… -
Moderna
@moderna_tx
There are more adults ages 35-49 living with #longcovid than any other age group.
Long COVID can impact everyone, regardless of age or health status. The only way to not get Long COVID is to not get COVID.
Learn more about Long COVID: www.modernatx.com/en-US/media-center/all-media/blogs/long… -
Moderna reposted
Citeline
@Citeline
Our final Award of the evening has been handed to Moderna and ProofPilot, winners of the Citeline Award for Clinical Partnership of the Year! Congratulations to all of tonight’s winners! #citelineawards citeline.com/awards/citelineawards/
-
Moderna reposted
Citeline
@Citeline
We're thrilled to announce that Moderna and ProofPilot are the winners of the Citeline Awards for Best Patient-facing Technology Initiative! Congratulations! #citelineawards
citeline.com/en/awards/citelineawards/ -
Moderna
@moderna_tx
Long COVID is having a major impact on the productivity of health systems and the wider workforce.
One recent estimate suggests that #longcovid may have cut labor supply in the European Union by more than 1 million full-time workers in 2022.
Moderna
@moderna_tx
Studies in the US and UK have reached similar conclusions, indicating that the condition has driven the recent increase in workplace absence in many countries.
Read more in this article from Financial Times: www.ft.com/content/bb09a03d-4a87-4cea-ae87-986769fd4680 -
Moderna
@moderna_tx
Your risk of #longcovid rises with each additional infection.
A recent study has shown that by their third COVID infection, patients have a 40% chance of developing Long COVID symptoms.
Learn more about the threat of Long COVID: www.modernatx.com/en-US/media-center/all-media/blogs/long… -
Moderna
@moderna_tx
In our latest #irinsights video, members of our executive team sat down to recap this morning’s earnings report for the first quarter of 2024, and provide more insight into upcoming pipeline milestones, and exciting clinical and corporate developments happening at Moderna.
Watch the full video: www.modernatx.com/en-US/media-center/all-media/blogs/reca… -
Moderna
@moderna_tx
Today, we reported financial results and provided business updates for the first quarter of 2024.
Read more: news.modernatx.com/news/news-details/2024/Moderna-Reports… -
Moderna
@moderna_tx
We’ve just concluded an enriching four days at the @ESCMID Global Congress in Barcelona. Thank you to everyone who joined us! Here are some highlights from Moderna at ESCMID:
🧬 Presented nine presentations, including two late-breaker oral presentations, two oral presentations, and five poster presentations.
🛡️ Advanced Vaccine Research: Shared key research on the utilization of mRNA technology across multiple infectious disease areas, including COVID-19, #influenza, and respiratory syncytial virus (#rsv), in addition to advancing research in the area of #cytomegalovirus.
🗨️ Integrated Symposium Success: Our session on a multi-dimensional perspective on the adult burden of respiratory illness and how mRNA science plays a role was a standout, drawing insights into how mRNA science is transforming healthcare.
We are inspired by our conversations and the potential collaborations that await. Together, we are advancing mRNA research across infectious diseases.
#escmidglobal2024 -
Moderna
@moderna_tx
Earlier this month, Moderna, people.health and community organizations came together to open a mobile clinic in Detroit that provides free lung CT screenings, and evaluate patients for possible lung damage caused by various risk factors.
Moderna
@moderna_tx
For the latest episode of Podnosis, @gliadkovskaya sat down with James A. Mansi, our Vice President of Medical Affairs and Sandra Carey, President of people.health to discuss how the clinic collaborates with community-based organizations and other healthcare providers to carry out its work.
Moderna
@moderna_tx
Listen to the full podcast below ⬇🎙🎧
www.fiercehealthcare.com/providers/podnosis-mobile-clinic… -
Moderna
@moderna_tx
Vaccine-preventable diseases are rising, highlighting the urgency for adult immunization programs - which can return up to 19 times their initial investment to society.
With adult immunization playing a key role in addressing global health challenges, we need to prioritize a prevention-first mindset and shift our focus from treatment to prevention.
Learn more about the health benefits and socio-economic impact of vaccinations in this recent report from @OHENews ⬇
#worldimmunizationweek
Office of Health Economics
@OHENews
Gaps in adult vaccination programs impact global health goals. This report explores health and socioeconomic value across ten countries, focusing on influenza, pneumococcal disease, herpes zoster, and RSV. Urgency rises as vaccine-preventable diseases surge. Find out more below.
-
Moderna
@moderna_tx
What are latent #viruses? What kind of impact can they have long-term?
This #worldimmunizationweek, learn more about latent viruses, how they affect the immunocompromised, and how vaccination could help. -
Moderna
@moderna_tx
Respiratory syncytial virus (#rsv) is a highly contagious #respiratory #virus that can cause severe disease across the age spectrum. Older adults, especially those 65 years and older, are at highest risk for developing severe outcomes from RSV.
This #worldimmunizationweek, learn more about the health burden of RSV, and who is most at risk ⬇ -
Moderna
@moderna_tx
Moderna at @ESCMID 2024! 🔬🌍
We're excited to attend the #escmidglobal Congress in Barcelona, Spain. From key data and research from across our vaccine portfolio, including #covid19, #influenza, respiratory syncytial virus, and #cytomegalovirus, we’re at the forefront of developing vaccines against infectious diseases utilizing #mrna technology.
We will present nine presentations, including two late-breaker oral presentations, two oral presentations, and five poster presentations.
Join us at Booth B6 for insights into how these advances promise to help address the burdens of infectious diseases and the power of mRNA technology. -
Moderna
@moderna_tx
Congratulations to our Chief Legal Officer Shannon Thyme Klinger, who was named a Top 10 Corporate Counsel Award Winner at the 2024 @onconferences Icon Awards!
Shannon steps into every challenge with a heartfelt commitment to making the world a better place. Whether it's for patients, her team, or all of our colleagues worldwide, she shows up—fully, every day.
Thank you, Shannon, for your leadership!
#oncon2024
www.onconferences.com/24-legal-winners -
Moderna
@moderna_tx
Vaccines are one of the greatest public health interventions of the 20th century, second only to clean water in their impact on human health.
For #worldimmunizationweek, learn more about the role of #vaccines in advancing healthier societies in a blog by our Chief Medical Affairs Officer Francesca Ceddia: www.modernatx.com/en-US/media-center/all-media/blogs/vacc… -
Moderna
@moderna_tx
Vaccines work to protect us from diseases by training our immune system to recognize and fight off infections - and they also provide a significant return on healthcare dollars invested.
A recent study from the @OHENews shows that adult vaccines can return up to 19 times their initial investment to society - which translates to billions of dollars in net benefits to society, up to $4,637 per every individual full vaccination course.
Read the full study: www.ifpma.org/initiatives/vaccinesforlife
#worldimmunizationweek #vaccinesforlife -
Moderna
@moderna_tx
Moderna's oncology strategy integrates over a decade of #mrna expertise, strategic partnerships, and cutting-edge AI to research and develop transformative #cancer treatments. We’re actively exploring multiple innovative pathways, including therapies that aim to tailor treatment to each patient's unique cancer profile.
As we dive into the latest developments in oncology at this year’s @ASCO Congress, we look forward to sharing our groundbreaking work in cancer research. With the abstract titles now live, we want to highlight our unwavering commitment to revolutionizing cancer treatment through advanced mRNA technology.
Explore our abstract titles here: meetings.asco.org
#asco24 -
Moderna
@moderna_tx
We’re excited to announce our ongoing collaboration with @OpenAI to co-innovate with a shared vision of AI’s immense potential in the future of business and healthcare. #ai and collaborations like this will be a key component to our ability to scale and maximize our impact on patients.
Watch the video below and read our blog to learn more about our work with #openai: www.modernatx.com/media-center/all-media/blogs/collaborat…This media couldn't be displayed. See it on the original post. -
Moderna
@moderna_tx
Happy #earthday! 🌍💚
As a company working at the intersection of science, technology and health, we understand that the health of our planet is of great importance, and we are committed to doing our part to protect the environment not just today, but every day.
Learn more about our commitment to sustainability by design: preview.modernatx.com/en-US/media-center/all-media/blogs/… -
Moderna
@moderna_tx
We announced today a contract with the Ministry of Health in Brazil (@minsaude) to supply our mRNA COVID-19 vaccine as an integral part of Brazil's 2024 national vaccination campaign against COVID-19.
Under the contract, 12.5 million doses of our mRNA COVID-19 vaccine are anticipated for delivery in the second quarter of 2024, marking a significant milestone in Brazil's ongoing efforts to combat COVID-19.
Read more: investors.modernatx.com/news/news-details/2024/Moderna-An… -
Moderna
@moderna_tx
Today, as many as 16 million Americans may have symptoms of #longcovid, and many have never recovered.
We've come a long way since #covid19 was declared a national emergency, and while we’ve learned to live with the virus as an endemic, there's much we don't understand about Long COVID. At the very least, physicians have a greater understanding that long COVID exists and can cause serious long-term symptoms.
Read more about the progress: www.medscape.com/viewarticle/years-sobering-look-long-cov… -
Moderna
@moderna_tx
It is estimated that 65 million people globally, and as many as 16 million Americans may have symptoms of Long COVID. But what is it? What are its symptoms?
Learn and help spread awareness about #longcovid, which can impact many different parts of the body ⬇ -
Moderna
@moderna_tx
We know today that #viruses like SARS-CoV-2 continuously evolve as changes in their genetic code occur during replication – and these changes and #mutations can also allow viruses to become more resistant to treatments or #vaccines.
In our latest blog post, we take a look at how both #influenza and SARS-CoV-2 viruses evolve, and how virus mutations can impact vaccine efficacy overtime and necessitate seasonal updates.
Read more: www.modernatx.com/en-US/media-center/all-media/blogs/how-… -
Moderna
@moderna_tx
We are proud to be named a @LinkedIn Top Company for the first time, an accomplishment only made possible because of our incredible people.
Moderna is powered by teams who are constantly pushing the boundaries of science and challenging each other to make the impossible possible. From our labs and offices to the manufacturing floor, our teams are changing the future of medicine and making a positive impact on human health.
To our team: We’re so grateful to be part of your career journey. Thank you for bringing your best every day for patients and each other. 🔬🧪👩🏽🔬👨🏽🔬
#linkedintopcompanies
www.modernatx.com/media-center/all-media/blogs/linkedin-t… -
Moderna
@moderna_tx
Happy #worldquantumday! ⚛🌎
Last month at #sxsw2024, our VP of Computational Science Wade Davis joined Heather Higgins, Partner, IBM Computing, in a fireside chat on how #quantum represents the art of the possible, and has the potential to change how we address society’s greatest challenges.
In the video below, Wade covers some of the real-world applications of quantum computing to #mrna science ⬇
Watch their full panel here: youtu.be/vXJHtjTBJyE -
Moderna
@moderna_tx
For over ten years, we have advanced #mrna technology to reimagine how medicines are made. A critical and sometimes overlooked piece of the puzzle is developing and improving delivery methods – or how those mRNA #medicines are delivered to cells for the prevention or treatment of diseases.
Learn more about our different innovative approaches to mRNA medicine delivery: www.modernatx.com/en-US/media-center/all-media/blogs/inno… -
Moderna
@moderna_tx
Over the past four years, Theo has contracted #covid19 a total of three times, and each case has been mild. It's what happens in the weeks and months after the COVID-19 diagnosis that he says has impacted his normal life.
Moderna
@moderna_tx
Theo's story is a stark reminder that #longcovid can affect anyone, regardless of age, and can have lasting impacts well beyond the initial infection.
Read more about his battle with Long COVID: abcnews.go.com/GMA/Wellness/boy-describes-years-long-batt… -
Moderna
@moderna_tx
At #aacr24, we will present data on our investigational triplet therapy, mRNA-2752.
This investigational intratumoral therapeutic is designed to specifically combine two approaches into a single therapy: a T-cell costimulatory signal to strengthen adaptive anti-cancer immune responses and two pro-inflammatory cytokines to ignite and transform an inflammatory response within the tumor microenvironment, with the goal of also minimizing systemic toxicity.
Moderna is investigating mRNA-2752 across a number of tumor types, including ductal carcinoma in situ and advanced #melanoma that has previously been treated with an immune checkpoint inhibitor.
www.abstractsonline.com/pp8/ -
Moderna
@moderna_tx
Congratulations to our Chief Technical Operations and Quality Officer Jerh Collins on being named a finalist for the 2024 Manufacturing Leadership Awards! 🎉
ML Council
@MfgExecutive
Now in its 20th year, the Manufacturing Leadership Awards honor the most outstanding #manufacturing companies & high-performing leaders for groundbreaking use of advanced manufacturing technology.
Learn more & access the complete Finalists list now: manufacturingleadershipcouncil.com/mlc-announces-manufact… -
Moderna
@moderna_tx
Moderna is taking a multipronged approach in #oncology with investigational #mrna candidates targeting multiple cancer types.
One such approach is our investigational individualized neoantigen therapy, which we are developing in collaboration with @Merck, and is being investigated in skin, lung, bladder, and kidney cancer.
Every person and every tumor is one-of-a-kind, arising from a unique set of evolving tumor mutations. With an improved understanding of cancer biology and immunology, the scientific community is making great strides toward accounting for this uniqueness and tailoring treatment to the makeup of a patient’s cancer.
#aacr24 -
Moderna
@moderna_tx
Moderna is exploring the potential of #mrna in immuno-oncology across various #cancer types, harnessing the body’s immune system to identify and kill cancer cells.
We believe the adaptability of mRNA technology can be leveraged to create an innovative and diverse portfolio of investigational cancer therapies, including individualized approaches.
Join us at #aacr24 in San Diego at booth 441 as we continue to showcase the potential of mRNA technology and the possibility of changing cancer care and improving outcomes for patients. -
Moderna
@moderna_tx
🌍 This #worldhealthday, the Moderna Charitable Foundation is proud to announce a multi-year grant awarded to @AMREFUSA, the largest Africa-based healthcare nonprofit, to improve healthcare in Kenya’s Nakuru and Nyeri Counties. This is our second collaboration with Amref Health Africa and continues our commitment to health equity and quality care for underserved populations.
Through this grant, Amref will train more than 1,100 healthcare workers, enhance comprehensive care, and leverage data to optimize health system performance. Our joint efforts with Amref underscore the importance of public and private partnerships in advancing global health.
👉 Learn more about our impact together: modernatx.com/en-US/media-center/all-media/blogs/world-he…
#healthforallThis media couldn't be displayed. See it on the original post. -
Moderna
@moderna_tx
Our CEO Stéphane Bancel recently joined @NasdaqExchange for an episode of Innovation Answered to discuss our vision, our platform, and answer questions about the future of #healthcare and technology innovation.
Watch the full video in the link below ⬇
Nasdaq Exchange
@NasdaqExchange
🩺 Health care reimagined: In this episode of Innovation Answered, leaders from #nasdaqlisted @GEHealthCare, @Moderna_tx, and Dexcom discuss how the healthcare industry is at the cusp of a technological evolution, and how the @InvescoUS QQQ ETF is at the forefront of this evolution, empowering investors to become agents of innovation.
➡️ Watch the full episode here: www.nasdaq.com/campaign/sponsored/invescoqqq/innovation-a… -
Moderna
@moderna_tx
Long COVID has significant societal impacts on the healthcare system and on the economy - and as many as 4 million Americans are out of work because of it.
According to a recent survey from the US CDC, #longcovid cases are surging, and a sudden rise in January has persisted into a second month.
Read more: www.medscape.com/viewarticle/new-data-long-covid-cases-su… -
Moderna
@moderna_tx
Today, we announced that interim data for a first-in-human, phase 1/2 study of mRNA-3927, an investigational #mrna #therapy for propionic acidemia (PA), has been published in Nature. This is the first published clinical data utilizing mRNA therapy for intracellular protein replacement.
mRNA-3927 is a novel investigational mRNA therapy that encodes for the PCC enzyme, and has the potential to replace a missing or dysfunctional enzyme.
The premise has always been that an mRNA-based approach to making #medicine could advance at the pace of information – and we believe that our mRNA platform could change how medicines for rare diseases may be delivered in the future.
Read more: investors.modernatx.com/news/news-details/2024/Phase-12-I… -
Moderna
@moderna_tx
Leveraging our #mrna platform, we continue to build a broad portfolio that seeks to address considerable health burdens, and are dedicated to meeting the urgent and diverse health needs of populations worldwide.
At the 2024 World Vaccine Congress, our leaders will participate in panel discussions and present our research on investigational candidates ranging from individualized neoantigen therapies to mRNA-based vaccines for respiratory syncytial virus.
We look forward to sharing our #science and expertise - come join us: www.terrapinn.com/conference/world-vaccine-congress-washi…
#wvcdc #worldvaccinecongress -
Moderna
@moderna_tx
#mrna can potentially change how we prevent and fight diseases. But how did we get here?
Hear more from Cleo Abram about the years of research that went into studying how mRNA could help teach the body to fight #diseases. ⬇This media couldn't be displayed. See it on the original post. -
Moderna
@moderna_tx
In our latest #irinsights video, our CEO Stéphane Bancel, President Dr. Stephen Hoge, CFO Jamey Mock, and SVP and Head of Development for Infectious Diseases Dr. Jacqueline Miller provide an overview of the key clinical updates presented earlier today at our fifth annual #vaccinesday event.
Watch the full video ⬇
www.modernatx.com/en-US/media-center/all-media/blogs/reca…This media couldn't be displayed. See it on the original post. -
Moderna
@moderna_tx
Today, we will be hosting our fifth annual #vaccinesday, where we will announce clinical and program updates demonstrating advancement and acceleration of our mRNA pipeline. Some key updates include:
- mRNA-1283, our next-generation #covid19 #vaccine, is the fourth respiratory vaccine to successfully meet its Phase 3 endpoints.
- Two more Phase 3 readouts in 2024, including combination vaccine against #flu and COVID-19, and vaccine against CMV, expected in 2024.
- Clinical trial data from three new vaccines against viruses that cause significant burden (Epstein-Barr virus, Varicella-Zoster virus, norovirus) and program advancements.
Read more: investors.modernatx.com/news/news-details/2024/Moderna-Ad…
Join us live for our Vaccines Day presentation here: moderna-vaccines-day-2024.open-exchange.net/registration -
Moderna
@moderna_tx
We announced today that mRNA-1283, our next-generation #covid19 #vaccine, has successfully met the primary endpoints of its Phase 3 clinical trial.
The storage, shelf life and pre-filled syringe presentation of mRNA-1283 could alleviate healthcare provider burden and potentially increase access into new settings to serve public health.
Read more: investors.modernatx.com/news/news-details/2024/Moderna-Ac… -
Moderna
@moderna_tx
This month marked 4 years since #covid19 was declared a global pandemic, and while the threat of severe illness and death has faded, the long-term effects of a COVID-19 infection have reshaped life for millions of Americans.
Read more about the significant public health burden of #longcovid in a blog by Francesca Ceddia, our Chief Medical Affairs Officer ⬇
HLTH
@HLTHEVENT
There is a lot we don’t understand about Long COVID – but let’s focus on what we do know. Read the blog by Francesca Ceddia, Chief Medical Affairs Officer,
@moderna_tx
📖 hlth.com/digital-content/hlth-matters/blog/community-heal… #longcovid #publichealth #healthcare -
Moderna
@moderna_tx
It's all about #proteins. Your body makes >100,000 different kinds of proteins - from enzymes to antibodies - in a process called protein synthesis. And that's where #mrna comes in.
Learn more about how we are studying mRNA to see if one day it can teach our bodies to make its own #medicine ⬇ -
Moderna reposted
STAT
@statnews
Mikael Dolsten, Rose Loughlin and @mmammen share how they navigate the fast-changing landscape of drug development with @damiangarde. #statbreakthrough
-
Moderna
@moderna_tx
Being a creator is at the heart of who we are - and at Moderna, building and carving out new paths is celebrated and necessary for us to change the future of #medicine.
In our latest video, meet members of our Automation Engineering team who are not just dreaming of a better future, but are actively building it, one innovation at a time. 🔬 🦾
www.modernatx.com/media-center/all-media/blogs/moderna-ch…This media couldn't be displayed. See it on the original post. -
Moderna
@moderna_tx
It’s been four years since #covid19 was declared a national emergency, and while we’ve learned to live with the virus as an endemic, millions continue to suffer from long-term effects of a COVID-19 infection.
One such patient is Rachel, a wife and mother to three children, who was diagnosed with #longcovid in May 2021 after a COVID-19 infection two months prior that unbeknownst to her, would turn her life upside down.
Learn more about Rachel's story: www.modernatx.com/en-US/media-center/all-media/blogs/long…
#longcovidawarenessdayThis media couldn't be displayed. See it on the original post. -
Moderna
@moderna_tx
mRNA, or messenger RNA, is a molecule that carries instructions to make a specific protein. It exists in all of the cells in your body, is an essential component of all living organisms and has been in cells for billions of years.
Learn more about the potential applications of #mrna and how we believe it can transform the fight against #diseases ⬇ -
Moderna
@moderna_tx
Latino Americans are almost twice as likely to test positive for #covid19 as White Americans - yet, less than 15% of Latino adults have received their latest COVID-19 shots.
Read more from @MariaTeresa, CEO of @votolatino, on the importance of getting vaccinated against COVID-19: www.modernatx.com/en-US/media-center/all-media/blogs/voto… -
Moderna
@moderna_tx
📢 Join Our #sxsw2024 panels tomorrow!
"Disrupting Cancer Care for the Whole Patient" starts at 10 am CT on the Next Stage, and "Why We Should Be Talking About Quantum" starts at 4 pm CT in Salon J at the Hilton Austin Downtown.
We look forward to seeing you there!
Moderna
@moderna_tx
We're heading south to @sxsw ‘24! Come join us at the Austin Convention Center as we discuss innovations that could power the future of #healthcare – from individualized #medicine to #quantum computing. 🔬⚛
-
Moderna
@moderna_tx
Happy International Women's Day!
Today, we honor the achievements and resilience of women around the globe. At Moderna, we believe that our diversity is our strength, and we're proud to stand for equality and inclusivity every day.
Equal pay for equal work is not just a policy at Moderna; it's a practice embedded in our culture. We are proud to say that we ensure equitable compensation for all our people, recognizing the dedication that everyone brings to helping us achieve our mission.
Thank you to all the women and allies at Moderna who work relentlessly to make a positive impact on human health.
#iwd2024 -
Moderna
@moderna_tx
We are joining the rare disease community to raise awareness for the 300 million people worldwide living with a rare disease. We believe in the potential of #mrna to improve the well-being for those affected by rare diseases, and we are thankful for the participants in our studies and the clinical trial teams working relentlessly to help advance mRNA research.
This #rarediseaseday, @Kyle Holen, MD, Senior Vice President, Head of Development, Therapeutics and Oncology, shares more about our progress, including our clinical trial for GSD1a with the hope of bringing better health to patients like Jordan and so many others affected by rare diseases. Read more: www.modernatx.com/en-US/media-center/all-media/blogs/cele…. -
Moderna
@moderna_tx
We're heading south to @sxsw ‘24! Come join us at the Austin Convention Center as we discuss innovations that could power the future of #healthcare – from individualized #medicine to #quantum computing. 🔬⚛
Moderna
@moderna_tx
On March 10th, join Kyle Holen, @Kris_Carr, and @bradludden at the Next Stage as they discuss changing the future of #cancer care through individualized and holistic approaches - schedule.sxsw.com/2024/events/PP146054
Moderna
@moderna_tx
Later in the day, head to the Hilton Austin Downtown, Salon J where Wade Davis will join Heather Higgins to discuss how quantum computing has the potential to change how researchers, scientists, and engineers address society’s greatest challenges - schedule.sxsw.com/2024/events/PP133385
#sxsw2024 -
Moderna
@moderna_tx
Inborn errors of metabolism are rare #genetic disorders that disrupt the way the body metabolizes or breaks down food.
In this video, @KathyStagni, Executive Director of @OrganicAcidemia Association and mom to Melissa, who lives with Propionic Acidemia, shares how #newbornscreening is giving the world a better picture of the true impact of rare metabolic disorders like methylmalonic acidemia (MMA) and propionic acidemia (PA).
#rarediseaseday -
Moderna
@moderna_tx
In our latest #irinsights video, our CEO Stéphane Bancel and CFO Jamey Mock recap this morning’s fourth quarter of 2023 earnings report, and provide more insight into our financial performance, key milestones, and the exciting clinical and corporate developments happening at Moderna.
Watch the full video: www.modernatx.com/en-US/media-center/all-media/blogs/reca… -
Moderna
@moderna_tx
Today, we reported financial results and provided business updates for the fourth quarter and fiscal year 2023.
Read more: investors.modernatx.com/news/news-details/2024/Moderna-Re… -
Moderna
@moderna_tx
Patient needs are at the center of our work every day, and listening to the patient community is a top priority for us.
Propionic acidemia (PA) is a #raredisease in which the body is unable to process certain parts of #proteins and #lipids properly, which can cause serious health problems. For those caring for someone with PA, the condition becomes a central part of their lives.
In this video, hear from Honey Stecken, who recently shared with us her story of caring for her daughter, Maren, with PA.
#rarediseaseday -
Moderna
@moderna_tx
It is important for everyone to help protect themselves against #covid19, but the stakes are particularly high for the sandwich generation and the ongoing balancing of caregiving and self-care.
In honor of National Caregiver Day, Christy Shaw, our VP & Portfolio Head of Respiratory Vaccines, shares some facts on the benefits of vaccination for not only yourself, but for the vulnerable populations you care for: www.modernatx.com/en-US/media-center/all-media/blogs/navi… -
Moderna
@moderna_tx
In the latest episode of @Bloomberg's Tech Disruptor podcast, our CIO Brad Miller sits down with Sam Fazeli and Mandeep Singh to discuss the data and technology stack powering our #mrna platform, speeding up research and development for #rarediseases, and all things generative #ai.
Listen to the full podcast below 🎙🎧
podcasts.apple.com/us/podcast/moderna-and-drug-discovery-… -
Moderna
@moderna_tx
Inborn errors of metabolism are rare #genetic disorders that disrupt the way the body metabolizes or breaks down food. They are often caused by missing or not completely functional #enzymes, or #proteins, that normally help turn food into energy.
Learn more about organic acidemias, a large and important class of rare inborn errors of metabolism ⬇
#rarediseases -
Moderna
@moderna_tx
Today, as we celebrate International Women and Girls in Science Day, join us as we highlight two Moderna Foundation partners making a difference in working to address inequalities in #stem around gender, race and socioeconomics.
As we work to maximize our positive impact on human health, we will continue to advocate for diversity of thought, champion the role of women in science, and empower the next generation of women STEM leaders. Their contributions are fundamental to the advancement of science and technology.
#idwgis #womeninscience
www.modernatx.com/en-US/media-center/all-media/blogs/cele… -
Moderna
@moderna_tx
#rarediseases are often genetic, caused by a missing or not completely functional protein due to genetic mutations. Cumulatively, there are over 7,000 different types of rare diseases affecting more than 30 million Americans. 🦓
Learn more about rare diseases ⬇
#showyourstripes #rarediseaseday -
Moderna
@moderna_tx
Respiratory syncytial virus (RSV) is a common #respiratory #virus that for some, causes mild, cold-like symptoms. While most people recover in a week or two, some vulnerable populations, like infants and older adults, are more likely to develop severe RSV complications that could require hospitalization.
Cases of #rsv are on the rise again this winter, and as RSV becomes a seasonal concern, it’s critical we understand the virus, its burden, and who is most at risk.
Learn more: www.modernatx.com/en-US/media-center/all-media/blogs/resp… -
Moderna
@moderna_tx
Congratulations to our Chief Executive Officer Stéphane Bancel for being elected to the @theNAEng, in recognition of his distinguished contributions to engineering and the development and manufacturing of pharmaceutical products, including Moderna’s COVID-19 vaccine. Stéphane has served as our Chief Executive Officer since October 2011, and in the 13 years since he joined Moderna, he has led the company from startup to global commercial enterprise. #nae2024
news.modernatx.com/news/news-details/2024/Moderna-Chief-E… -
Moderna
@moderna_tx
Americans of all ages and races are affected by #longcovid - with a staggering 31% of those affected reporting that the symptoms have reduced their ability to carry out daily activities.
Long COVID is more common than you may think. Learn more about how staying up to date with your COVID-19 #vaccine can help: www.modernatx.com/en-US/media-center/all-media/blogs/long… -
Moderna
@moderna_tx
Based on data from 2015-2017, nearly 40% of men and women will be diagnosed with #cancer at some point during their lifetimes - so there is vast potential to impact millions of lives around the globe with innovative treatments and approaches.
In honor of #worldcancerday, Dr. Michelle Brown, our Vice President of INT Oncology, offers her perspective on the future of cancer care and the role #mrna technology could play in improving cancer care.
#closethecaregap
www.modernatx.com/en-US/media-center/all-media/blogs/worl… -
Moderna
@moderna_tx
Last month, more than 130,000 attendees gathered in Las Vegas to kick off 2024 at @CES, one of the largest technology shows in the world.
#ces2024 was our second consecutive year at the event as a #digitalhealth sponsor - and our leaders Stephen Hoge and Brad Miller shared insights from our work with individualized therapies, and harnessing the power of #ai to advance our pipeline.
Read more about our presence at the event, and watch the full sessions ⬇
www.modernatx.com/en-US/media-center/all-media/blogs/CES-… -
Moderna
@moderna_tx
📢 #rarediseaseday is just 29 days away! 💙💜💚
Join us this month to raise awareness for the nearly 400 million people worldwide living with a #raredisease, their families, and their caregivers. 🦓
Learn more about how you can get involved: www.rarediseaseday.org -
Moderna
@moderna_tx
🎉 Exciting news! We are honored to be recognized on @FortuneMagazine's World’s Most Admired Companies list as part of its “All-Star” top-50 companies. 🌟
Fortune’s annual list is considered one of the leading measures of corporate reputation among global organizations and serves as a testament to our transformative #mrna platform and commitment to excellence. This recognition underscores our dedication to advancing our mission and positively impacting communities around the globe by promoting public health, access and equality.
Learn more about our recognition and the Fortune 2024 World’s Most Admired Companies list here: investors.modernatx.com/news/news-details/2024/Moderna-Na… -
Moderna reposted
National CMV
@NationalCMV
During #birthdefects Awareness Month, we want to remind you that #cmv is a leading cause of birth defects.🧡
Spread #cmvawareness with those who are pregnant or planning to be pregnant.
Learn more at www.nationalcmv.org
#stopcmv -
Moderna reposted
WHO/Europe
@WHO_Europe
🆕research shows a staggering 1⃣ . 4⃣ million lives at least were saved by #covid19 vaccination across 34 countries in @WHO_Europe
Read more ➡️ www.who.int/europe/news/item/16-01-2024-covid-19-vaccinat…
We can continue to protect vulnerable populations & save lives through vaccination this winter ❄️#vaccineswork -
Moderna
@moderna_tx
Wastewater monitoring is an early detection tool that can help communities prepare for and take action to address increasing cases of infectious diseases. According to the latest CDC data, the wastewater levels of SARS-CoV-2 are at the 2nd highest level since the pandemic began.
COVID-19’s threat remains persistent in our community – and despite all we’ve learned, there is still so much we have yet to understand about it’s long-term symptoms, known as #longcovid. Learn more: www.modernatx.com/en-US/media-center/all-media/blogs/long… -
Moderna
@moderna_tx
Results from the Phase 2b randomized KEYNOTE-942/mRNA-4157-P201 study, a clinical trial evaluating mRNA-4157 (V940), an investigational individualized #neoantigen therapy (INT), in combination with KEYTRUDA, @Merck's anti-PD-1 therapy, in patients with resected high-risk #melanoma (stage III/IV) following complete resection, were published today in @TheLancet.
This publication details the primary analyses of the ongoing KEYNOTE-942/mRNA-4157-P201 study, including the primary endpoint of recurrence-free survival and secondary endpoints, including distant metastasis-free survival and safety.
www.thelancet.com/journals/lancet/article/PIIS0140-6736(2…
Moderna
@moderna_tx
In December 2023, Moderna and Merck announced follow-up data from the KEYNOTE-942/mRNA-4157-P201 study, providing further data from a planned analysis with a median follow-up of approximately three years. These results are planned to be shared at an upcoming oncology medical conference.
The companies have initiated Phase 3 studies in the adjuvant setting in patients with high-risk melanoma and non-small cell lung #cancer and plan to rapidly expand to additional tumor types.
Learn more: investors.modernatx.com/news/news-details/2023/Moderna-An… -
Moderna
@moderna_tx
According to a report published by the Brookings Institution, Long #covid may be keeping as many as 4 million people out of work in the U.S. – adding up to at least $170 billion in lost wages annually.
COVID-19’s threat remains persistent in our community. Learn more about how staying up to date with your COVID-19 #vaccine can help: www.modernatx.com/en-US/media-center/all-media/blogs/long… -
Moderna
@moderna_tx
Pharmacists play a critical role in daily patient care, with consumers increasingly relying on their local pharmacy for wellness information, routine vaccinations, drug consultations and non-emergency services.
This National Pharmacist Day, we not only celebrate the vital contributions of community pharmacists, but also recognize ways we can simplify their workflow to help improve their experience and patient safety.
www.modernatx.com/media-center/all-media/blogs/National-P… -
Moderna
@moderna_tx
That’s a wrap at #ces2024 - and we're proud to have been a #digitalhealth sponsor for the second consecutive year!
Our President Stephen Hoge joined American College of Cardiology's @AmiBhattMD for a discussion on the potential of mRNA therapeutics in oncology and using AI to drive the future of individualized therapies in #medicine.
Thanks to the Digital Health Summit at @CES for convening partners, customers and policymakers across the #healthcare ecosystem for meaningful conversations that can ultimately effect change in more impactful ways. -
Moderna
@moderna_tx
Our Chief Information Officer Brad Miller stopped by the anchor desk at #ces2024 to talk about #generativeai, #quantumcomputing, and leading the technological innovation at Moderna.
Watch the full interview with @briantong below ⬇
CES
@CES
@moderna_tx stops by the Anchor Desk to talk about the future of patient care and the role AI can play in healthcare.
This media couldn't be displayed. See it on the original post. -
Moderna
@moderna_tx
In the latest episode of the Invest in Progress podcast, our CEO Stéphane Bancel sits down with Tom Slater to discuss the versatility of Moderna's #mrna technology, its future potential, and addressing some of the biggest health needs of our time.
Listen to the full podcast below 🎙🎧
Scottish Mortgage Investment Trust
@ScotMortgage_UK
✨🎙️ Up next on the #investinprogress podcast is @moderna_tx. Find out why we believe, with its focus on innovation and potential to address unmet clinical needs, it offers hope for a healthier future for millions. Listen now: link.chtbl.com/InvestInProgressS2Ep4 Capital at risk.
-
Moderna reposted
CES
@CES
Tune in NOW at the LVCC, North Level 2N250! Join @moderna_tx President Stephen Hoge as he discusses how the power of AI will shape a future class of medicines. www.ces.tech/sessions-events/dhth/dhth05.aspx
-
Moderna
@moderna_tx
Stephen’s session @CES, “The Future of Medicine: Individualized Treatments,” is tomorrow - join him at 9 am PDT!
#digitalhealth #ces2024
Moderna
@moderna_tx
We're back at @CES! On Jan 11, stop by N250 in the North Hall (Level 2) to join our President Stephen Hoge as he discusses how the power of #ai will shape a future class of individualized #medicines. #ces2024
-
Moderna
@moderna_tx
Jamey Mock, our Chief Financial Officer, sat down with Jack Sweeney to talk about Moderna's #mrna technology, pipeline, and appetite for innovation in the latest episode of @CFOTL.
Listen to the full podcast below 🎙🎧
cfothoughtleader.com/cfopodcasts/963-how-a-biotech-disrup… -
Moderna
@moderna_tx
In the third episode of our #irinsights series, our Chief Financial Officer Jamey Mock gives an overview of updates on Moderna’s business and pipeline of #mrna development programs presented earlier today at the 42nd Annual @jpmorgan Healthcare Conference.
Learn more: www.modernatx.com/media-center/all-media/blogs/IR-Insight…
#jpm2024This media couldn't be displayed. See it on the original post. -
Moderna
@moderna_tx
According to latest CDC figures, #covid19 cases are on the rise. Compared with the week prior, the week ending Dec. 30 reported almost 35,000 COVID hospitalizations across the country (a 20.4% increase), with 24 states experiencing a substantial increase in COVID-related hospitalizations.
#vaccination is one of the most effective ways to protect yourself and your loved ones from COVID-19, and it's a proactive step that can significantly reduce the risk of severe disease and hospitalization.
Learn more about getting vaccinated this season: www.modernatx.com/media-center/all-media/blogs/why-you-sh… -
Moderna reposted
BiotechTV
@BiotechTV
𝐒𝐜𝐢𝐞𝐧𝐜𝐞 𝐄𝐱𝐩𝐥𝐚𝐢𝐧𝐞𝐝: @moderna_tx CEO Stéphane Bancel on the future of mRNA therapies.
This media couldn't be displayed. See it on the original post. -
Moderna
@moderna_tx
Jamey Mock our Chief Financial Officer, will present an update on the Company and its pipeline of #mrna development programs on Monday, January 8th, 2024, at 3:45 p.m. PT/6:45 p.m. ET at the 42nd Annual @jpmorgan Healthcare Conference. #jpm2024
Learn more: -
Moderna
@moderna_tx
We're back at @CES! On Jan 11, stop by N250 in the North Hall (Level 2) to join our President Stephen Hoge as he discusses how the power of #ai will shape a future class of individualized #medicines. #ces2024
-
Moderna reposted
BiotechTV
@BiotechTV
New Today: @moderna_tx CEO Stéphane Bancel talks COVID vaccines, RSV, CMV, cancer, and the future of mRNA.
Full video: www.biotechtv.com/post/moderna-stephane-bancel-january-3-…This media couldn't be displayed. See it on the original post. -
Moderna
@moderna_tx
Long #covid may not affect everyone in the same way, but is more common than you think. Fatigue, cough, chest pain, and shortness of breath are some of the more frequent symptoms, but there is a wide range of health problems and outcomes that may persist, resolve, and reemerge over different lengths of time.
Learn more about protecting yourself and your loved ones against long COVID: www.modernatx.com/media-center/all-media/blogs/long-covid -
Moderna reposted
BiotechTV
@BiotechTV
Tomorrow: @moderna_tx CEO Stéphane Bancel joins BiotechTV to discuss what's ahead in 2024.
-
Moderna
@moderna_tx
Through more than a decade of progress and investment in science, Moderna has led in establishing the field of #mrna medicine. As we reflect on the past year, our commitment to leveraging mRNA to deliver transformative medicines for patients has never been stronger. We have the platform, technology, resources and the team to establish a new era of medicine.
Read more in our CEO Stéphane Bancel's annual letter to shareholders for updates on our journey to advance our Mission to deliver the greatest possible impact to people through mRNA medicines: www.modernatx.com/media-center/all-media/blogs/moderna-20… -
Moderna
@moderna_tx
#teammoderna wishes you a #happynewyear, and hope that 2024 brings you health and happiness! ✨🎊
-
Moderna
@moderna_tx
Respiratory syncytial virus (#rsv) is a highly contagious #respiratory #virus that causes severe disease across the age spectrum. Older adults, especially those 65 years and older, are at highest risk for developing severe outcomes from RSV. Learn more ⬇
-
Moderna
@moderna_tx
Our commitment to Environmental, Social, and Governance (ESG) principles is not just a corporate mandate, it's a strategic framework that guides every facet of our operations.
Read the highlights from of our second annual ESG Investor Event, where we highlighted the five key areas of our #esg strategy, reflecting a holistic approach to #sustainability and corporate citizenship: www.modernatx.com/media-center/all-media/blogs/highlights… -
Moderna
@moderna_tx
#teammoderna wishes you a safe and festive holiday season, and hope that 2024 brings you health and happiness! 🎉 🎁
#happyholidays #happynewyear -
Moderna
@moderna_tx
For the second consecutive year, we're proud to be a #digitalhealth sponsor at @CES!
On Jan 11th, hear from our President Stephen Hoge about the role of AI in individualized #medicine, and be sure to enjoy our lounge in the Digital Health space January 9-12. #ces2024
CES
@CES
As #ai continues to develop across sectors, could it help shape a new class of #medicines? On Jan. 11th join @Moderna_tx President Stephen Hoge as he discusses individualized treatments & the future of medicine. #sponsored
Add this session to your CES plan www.ces.tech/sessions-events/dhth/dhth05.aspx -
Moderna
@moderna_tx
As the holiday season approaches and we gather with families and friends to celebrate, it's crucial to look after your own health and help protect your loved ones from #covid19 - and #vaccination is one of the most effective ways to do that!
Not sure if you qualify for the updated COVID vaccine? Take our quick and simple eligibility quiz to find out ⬇
www.modernatx.com/media-center/all-media/blogs/why-you-sh… -
Moderna
@moderna_tx
One therapy, for one patient. We, along with our partner @Merck, are pioneering a new frontier in the fight against #cancer by researching an mRNA-based investigational individualized #neoantigen therapy (INT) with the goal of targeting each patient’s unique cancer cells.
Learn more about how INT works: www.modernatx.com/media-center/all-media/blogs/advancing-… -
Moderna
@moderna_tx
In the second episode of our #irinsights series, our President Dr. Stephen Hoge and Head of Development, Oncology and Therapeutics Dr. Kyle Holen give an overview of the follow-up data from our INT program announced last week, and what the future holds for our #oncology franchise and partnership with @Merck.
Learn more: www.modernatx.com/media-center/all-media/blogs/insight-re…This media couldn't be displayed. See it on the original post. -
Moderna
@moderna_tx
According to latest CDC data, the week ending in Dec 9th reported the highest number of new #covid19 hospital admissions (23,432) thus far this season – which is more than 3x than those from #influenza (7,090).
Learn more about what sets this year’s COVID-19 season apart, and how #vaccination can help keep us and our loved ones protected: www.modernatx.com/media-center/all-media/blogs/Why-Get-Va… -
Moderna
@moderna_tx
What is respiratory syncytial virus (RSV)? #rsv is a highly contagious common #respiratory #virus that usually causes mild, cold-like symptoms, but can be serious, especially for very young children and older adults.
RSV poses a significant burden in the United States each year, leading to approximately 58,000 - 80,000 hospitalizations among children younger than 5 years old and 60,000 - 160,000 among adults 65 years and older. Learn more ⬇ -
Moderna
@moderna_tx
Results from our phase 2–3 efficacy trial of mRNA-1345, an investigational mRNA-based #rsv vaccine, were published today in the in the @NEJM.
This publication details the primary analyses of our ongoing ConquerRSV trial, which is an international phase 2–3 trial to assess the safety and efficacy of the mRNA-1345 vaccine in preventing a first episode of RSV-associated lower #respiratory tract disease in adults 60 years of age or older.
Read more: investors.modernatx.com/news/news-details/2023/Moderna-An… -
Moderna
@moderna_tx
Moderna and @Merck today announced follow-up data from the Phase 2b randomized KEYNOTE-942/mRNA-4157-P201 study, a clinical trial evaluating mRNA-4157 (V940), an investigational individualized neoantigen therapy (INT), in combination with KEYTRUDA, Merck's anti-PD-1 therapy, in patients with resected high-risk #melanoma (stage III/IV) following complete resection.
The companies have initiated Phase 3 studies in the adjuvant setting in patients with high-risk melanoma and non-small cell lung cancer and plan to rapidly expand to additional tumor types.
Learn more: investors.modernatx.com/news/news-details/2023/Moderna-An… -
Moderna
@moderna_tx
In the latest episode of HLTH matters with @SaulWMarquez, our Chief Legal Officer Shannon Thyme Klinger discusses the pivotal role of #ai in Moderna's research and development and the #healthcare industry's need to find a balance between regulating AI and fostering innovation.
Tune in 🎙🎧⬇
HLTH
@HLTHEVENT
Balancing regulation with innovation is crucial when it comes to AI and healthcare.
Shannon Klinger, @moderna_tx, shares her inspiring journey, emphasizing the pivotal role of AI in Moderna's R&D.
Listen in 🎧 hlth.com/digital-content/hlth-matters/podcast/s4-e11-stri… -
Moderna
@moderna_tx
.@Merck and Moderna announced today the initiation of INTerpath-002, a pivotal Phase 3 randomized clinical trial evaluating V940 (mRNA-4157), an investigational individualized neoantigen therapy (INT), in combination with KEYTRUDA (pembrolizumab) for adjuvant treatment of patients with certain types of resected non-small cell lung #cancer.
Learn more: investors.modernatx.com/news/news-details/2023/Merck-and-… -
Moderna
@moderna_tx
Our ESG framework is critical to deliver on our mission.
Moderna
@moderna_tx
We're excited to review our Environmental, Social and Governance (ESG) progress and ambitions at our second #esg day!
Building off our inaugural ESG Day in November 2022, we will highlight the year’s progress on our ESG journey, our efforts to advance global #health and environmental #sustainability, and our commitments to employees and communities.
Learn more: investors.modernatx.com/news/news-details/2023/Moderna-to…Post not available here, view on X
Moderna
@moderna_tx
Purpose-driven employees bring passion for our mission and communities.
Moderna
@moderna_tx
We are continuing to embed sustainability across our supply chain.
-
Moderna
@moderna_tx
We're excited to review our Environmental, Social and Governance (ESG) progress and ambitions at our second #esg day!
Building off our inaugural ESG Day in November 2022, we will highlight the year’s progress on our ESG journey, our efforts to advance global #health and environmental #sustainability, and our commitments to employees and communities.
Learn more: investors.modernatx.com/news/news-details/2023/Moderna-to… -
Moderna
@moderna_tx
This #worldaidsday, we honor and remember those we have lost to the HIV/AIDS epidemic, and recognize our partner organizations that work to address inequalities and help #endtheepidemic.
We continue to be a proud supporter of @FenwayHealth & The @AliForneyCenter - organizations leading the charge in empowering and providing equitable healthcare to underserved communities.
We're also pleased to be a ‘Remembrance Partner' of National @aids_memorial World AIDS Day events, which brings leaders together for conversations on the ongoing efforts to end the epidemic, progress made, and hope for the future. -
Moderna
@moderna_tx
According to latest CDC figures, only about 17% of nursing home residents and 2% of staff are up to date on their #covid19 vaccines.
The pandemic showed how nursing homes can quickly become overwhelmed by the spread of this #virus, and it is crucial to ensure that vulnerable populations and those with underlying health conditions get vaccinated.
Learn more about navigating this fall and winter with confidence: www.modernatx.com/media-center/all-media/blogs/navigate-c… -
Moderna
@moderna_tx
We're proud to announce that we've received an #equality100 score on @HRC Foundation’s Corporate Equality Index, the nation’s foremost benchmarking survey and report measuring corporate policies and practices related to LGBTQ+ workplace equality.
We celebrate our diverse workforce, and are committed to fostering a culture of belonging, inclusion and diversity in all its forms! #cei2023
www.hrc.org/resources/cei-equality-100-award -
Moderna
@moderna_tx
Our executive leadership team kicked off our 5th Annual #volunteerweek by preparing and serving food for the shelter guests at @PineStreetInn! 🍴🍝🍰
Moderna
@moderna_tx
Pine Street Inn provides supportive housing, street outreach, emergency services, job training and connections to employment for Boston's most vulnerable, helps them move from the streets and shelter to a home, and provides support services to help them stay housed. We are proud of our long-standing partnership!
#modernagivesback -
Moderna
@moderna_tx
This #givingtuesday, we’re excited to kick off our 5th Annual #volunteerweek. We’re proud to be volunteering with more than 30 different charitable organizations around the world this year!
From preserving the Rhine River in Basel with Aktion Pinguin, to accompanying people with disabilities in Taipei with @edenfortaiwan, our teams across the globe will come together during the week to give back in our local communities and support those in need.
www.modernatx.com/responsibility/our-commitment -
Moderna
@moderna_tx
This #thanksgivingday, we’d like to say thanks to everyone who makes it possible for us to do what we do. ❤️
Wishing everyone a happy, healthy, and safe Thanksgiving! 🦃 #thanksgiving2023 #turkeyday -
Moderna
@moderna_tx
The holiday season will be filled with wonderful gatherings of family and friends, but it can also come with surges in respiratory disease.
To keep the holidays merry, it’s important that we arm ourselves with the latest facts about #covid19.
Learn more: www.modernatx.com/media-center/all-media/blogs/navigate-c… -
Moderna
@moderna_tx
We are passionate about contributing to the communities where we live and work. That’s why, in 2022, we launched the Moderna Charitable Foundation to support organizations that provide access to quality #healthcare, advance scientific education and innovation, and advocate for diversity and inclusion, particularly in underserved populations.
Learn more about our work with two local nonprofit organizations in the Boston area — @The_BMC’s Good Grief Program and @HeadingHomeInc: www.modernatx.com/media-center/all-media/blogs/aspiring-l… -
Moderna
@moderna_tx
As we navigate #covid19 and #flu in a fast-approaching holiday season filled with travel and celebrations, it is important to prioritize our health.
Learn more about what sets this year’s COVID-19 season apart, what we can do to care for the most vulnerable, and how we can help limit their disruption to this year’s holiday season: www.modernatx.com/media-center/all-media/blogs/Why-Get-Va… -
Moderna
@moderna_tx
Today and every day, we thank our nation's heroes, for their courage, sacrifice, and service.
#veteransday -
Moderna
@moderna_tx
While the pandemic may be over, respiratory virus season is currently in full swing, and vaccination is a key way to help protect yourself and your vulnerable loved ones.
As we approach the holiday season on this #worldimmunizationday, let's remember the importance of staying up-to-date with our vaccines.
www.modernatx.com/media-center/all-media/blogs/staying-he…
#vaccineswork -
Moderna
@moderna_tx
Our mission to deliver the greatest possible impact through #mrna #medicines goes hand in hand with our commitment to innovation.
For the second year running, we are excited to be on the @Deloitte Technology #fast500 - a diverse group of North American companies across industries, all pushing the boundaries of innovation.
www2.deloitte.com/us/en/pages/technology-media-and-teleco… -
Moderna
@moderna_tx
As a platform company with data at its core, Moderna is well positioned to scale using AI. #aiday
Moderna
@moderna_tx
Today, we will unveil our comprehensive #ai and digital strategy at our second Digital Investor Event.
The presentation will highlight our leading position in AI-powered innovation, our ability to harness the power of AI to improve efficiency and scalability across the value chain, and the development of an AI-centric culture.
Learn more: investors.modernatx.com/news/news-details/2023/Moderna-Hi…Post not available here, view on X
Moderna
@moderna_tx
The informational nature of mRNA technology lends itself to design and optimization using AI.
Moderna
@moderna_tx
Recognizing the power of #ai, we are now rapidly expanding our use of AI across all of Moderna and embracing the idea of transforming the way we work.
-
Moderna
@moderna_tx
Today, we will unveil our comprehensive #ai and digital strategy at our second Digital Investor Event.
The presentation will highlight our leading position in AI-powered innovation, our ability to harness the power of AI to improve efficiency and scalability across the value chain, and the development of an AI-centric culture.
Learn more: investors.modernatx.com/news/news-details/2023/Moderna-Hi… -
Moderna
@moderna_tx
We are proud to be ranked #1 on @biospace's Best Places to Work list of large employers for the third year running! 🎉
This report highlights the organizations recognized as the most sought-after employers by the life sciences community, with a particular focus on culture and innovation.
#bestplacestowork #teammoderna
investors.modernatx.com/news/news-details/2023/Moderna-To… -
Moderna
@moderna_tx
Join us at @sitcancer's 38th Annual Meeting in San Diego, CA from November 1-5, where we will be presenting the latest updates from our #oncology pipeline!
Moderna
@moderna_tx
Our representatives will also be at booth #321 to answer your queries about our oncology research. We look forward to meeting you - stop by and say hello!
#sitc23 -
Moderna
@moderna_tx
We’re excited to launch a new video series, IR Insights, to keep you up to date on the Moderna story. Our first installment in the series features our CEO Stéphane Bancel, President Stephen Hoge, and CFO Jamey Mock recapping this morning’s third quarter of 2023 earnings report.
Click here to watch the full video: www.modernatx.com/media-center/all-media/blogs/recapping-… -
Moderna
@moderna_tx
Today, we're reporting financial results and providing business updates for the third quarter of 2023.
Read more: investors.modernatx.com/news/news-details/2023/Moderna-Re… -
Moderna
@moderna_tx
It’s @GPTW_US #certificationnationday, and we're excited to celebrate!
A big shoutout to #teammoderna - thank you all for bringing your whole selves to work, embracing our Mindsets, and helping make Moderna a #greatplacetowork 💯 -
Moderna
@moderna_tx
Why do we like candy? This #halloween, learn more about what drives our love for sweet foods! 🍭🍫
#happyhalloween 👻🎃🧪 -
Moderna
@moderna_tx
We have entered into a strategic partnership with @CEPIvaccines that will harness our #mrna platform to accelerate the development of #vaccines against viral disease outbreaks that threaten global health.
The work undertaken as part of this partnership could expand the infectious disease targets for mRNA vaccine technology and strengthen pandemic preparedness and public health efforts in alignment with the 100 Days Mission, a global goal to compress vaccine development timelines to 100 days.
Learn more: investors.modernatx.com/news/news-details/2023/CEPI-and-M… -
Moderna
@moderna_tx
We welcome over 200 representatives from Australia’s mRNA-interested community, meeting for the second year in Melbourne for Moderna’s Advances in #mrna Science (AIMS) Conference.
We’re delighted to have international guests Prof Barney Graham, @MSMEDU and Prof Robin Shattock, @ImperialCollege join us this year with presentations exploring mRNA’s role in the future of vaccinology and how pathways can be accelerated!
#aims2023 -
Moderna
@moderna_tx
We give our people a platform to change medicine - and an opportunity to change the world. Here, collaboration and innovation thrive, helping us to push boundaries, and develop potentially groundbreaking treatments for patients worldwide.
Hear more from #teammoderna ⬇ -
Moderna
@moderna_tx
We are excited to be recognized as one of the world’s top #biopharma employers by @ScienceCareers for the 9th consecutive year! 🏆🎉
Learn more about the recognition here: investors.modernatx.com/news/news-details/2023/Moderna-Na…
#sctopemployers -
Moderna
@moderna_tx
What is respiratory syncytial virus (RSV)? #rsv is a highly contagious common respiratory virus that usually causes mild cold-like symptoms, but can be serious for very young children and older adults. This October, #rallyagainstrsv by spreading awareness.
#rsvawarenessmonth -
Moderna
@moderna_tx
We announced today that the first participant has been dosed in a Phase 3 study of our combination #vaccine candidate against #influenza and COVID-19 (mRNA-1083) in the U.S.
Phase 3 study is expected to enroll approximately 8,000 adults in the Northern Hemisphere, and follows data from the Phase 1/2 trial.
Read more: investors.modernatx.com/news/news-details/2023/Moderna-An… -
Moderna
@moderna_tx
Cancer continues to cast a wide shadow, and in 2020 alone, the global impact of #cancer escalated to over 19 million new cases and 10 million deaths.
However, the way cancer is treated is changing, and we now have the potential to customize treatment to the individual.
Learn more about the potential of #mrna to address challenges in cancer research and advance cancer care: www.modernatx.com/media-center/all-media/blogs/revolution… -
Moderna
@moderna_tx
Dr. Jeffrey S. Weber’s presentation starts shortly - join him at the Valencia Auditorium - Hall 10. #esmo23
Moderna
@moderna_tx
Individualized neoantigen therapies (INTs) are an innovative approach that tailor treatment to each patient's individual #cancer, and are designed and produced based on the specific mutational signature of the DNA sequence of the patient’s tumor.
Join us at the #esmo23 congress in Madrid, Spain from 20-24 October, where we will be presenting the latest updates from our INT program!
On October 23rd, Dr. Jeffrey S. Weber we will be presenting clinical results and treatment outcomes from our Phase 2b KEYNOTE-942/mRNA-4157-P201 trial.
Our representatives will also be at booth #588 to answer your queries about our #oncology research. We look forward to meeting you - stop by and say hello!
Learn more: www.esmo.org/meeting-calendar/esmo-congress-2023 -
Moderna
@moderna_tx
Individualized neoantigen therapies (INTs) are an innovative approach that tailor treatment to each patient's individual #cancer, and are designed and produced based on the specific mutational signature of the DNA sequence of the patient’s tumor.
Join us at the #esmo23 congress in Madrid, Spain from 20-24 October, where we will be presenting the latest updates from our INT program!
On October 23rd, Dr. Jeffrey S. Weber we will be presenting clinical results and treatment outcomes from our Phase 2b KEYNOTE-942/mRNA-4157-P201 trial.
Our representatives will also be at booth #588 to answer your queries about our #oncology research. We look forward to meeting you - stop by and say hello!
Learn more: www.esmo.org/meeting-calendar/esmo-congress-2023 -
Moderna
@moderna_tx
#covid19 remains a significant health threat. According to the CDC COVID data tracker, in the last week, 33 states have recorded more than 10% of tests as positive, and there have been more than 16,000 hospitalizations nationwide.
Now that we are in the height of the respiratory #virus season, it is important to keep yourself and your loved ones protected – and one of the best ways to do that is by staying up to date on your vaccines. The flu and COVID-19 vaccines help protect against severe outcomes – and the CDC states that the two #vaccines can be safely administered together.
Learn more: www.modernatx.com/media-center/all-media/blogs/better-tog… -
Moderna reposted
Billie Jean King
@BillieJeanKing
Living a healthy lifestyle includes scheduling yearly check-ups and staying up-to-date on vaccinations.
One of the ways to stay healthy this season is by getting the updated COVID-19 vaccine.
Read more in this blog, in partnership with @moderna_tx: www.modernatx.com/media-center/all-media/blogs/champion-y…. -
Moderna
@moderna_tx
Today we released an updated statement regarding anticipated 2023 COVID-19 sales: investors.modernatx.com/Statements--Perspectives/Statemen….
-
Moderna
@moderna_tx
That's a wrap! We're grateful to @IDWeekmtg for the opportunity to participate in and present at #idweek2023. We would like to thank all the researchers, clinicians, advocates and staff that made the meeting such a success - and the attendees who joined us in Boston and online!
-
Moderna
@moderna_tx
Join Angela Branche, MD, William Fischer, PhD, and Buddy Creech, MD, MPH, at our @IDWeekmtg Learning Lounge today at 12:15 pm EDT for a discussion on the importance of establishing infectious disease specialists as vaccinology experts within communities, and exploring the challenges providers face with patients when recommending COVID-19 vaccination.
Find more details about the learning lounge: idweek2023.eventscribe.net/index.asp?presTarget=2382369
#idweek2023 -
Moderna
@moderna_tx
As we continue to highlight our latest research in our infectious disease portfolio at #idweek2023, we will be presenting two late-breaking abstracts, one on the impact of age and booster timing on #covid19 outcomes, and the other detailing results from the Phase 2 trial of mRNA-1647, Moderna’s investigational mRNA-based vaccine against #cytomegalovirus (CMV).
Learn more: www.modernatx.com/media-center/all-media/blogs/IDWeek -
Moderna
@moderna_tx
Stop by our @IDWeekmtg Learning Lounge today at 11:15 am EDT to hear from Stuart H. Cohen, MD, Medical Director of Hospital Epidemiology and Division Chief, Infectious Disease, @ucdavis, as he discusses the enduring impact of #covid19 on public health and how vaccination can help address the evolving needs for protection against COVID-19, especially in higher-risk populations.
Find more details about the learning lounge: idweek2023.eventscribe.net/index.asp?presTarget=2382269
#idweek2023 -
Moderna
@moderna_tx
At @IDWeekmtg 2023? Stop by our booth #2208 to take an immersive virtual reality tour of Moderna’s manufacturing facility, and explore the world of #mrna therapeutics manufacturing!
#idweek2023This media couldn't be displayed. See it on the original post. -
Moderna
@moderna_tx
Today kicks off @IDWeekmtg 2023, one of the leading infectious disease events in the world – and we are looking forward to engaging with the infectious disease community from around the globe.
We will be presenting 15 posters and two late-breaking oral presentations that highlight our latest research in our infectious disease portfolio, and hosting two learning lounges to foster fruitful discussion on the future of #covid19 vaccination.
Learn more about our presence at #idweek2023, join us at booth 2208!
www.modernatx.com/media-center/all-media/blogs/IDWeek -
Moderna
@moderna_tx
Shannon’s session @HLTHEVENT, “Empowering Communities to Build Resilient Health Systems in Africa,” starts shortly - join her at the Impact Stage at 2:45 pm PDT!
@hlthfoundation #healthequity
Moderna
@moderna_tx
We're back at @HLTHEVENT! On Oct. 9, stop by the Sky Stage to hear our Chief Information Officer Brad Miller discuss generative #ai, and the Impact Stage to hear our Chief Legal Officer Shannon Thyme Klinger discuss building resilient #health systems in Africa. #hlth2023.
-
Moderna
@moderna_tx
Brad’s session @HLTHEVENT, “A Drug Discovery Renaissance,” starts shortly - join him at the Sky Stage at 11 am PDT!
#hlth2023 #ai
Moderna
@moderna_tx
We're back at @HLTHEVENT! On Oct. 9, stop by the Sky Stage to hear our Chief Information Officer Brad Miller discuss generative #ai, and the Impact Stage to hear our Chief Legal Officer Shannon Thyme Klinger discuss building resilient #health systems in Africa. #hlth2023.
-
Moderna
@moderna_tx
We announced today positive interim results from the Phase 1/2 trial of mRNA-1083, an investigational combination #vaccine against #influenza and #covid19. Our investigational combination vaccines are designed to deliver value to individuals, providers and healthcare systems.
Read more: investors.modernatx.com/news/news-details/2023/Moderna-An… -
Moderna
@moderna_tx
#covid19 is still a significant health threat - leading to more than 19,000 hospitalizations just last week.
Staying up to date on #vaccinations, combined with other proactive steps, can help us successfully navigate the upcoming season with minimal disruption and protect vulnerable populations from severe illness.
Read our recent blog to learn more about the 2023–2024 COVID-19 season: www.modernatx.com/media-center/all-media/blogs/3-things-a… -
Moderna
@moderna_tx
We're back at @HLTHEVENT! On Oct. 9, stop by the Sky Stage to hear our Chief Information Officer Brad Miller discuss generative #ai, and the Impact Stage to hear our Chief Legal Officer Shannon Thyme Klinger discuss building resilient #health systems in Africa. #hlth2023.
-
Moderna
@moderna_tx
🎉 Congratulations to Katalin Karikó and Drew Weissman on winning the 2023 #nobelprize in Physiology or Medicine! Their work in #mrna research has helped pave the way for transformative medicines and bring us closer to conquering some of the most challenging diseases. Thank you for your contributions to mRNA research!
The Nobel Prize
@NobelPrize
BREAKING NEWS
The 2023 #nobelprize in Physiology or Medicine has been awarded to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19. -
Moderna
@moderna_tx
Congenital cytomegalovirus (CMV) affects approximately 30,000 babies in the U.S. annually, and is one of the most common preventable causes of neonatal disability.
Learn more about how #newbornscreening can have a big impact on #cmv prevention ⬇
#2023nbs #nbs60years -
Moderna
@moderna_tx
We're thrilled to share that our Chief Human Resources Officer @traceyrfranklin was named to the 2023 @INvolvePeople Heroes Top 100 Women Executives list!
This list celebrates a global group of role models championing inclusion, driving strategic change within their organizations, and increasing gender diversity in the workplace.
Congratulations, Tracey!
heroes.involverolemodels.org/poll/2023-top-100-women-exec… -
Moderna
@moderna_tx
Proud to be a #flagshipfounded company.
#weareflagship
Flagship Pioneering
@FlagshipPioneer
At Flagship, we believe the profound, urgent challenges of today and tomorrow will be best met by taking bold scientific leaps. #weareflagship
This media couldn't be displayed. See it on the original post. -
Moderna
@moderna_tx
For the second consecutive year, we're proud to be a health equity sponsor at @HLTHEVENT! Join us October 8-11 in Las Vegas in support of HLTH’s charter to elevate humanity as we use #mrna technology to create a new category of medicines.
From the impact of generative AI on drug discovery and development to building resilient health systems in Africa, learn more about our presence at #hlth23 in our latest blog: www.modernatx.com/media-center/all-media/blogs/creating-b… -
Moderna
@moderna_tx
The #gracehoppercelebration is in full swing, and we're thrilled to be part of this incredible event! Come join us at booth #1100 to learn about how #ai is accelerating our mission to deliver the greatest possible impact to people through #mrna medicines, and how you can too!🧬🔬
-
Moderna
@moderna_tx
We are thrilled to share that our @CEO Stéphane Bancel was named to the @BosBizJournal's Power 50 list, which includes leaders who are breaking barriers, driving change and building a better Boston.
We are grateful to Stéphane for emboldening #teammoderna to be #changemakers, as we continue to make historic strides under his leadership.
Boston Business Journal
@BosBizJournal
The Boston Business Journal has released its annual list of the region’s 50 most influential people who are using their power to improve the community. www.bizjournals.com/boston/news/2023/09/21/boston-busines…
-
Moderna
@moderna_tx
In recognition of #worldcancerresearchday, Michelle Brown, our VP, Portfolio Leadership for Individualized Neoantigen Therapy, explains how #mrna could individualize how we approach cancer.
We remain committed to doing whatever it takes to accelerate progress in the oncology space – this is just the beginning of our fight against #cancer. -
Moderna
@moderna_tx
Will you be joining us at the upcoming #gracehoppercelebration in Orlando next week? We would love to connect with you and share how we're using our technology platform to create a new generation of medicines for patients. Save the date for September 26th – 29th, and join us at booth #1100!
Learn about our presence at @GHC '23, and how you can change way more than just your job in our latest blog: www.modernatx.com/media-center/all-media/blogs/celebratin…
See you there! #ghc23 -
Moderna
@moderna_tx
September marks the start of respiratory infection season, which is when #flu and #covid19 cases are expected to be at their highest. Whether you are at increased risk for severe complications or someone you love is, getting protection from both diseases can help prevent the spread of infection to those who are more vulnerable.
Read our latest blog to learn more about how getting your Flu and COVID-19 #vaccines at the same time can keep you healthy this fall: www.modernatx.com/media-center/all-media/blogs/better-tog… -
Moderna
@moderna_tx
Proud to join @SecBecerra, @pfizer and @CVSHealth today united in our commitment to #publichealth and encouraging everyone to stay up to date on their #covid19 and #flu vaccines!
Secretary Xavier Becerra
@SecBecerra
Working with our private sector partners at @moderna_tx & @pfizer, who joined us for a press conference at @CVSHealth today, we were able to make the HHS Bridge Access Program a reality, removing cost as a barrier to COVID-19 vaccine access for uninsured & underinsured adults.
-
Moderna reposted
Longwood Healthcare Leaders
@LongwoodLeaders
Wonderful learning about innovative commercial models with @moderna_tx @arpagaray, @AkiliLabs @EddieMartucci, @Ocugen Mike Shine @OvidRx @JasonTardio & @klickhealth Brian Fox! #longwoodhealthcareleaders
-
Moderna reposted
Concordia
@ConcordiaSummit
We are talking Collaborative Efforts to Build Resilient Healthcare Systems at #concordia23
-
Moderna
@moderna_tx
Our Chief Legal Officer Shannon Klinger will be joining @_AnilSoni, @KarlHofmannPSI, Elisabeth Staudinger, and Alejandro Rincón to discuss ways to drive forward innovative solutions to global health challenges and build resilient health systems @ConcordiaSummit.
Tune in live today @ 16.25 CEST ⬇ -
Moderna
@moderna_tx
In recognition of #worldpatientsafetyday2023, José Vega, our SVP, Chief Safety Officer, explains Moderna’s unwavering commitment to #patientsafety.
-
Moderna
@moderna_tx
What is #newbornscreening? Which conditions are screened for at birth?
This Newborn Screening Awareness Month, learn more about this public health service that reaches almost 4 million babies born in the US each year ⬇
#2023nbs #nbs60years -
Moderna
@moderna_tx
In partnership with @NatureConf, we're organizing 'Cracking the Code: The Dawn of Nucleic Acid Medicines' — a conference to discuss recent clinical successes, and current and upcoming challenges in the development of nucleic acid #medicines.
By bringing together academics in basic and translational research and their peers in thriving #biotechnology companies and promising start-ups, the conference aims to foster dialog and to spearhead collaborations.
Join us the conference: conferences.nature.com/event/27e02cc5-5f15-4297-a746-a4ed… -
Moderna
@moderna_tx
We announced today that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending marketing authorization for our updated #covid19 #vaccine, in individuals six months of age and older.
Following the CHMP’s positive opinion, the European Commission will make an authorization decision on the use of Moderna’s updated COVID-19 vaccine for autumn/winter 2023.
Read more: investors.modernatx.com/news/news-details/2023/EMA-Commit… -
Moderna
@moderna_tx
Moderna was founded and built to use nature’s information molecule, #mrna, to treat and prevent disease. 🔬
Post not available here, view on X
Moderna
@moderna_tx
Our four franchises provide foundation for future growth.
Moderna
@moderna_tx
View the full presentation for our seventh annual Research & Development Day: investors.modernatx.com/events-and-presentations/events/e…
-
Moderna reposted
Nasdaq Exchange
@NasdaqExchange
N100 member @moderna_tx is ringing in its 2023 R&D day at MarketSite. 🛎️ 🧬
In the 13 years since its inception, Moderna has carved out a new category of medicine that harnesses the power of mRNA to prevent and treat disease. We are proud to call $MRNA #nasdaqlisted. -
Moderna reposted
Nasdaq Exchange
@NasdaqExchange
.@moderna_tx is on a mission is to deliver the greatest possible impact to people through mRNA medicines.🔬
Today, $MRNA rings the @nasdaqexchange Opening Bell to celebrate its upcoming 5th listing anniversary and to kick off its R&D day here at MarketSite, where they will share updates around how they are transforming and innovating the development of life-changing treatments and vaccines. #nasdaqlisted -
Moderna reposted
Nasdaq Exchange
@NasdaqExchange
Welcoming @moderna_tx to the @NasdaqExchange Opening Bell. x.com/i/broadcasts/1BdGYyZydvDGX
-
Moderna
@moderna_tx
We're excited to be at @NasdaqExchange for our seventh annual Research & Development Day! Follow along Nasdaq's Twitter for live updates of Moderna at the Opening Bell 🔔 : x.com/NasdaqExchange
-
Moderna
@moderna_tx
Moderna was founded and built to use nature’s information molecule, #mrna, to treat and prevent disease. Staying true to our mission, over the next five years, we expect to advance up to 50 new candidate medicines into clinical trials across established and new modalities. This is just the beginning of the #mrnage.
Today at our seventh annual Research & Development Day, our team will announce business and clinical updates across our franchises, including new data on our Phase 3 #flu vaccine trial. Read more: investors.modernatx.com/news/news-details/2023/Moderna-Ex…
Tune in to our R&D Day presentation starting at 1 pm ET today: moderna-r-d-day-and-business-updates-sep-2023.open-exchan… -
Moderna reposted
Nature Conferences
@NatureConf
Our event exploring recent clinical and research developments of #nucleicacid medicines is now open! Get your tix and submit abstracts at conferences.nature.com/CrackingCode
In partnership with @moderna_tx @Alnylam @WPI @UMassChan @Nature @natBME @NatureBiotech @NatImmunol @NatRevDrugDisc -
Moderna
@moderna_tx
We announced today that the U.S. FDA has approved the supplemental Biologics License Application for Spikevax® for ages 12 years and above. The updated #vaccine will be available in pharmacies across the U.S. in the coming days. Read more ⬇
-
Moderna
@moderna_tx
Moderna and @immatics announced today a strategic research and development collaboration to pioneer novel and transformative therapies for #cancer patients with high unmet medical need.
This broad multi-platform collaboration will leverage the deep scientific expertise and core operational capabilities of both companies, combining Immatics’ TCR platform with Moderna’s cutting-edge #mrna technology, and span various therapeutic modalities including biospecifics, cell therapy and cancer vaccines.
Learn more: investors.modernatx.com/news/news-details/2023/Moderna-an… -
Moderna
@moderna_tx
Welcome to Moderna Night at the @usopen! 📸🎾🧬
#usopen2023 -
Moderna
@moderna_tx
For the second year, Moderna is proud to be a partner at the #usopen2023 - and tonight’s #modernanight! If you’re at the @usopen, join us at Arthur Ashe for a special evening - and follow along on our Instagram for updates! 📸🧬🎾
-
Moderna
@moderna_tx
As we approach the fall and winter seasons, it’s important to acknowledge that #covid19 is still a significant health threat and recent data shows a rise in infections and hospitalizations.
Updated #vaccines, combined with other proactive steps, can help us successfully navigate the upcoming season with minimal disruption and protect vulnerable populations from severe illness.
Read our latest blog about how staying up to date on your vaccinations, especially during the respiratory virus season, can help in slowing the spread: www.modernatx.com/media-center/all-media/blogs/3-things-a… -
Moderna
@moderna_tx
We announced today clinical trial data for our updated COVID-19 vaccine candidate in humans against BA.2.86 (Pirola), a variant under monitoring. Read more ⬇
-
Moderna
@moderna_tx
We're progressing towards the final week of the @usopen - but there’s still time to give yourself a US Open champion’s experience! 🎾
Drop by our booth located by the grandstand to get a cool picture of yourself signing the camera lens emailed to you!
#usopen2023 -
Moderna
@moderna_tx
One of the most powerful tools to protecting public health is #immunization. Immunizations alone are estimated to save 3.5–5 million lives each year.
This National Immunization Awareness Month, we are reiterating our commitment to vaccine innovation that help address today’s biggest #publichealth threats.
Read more in our latest blog: www.modernatx.com/media-center/all-media/blogs/immunizati…
#niam2023 #vaccineswork -
Moderna
@moderna_tx
This National Immunization Awareness Month, Moderna is proud to be at the forefront of vaccine #science, broadening horizons for healthier futures.
#vaccineswork #niam2023 -
Moderna
@moderna_tx
Tennis legend Arthur Ashe's career included an impressive three Grand Slam titles - but he also used his platform to launch a parallel path as an advocate for equity and inclusion for all Blacks and minorities.
Ashe is a #changemaker because he was known well for one thing, but stood for so much more. He didn’t just win at tennis; he changed the future of sports and what it looks like to be a champion.
Read our latest blog to see how Arthur Ashe became a #healthcare changemaker: www.modernatx.com/media-center/all-media/blogs/being-bold -
Moderna
@moderna_tx
He changed the rules, he changed the game, and he changed the world.
At this year’s @usopen, we honor the legacy of the late Arthur Ashe, the only Black man ever to win the singles titles at @Wimbledon, the US Open, and the @AustralianOpen. He was also an advocate for disease awareness, health equity, and social justice.
Here’s to the #changemakers.
#usopen2023This media couldn't be displayed. See it on the original post. -
Moderna
@moderna_tx
Today we commemorate Women’s Equality Day and celebrate building a culture at work that embraces gender diversity and provides equal opportunities.
At Moderna, we’re proud of how far we’ve come, but realize there is more work to be done on our part in creating a more equitable world.
#womensequalityday #embraceequity -
Moderna
@moderna_tx
Fan week might be coming to an end, but you can still give yourself a @usopen champion’s experience! 🎾
Drop by our booth located by the grandstand, sign the camera lens, and the picture will be emailed to you! 📸
#usopen2023 -
Moderna
@moderna_tx
Myth: It is better to have the disease than become immune through #vaccines.
Fact: Vaccine-preventable diseases could have serious complications that may be avoided through immunization. Vaccines stimulate the immune system to produce an immune response similar to natural infection, without potential complications from the #disease. 💪🏽
#niam #vaccineswork -
Moderna
@moderna_tx
We’re excited to be back as a proud sponsor of the @USOpen! 🎾 Our booth is ready for fan week, located near the Grandstand. Stop by to learn more about the promise and potential of #mrna to change the future of medicine.
#usopen2023 -
Moderna reposted
IRC - International Rescue Committee
@RESCUEorg
We were founded in 1933 to offer hope and assistance to those in need.
Nearly a century later, our 40,000 staff and volunteers all over the world continue to carry on this legacy.
Celebrate with us this #worldhumanitarianday: www.rescue.org/article/meet-7-humanitarian-frontline-work… -
Moderna
@moderna_tx
Myth: I don't need to be vaccinated if vaccine-preventable #diseases are rare or don't exist in my country.
Fact: You should get all vaccines recommended as part of your country's national immunization programs. As the coronavirus pandemic has reminded us, the potential exposure to vaccine-preventable diseases is unfortunately only a plane ride away in our globalized world. 🌎
#niam #vaccineswork -
Moderna
@moderna_tx
We announced today preliminary clinical trial data results for our updated #covid19 #vaccine candidate for the fall 2023 vaccination season against EG.5 and FL.1.5.1 variants. Learn more ⏬
-
Moderna
@moderna_tx
We’re excited to announce the first Canadian recipient of our Moderna Global Fellowship Program, from The University of British Columbia!
Dr. Gabrielle Gaultier was awarded a three-year fellowship for her project that aims to quantify humoral immune responses to #covid19 infection and vaccination in Canadian children through quantification of anti-spike #protein IgG concentration and function as well as B cell responses. The information gained from this work will be used for the optimization of COVID-19 vaccination schedules for children as well as contribute to establishing correlates of protection against SARS-CoV-2 infection.
Congratulations, Gabrielle!
#modernafellowship -
Moderna
@moderna_tx
#didyouknow 💡 In 94 low-and middle-income countries, every dollar invested in #vaccination across 10 antigens between 2011-2020 resulted in a net return of 44 times the cost. Watch the video to learn more 👇🏽
#niam2023 #vaccineswork -
Moderna
@moderna_tx
Latent viruses - such as cytomegalovirus (#cmv) and Epstein-Barr virus (#ebv) - can stay in your body for a long period of time, and cause serious and lasting health problems when they reawaken.
Hear more from @cleoabram about how we're researching #mrna vaccines that could one day help prevent people from getting infected with latent #viruses. -
Moderna
@moderna_tx
We're proud to join the ‘Net Zero: The Integrity Pathway’ campaign, which showcases best practices and innovative solutions in carbon reduction and offsetting.
Our team was excited to share how we are embedding #sustainability by design in our current and future facilities, and the progress we are making towards achieving our net-zero targets.
Watch the full video, made in partnership with the @IETA and @ICROA, to learn more ⏬
#netzero #theintegritypathwayThis media couldn't be displayed. See it on the original post. -
Moderna
@moderna_tx
Ticks are more active in warm weather, so it's important to take steps to stay safe and enjoy your summer without any tick troubles. 🦠☀
Learn more about what Lyme disease is, how to prevent it, and what treatment looks like in our latest blog from Obadiah Plante, our Senior Director of Infectious Diseases Research.
www.modernatx.com/media-center/all-media/blogs/ticks-are-…
#lymedisease -
Moderna
@moderna_tx
August is National Immunization Awareness Month! What is #immunization? What is the difference between immunization and #vaccination? Watch the video to learn more 👇🏽
#niam #vaccineswork -
Moderna
@moderna_tx
Today, we're reporting financial results and providing business updates for the second quarter of 2023.
Read more: investors.modernatx.com/news/news-details/2023/Moderna-Re… -
Moderna
@moderna_tx
Each person’s #cancer is different, which is why it can be difficult to treat. Hear more from @cleoabram about how we’re researching an individualized treatment approach specific to each person's #tumor, with the goal of training their immune system to fight back.
This media couldn't be displayed. See it on the original post. -
Moderna
@moderna_tx
Happy #rnaday! Today, we celebrate the RNA, one of the most versatile biomolecules we have seen come to life. Because of RNA, we have #mrna - and one strand of #mrna could change how we stand up to multiple diseases – from the widespread to the extremely rare! 🧬🔬
This media couldn't be displayed. See it on the original post. -
Moderna
@moderna_tx
As we continue to build our company, we are committed to accelerating the next generation of leaders - and our co-op program is a powerful example of how we are building the future of Moderna.
This spring, we welcomed one of our largest and most diverse cohorts ever – 100 students from 43 schools, with 69% women and 75% from underrepresented groups.
Meet and hear from a few of our spring co-ops as they reflect on their experience, in this latest blog from Tracey Franklin, our Chief Human Resources Officer: www.modernatx.com/media-center/all-media/blogs/building-m…
#campusrecruiting #coop #teammoderna -
Moderna reposted
ITN Business
@ITNBusiness
Moderna has joined our ‘#netzero: #theintegritypathway’ programme to showcase their work to achieve net zero carbon emissions, which includes partnering with stakeholders to ensure they meet their targets. Find out more on the @IETA website: ieta.wildapricot.org/Net-Zero-Integrity-Pathway.
-
Moderna
@moderna_tx
#mrna can potentially change how we fight and prevent diseases. Hear more from @cleoabram about the years of work #scientists have done to help us understand what mRNA is and how it can help teach the body to fight back against #diseases. ⬇
This media couldn't be displayed. See it on the original post. -
Moderna
@moderna_tx
Moderna and @Merck announced today the initiation of the pivotal Phase 3 randomized V940-001 clinical trial evaluating mRNA-4257 (V940), an investigational individualized neoantigen therapy, in combination with KEYTRUDA, Merck’s anti-PD-1 therapy, as an adjuvant treatment in patients with resected high-risk (Stage IIB-IV) #melanoma.
Global recruitment in V940-001 has begun, and the first patients are now enrolling in Australia.
Read more: investors.modernatx.com/news/news-details/2023/Merck-and-… -
Moderna
@moderna_tx
For more than a decade, we have been at the forefront of groundbreaking #mrna research that holds immense potential to revolutionize healthcare. Hear more from @cleoabram about how we are studying mRNA to see if one day it can teach our bodies to make its own #medicine.
-
Moderna
@moderna_tx
#mrna is a special molecule in the body that can help prevent and fight disease. For more than a decade, we have been relentlessly pursuing our mission to deliver the greatest impact to people through mRNA #medicines.
Learn more from @cleoabram about the potential applications of mRNA and how we believe it can transform the fight against #diseases ⬇ -
Moderna
@moderna_tx
Shannon Thyme Klinger, our Chief Legal Officer and President of the Moderna Charitable Foundation, shared with @rabbiweiner and @AuthorityMgzine a personal look into her career path, leading at Moderna, and influencing social impact.
Full interview ⬇ medium.com/authority-magazine/social-impact-heroes-why-ho… -
Moderna
@moderna_tx
Congratulations to the Moderna UK team for officially launching our 10-year strategic partnership with @GOVUK at the iconic @BatterseaPwrStn in London.
This media couldn't be displayed. See it on the original post. -
Moderna
@moderna_tx
We announced today global regulatory submissions for mRNA-1345, a vaccine for the prevention of RSV-associated lower respiratory tract disease (RSV-LRTD) and acute respiratory disease (ARD) in adults aged 60 years or older.
Read more: investors.modernatx.com/news/news-details/2023/Moderna-An…. -
Moderna
@moderna_tx
Happy #fourthofjuly from everyone at Moderna! Wishing everyone a safe, happy and healthy holiday! #independenceday
-
Moderna
@moderna_tx
We announced today that we have submitted a regulatory application to the European Medicines Agency for our updated #covid19 #vaccine.
The filing follows the recommendation from regulators and global public health bodies to develop monovalent XBB.1.5 COVID-19 vaccines.
Read more: investors.modernatx.com/news/news-details/2023/Moderna-Su… -
Moderna
@moderna_tx
"I wish we would have been told more about the spectrum of effects cytomegalovirus (CMV) can have on a developing baby's system and the different areas that can be impacted beyond just hearing loss. I wish we would have known, when I had my CMV diagnosis during pregnancy, which specialists we would want to see once the baby arrived if he tested positive (like he did!)." - Lisa Eickel, CMV Community Alliance Chair for Virginia, and mom to Owen who was born symptomatic and received a congenital #cmv diagnosis.
"I want other parents and potential new parents to know about CMV and how to prevent it, and be extra cautious if you are pregnant or thinking of becoming pregnant. CMV is one of the leading causes of late onset hearing loss in children—always go to your audiology appointments! For Owen, he passed his hearing test each year until he was 5—his late onset hearing loss was honestly a huge shock for us at that point in his life."
This #cmvawarenessmonth, learn and help spread awareness about #cmv, the leading infectious cause of birth defects in the US: nowiknowcmv.com?tc=soc_wm3nnq&cc=1013
#cytomegalovirus #birthdefects #stopcmv -
Moderna
@moderna_tx
We celebrate belonging, inclusion and diversity in all its forms, and provide our team members with the support they need to feel welcome and comfortable as their authentic selves at work each day.
Let's continue spreading joy, acceptance, and empowerment not just during #pridemonth, but all year round.
Happy #pride! -
Moderna
@moderna_tx
Congenital #cytomegalovirus (#cmv) is the most common infectious cause of birth defects and developmental disabilities in the U.S., impacting approximately one in 200 babies.
Despite the serious risks of pediatric birth defects, 91% of women have never heard of CMV. Most people, including Samantha Nikirk and Ayako Kamei, co-founder of the Association for Congenital Toxoplasma and Cytomegalovirus Infection, only find out after their child has been impacted by the #virus.
Read our blog to learn more about real stories from families impacted by CMV: www.modernatx.com/media-center/all-media/blogs/real-stori….
#cmvawarenessmonth#StopCMV -
Moderna
@moderna_tx
"I wish that the multiple doctors I saw during my pregnancy would have taken CMV more seriously." - Brandi Hurtubise, New York National CMV Alliance Chair and mom to Samantha, who was born with congenital #cytomegalovirus (#cmv).
"I wish that the multiple doctors I saw during my pregnancy would have taken CMV more seriously, and I want other parents to know that congenital cytomegalovirus is common and it's serious. What my daughter has been through in her short 7 years is incredibly unfair."
Learn more about Brandi's story: www.nationalcmv.org/resources/blog/october/volunteer-spot…
#cmvawarenessmonth #stopcmv -
Moderna
@moderna_tx
Cytomegalovirus (#cmv) is a viral infection that presents symptoms in adults much like a common cold. For most people, CMV does not pose a health risk. But for #pregnant women, CMV could have serious consequences including birth defects. Learn more about the impact CMV can have on #infants ⬇
nowiknowcmv.com?tc=soc_wm3nnq&cc=1013
#cmvawarenessmonth -
Moderna
@moderna_tx
We announced today that we have completed submission of a regulatory application to the U.S. Food and Drug Administration for our updated #covid19 vaccine containing spike proteins for the XBB.1.5 sublineage of SARS-CoV-2 (mRNA-1273.815).
Read the full press release: -
Moderna
@moderna_tx
Every year, 8,000 children develop lasting health problems caused by #cytomegalovirus (#cmv) – the most common of these symptoms being hearing loss, intellectual disabilities, and seizures. The more people are educated about CMV, the better chance we have at reducing the spread.
One of the most proactive and effective ways to prevent CMV transmission is to practice simple hygiene practices—the ones which are already a part of our lives.
Learn more: nowiknowcmv.com?tc=soc_wm3nnq&cc=1013
#cmvawarenessmonth #stopcmv -
Moderna
@moderna_tx
We are excited to share our second annual Environmental, Social and Governance report. Our #esg strategy and corporate social responsibility program are built upon a foundation of integrity, quality and respect. We are committed to transparency about our efforts as we build (1/2)
Moderna
@moderna_tx
and support long-term programs that demonstrate our dedication to patients, employees, the environment and our communities.
We will continue to challenge ourselves to expand the impact our commitments can have on our stakeholders and look forward to the journey ahead. (2/2) -
Moderna
@moderna_tx
House Bill 643, also known as “Journie’s Law,” requires newborns in Louisiana who fail their hearing tests to be screened for #cytomegalovirus (CMV). If passed, it may lead to earlier detection of #cmv in newborns, which is the leading infectious cause of birth defects in the US.
Moderna
@moderna_tx
Rep. Dodie Horton is the author of the bill, which is named after one of Horton’s constituents, Journie. Journie was not tested for the #virus after failing her newborn hearing test, and now lives with complications from the disease, including blindness and cerebral palsy.
-
Moderna
@moderna_tx
When a baby is born with a #cytomegalovirus (#cmv) infection, it is called congenital CMV. The risk of congenital CMV is higher when the pregnant person already has a child, who can expose the parent after contracting it at daycare or school.
Moderna
@moderna_tx
Of the babies born with congenital CMV, about twenty percent will have birth defects or other long-term health problems. Research also suggests that Black infants experience much higher infection rates of congenital CMV than other babies.
Moderna
@moderna_tx
This #cmvawarenessmonth, learn more about CMV, how it spreads, and ways to prevent it: 19thnews.org/2022/06/cytomegalovirus-cmv-awareness-newbor…
-
Moderna
@moderna_tx
We’re excited to share that Moderna has been named to the 2023 #fortune500 list for the second year in a row!
fortune.com/company/moderna/fortune500/
Moderna
@moderna_tx
This is a testament to the hard work and dedication of #teammoderna. Thank you for your commitment to excellence and unwavering focus on improving human health. We’re excited to continue working together to deliver the greatest possible impact to people through #mrna medicines.
-
Moderna
@moderna_tx
That's a wrap! We're grateful to @ASCO for the opportunity to present and participate in the #asco23 Annual Meeting. We would like to thank all of the researchers, advocates and staff that made the meeting such a success - and the attendees who joined us in Chicago and online!
-
Moderna reposted
POLITICO Live
@POLITICOLive
NOW LIVE! @POLITICO chats with health care leaders at the 2023 #politicohealth Care Summit.
Hear from @DrGupta46 White House Director of National Drug Control Policy @ONDCP.
WATCH LIVE ⬇️ x.com/i/broadcasts/1ZkJzXLdPdLKv -
Moderna
@moderna_tx
Our Chief Legal Officer Shannon Thyme Klinger will join @hirshjain, @_bakulpatel and Cris Ross at @POLITICOLive's 2023 Health Care Summit to discuss the impact of #ai on healthcare.
Tune in live at 12:50 pm EDT today! ⬇
#politicohealth
POLITICO Live
@POLITICOLive
TMRW – @politico will host its annual Health Care Summit. Hear from @SecBecerra of @HHSGov, @DrGupta46 @WhiteHouse Director of @ONDCP, @DCarnival46 Deputy Assistant to President Biden for the Cancer Moonshot @WHOSTP, & many more!
#politicohealth
RSVP: politicohealthcaresummit.splashthat.com/Twitter -
Moderna reposted
Flagship Pioneering
@FlagshipPioneer
Flagship kicks off a busy day at #bio2023 as @NoubarAfeyan, @afzelius_lovisa, @GVMaltzahn, @ring_tx's Tuyen Ong & @moderna_tx's Hamilton Bennett join conversations to share their views on the future of human health & biotech. More on our BIO line up here: www.flagshippioneering.com/stories/flagship-bio-2023
-
Moderna
@moderna_tx
🌍 Happy #worldenvironmentday! At Moderna, We believe that human and planetary health are interconnected and that we have a responsibility to protect our planet. Together, we can build a greener, healthier world for all. 💚
-
Moderna
@moderna_tx
Dr. @AdnanKhattakOnc's presentation starts shortly - join him for the Oral Abstract Session in Hall D1!
meetings.asco.org/abstracts-presentations/218505
#asco23
Moderna
@moderna_tx
Moderna and @Merck announced today that mRNA-4157 (V940), an investigational individualized neoantigen therapy, in combination with KEYTRUDA, Merck’s anti-PD-1 therapy, demonstrated a statistically significant and clinically meaningful improvement in distant metastasis-free survival (DMFS) in patients with high-risk stage III/IV #melanoma following complete resection, compared with KEYTRUDA alone.
These late-breaking data are being presented for the first time today at 5:00 p.m. ET during an oral abstract session at the 2023 @ASCO Annual Meeting (abstract #lba9503).
Learn more: investors.modernatx.com/news/news-details/2023/Moderna-an… -
Moderna
@moderna_tx
Each person’s #cancer is different because cancer cells have genetic mutations that make them unique, which can make cancer difficult to treat. That’s why we, in collaboration with @Merck, are researching #mrna medicines that are designed specifically for an individual patient. Read more from Michelle Brown about the latest developments in individualized neoantigen therapy, the data being presented today at #asco23 and what lies ahead: www.modernatx.com/media-center/all-media/blogs/individual…
-
Moderna
@moderna_tx
Moderna and @Merck announced today that mRNA-4157 (V940), an investigational individualized neoantigen therapy, in combination with KEYTRUDA, Merck’s anti-PD-1 therapy, demonstrated a statistically significant and clinically meaningful improvement in distant metastasis-free survival (DMFS) in patients with high-risk stage III/IV #melanoma following complete resection, compared with KEYTRUDA alone.
These late-breaking data are being presented for the first time today at 5:00 p.m. ET during an oral abstract session at the 2023 @ASCO Annual Meeting (abstract #lba9503).
Learn more: investors.modernatx.com/news/news-details/2023/Moderna-an… -
Moderna reposted
Moderna
@moderna_tx
One therapy, for one patient. We, along with our partner @Merck, are pioneering a new frontier in the fight against #cancer by designing an mRNA-based investigational individualized #neoantigen therapy - that targets each patient’s unique cancer cells.
Learn more ⬇
#asco23 -
Moderna
@moderna_tx
Dr. Matteo S. Carlino’s presentation starts shortly - join him for the Poster Discussion Session S406!
#asco23
Moderna
@moderna_tx
Dr. Matteo S. Carlino will be presenting his abstract on Phase 2 data for mRNA-4157 (V940), an investigational #mrna individualized neoantigen therapy, at the 2023 @ASCO Annual Meeting today.
Join him for the Poster Discussion Session S406 at 4:30 pm CDT today!
meetings.asco.org/abstracts-presentations/218507
#asco23 -
Moderna
@moderna_tx
Dr. Matteo S. Carlino will be presenting his abstract on Phase 2 data for mRNA-4157 (V940), an investigational #mrna individualized neoantigen therapy, at the 2023 @ASCO Annual Meeting today.
Join him for the Poster Discussion Session S406 at 4:30 pm CDT today!
meetings.asco.org/abstracts-presentations/218507
#asco23 -
Moderna
@moderna_tx
One therapy, for one patient. We, along with our partner @Merck, are pioneering a new frontier in the fight against #cancer by designing an mRNA-based investigational individualized #neoantigen therapy - that targets each patient’s unique cancer cells.
Learn more ⬇
#asco23 -
Moderna
@moderna_tx
We’re excited to join the 2023 @ASCO Annual Meeting and present two abstracts from Phase 2 data on mRNA-4157 (V940), an investigational #mrna individualized neoantigen therapy.
#teammoderna will be at booth 22145 – stop by and say hello! Learn more: investors.modernatx.com/news/news-details/2023/Moderna-An…
#asco23 -
Moderna
@moderna_tx
June is CMV Awareness Month. CMV, or #cytomegalovirus, is the most common infectious cause of birth defects in the US.
Stay tuned this month for more information about #cmv, how it’s identified, and how to prevent it. Learn more at nowiknowcmv.com.
#cmvawarenessmonthThis media couldn't be displayed. See it on the original post. -
Moderna
@moderna_tx
It was an honor to host @MassGovernor, @MassEOED Secretary Hao and @kennturner at our Norwood manufacturing facility. Thank you all for your leadership and support!
Kenn Turner
@kennturner
Under my leadership, the @MALifeSciences will continue to deploy every resource necessary to support life science companies of all sizes and sub-sectors. It was a privilege to join @MassGovernor and @MassEOED Secretary Yvonne Hao for a visit with @moderna_tx in Norwood, MA.
-
Moderna
@moderna_tx
As we celebrate National Cancer Research Month, we look forward to joining @ASCO's 2023 Annual Meeting, where we will be presenting two abstracts on mRNA-4157 (V940), an investigational #mrna individualized neoantigen therapy.
Learn more: investors.modernatx.com/news/news-details/2023/Moderna-An…
#asco23 #ncrm23 -
Moderna
@moderna_tx
This #memorialday, we honor those who have served, and sacrificed it all in service to our country.
Our employee resource group for veteran employees and allies, mVETS, held a ceremony to pay tribute to Moderna #veterans and learn from their time serving our country. -
Moderna
@moderna_tx
In 2021, we announced our goal to achieve #netzero carbon emissions in our global operations (scope 1 & 2) by 2030. Scope 1 includes #emissions generated from Moderna-owned or operated equipment (e.g., fossil-fuel-fired equipment), and Scope 2 covers emissions generated from purchased energy, such as purchased electricity that is generated off-site.
All other greenhouse gas emissions associated with our operation (i.e., indirect emissions occurring within our value chain) are considered Scope 3 emissions. For Moderna, and many of our peers, Scope 3 emissions represent the largest category of emissions and the most challenging to reduce.
Deborah Donovan, SVP of Environment, Health and Safety at Moderna, sat down with Patrick Schuster, Global Head of Strategy Road Logistics at @Kuehne_Nagel, to talk about how both companies have come together to tackle their Scope 3 emissions and why this is vital to ensuring a sustainable future.
home.kuehne-nagel.com/-/market-insights/podcast/partnersh…
#sustainability #podcast -
Moderna
@moderna_tx
We're honored to be recognized by the @BCG for “pioneering #ai driven innovation,” and as one of the world’s most innovative companies for the third year in a row! 🎉
Innovation is at the core of what we do, and is the key to delivering the greatest possible impact to people through #mrna #medicines.
Thanks to #teammoderna for fostering an innovation-driven culture, and for your relentless pursuit of #learning!
Learn more: www.bcg.com/publications/2023/advantages-through-innovati… -
Moderna
@moderna_tx
As we celebrate International #clinicaltrialsday this weekend, we want to thank the participants, investigators, and sites who support our clinical trials. Together, we can work to improve the future of #medicine. Join the Moderna Community to learn more: trials.modernatx.com/moderna-community
-
Moderna
@moderna_tx
On #clinicaltrialsday, we would like to express our sincere gratitude to clinical trials organizations and the many people who participate in clinical trials around the world. You are true partners as we work to deliver the greatest possible impact to human health through #mrna #medicines.
It is because of clinical research sites, and the dedicated individuals who work there, that we can work to evaluate investigational treatments and vaccines for people around the world. Thank you for all that you do and for the vital role your site plays in our clinical trials and advancement of research!
#ctd2023 -
Moderna
@moderna_tx
In honor of International #clinicaltrialsday on May 20th, we're highlighting our commitment to patient-centricity at Moderna. Putting #patients at the center of everything we do is key to advancing research with the goal of improving #healthcare outcomes.
Check out our recent blog post to learn more about our patient-centric approach and our work to bring participants into the clinical trial process at every stage of development: www.modernatx.com/media-center/all-media/blogs/patient-ce… -
Moderna
@moderna_tx
We recently reported on interim data from the Phase 1/2 trial of mRNA-3927, an investigational #mrna therapy for propionic acidemia (PA). The data was presented at the 2023 @ASGCTherapy Annual Meeting. Read more: investors.modernatx.com/news/news-details/2023/Phase-12-I…
#asgct23 #propionicacidemia -
Moderna
@moderna_tx
Today is HIV Vaccine Awareness Day, a day to recognize the importance of #hiv #vaccine research and to raise awareness about the ongoing efforts to develop a safe and effective vaccine.
At Moderna, we’re committed to advancing the field of #mrna vaccines and are proud to be working on an investigational mRNA-based vaccine for HIV. We believe that mRNA technology has the potential to revolutionize the way we prevent and treat infectious diseases, and we’re excited to be a part of this important work.
Hear from our colleagues and partners about the critical role of vaccine research in improving #globalhealth.
#hvad #aids -
Moderna
@moderna_tx
We’re excited to attend this week’s 2023 @ASGCTherapy Annual Meeting! An abstract will be presented based on interim data from our Phase 1/2 trial of mRNA-3927, an investigational #mrna therapy for propionic acidemia (PA). Stay tuned for updates from the conference!
#asgct #asgct23 #propionicacidemia -
Moderna
@moderna_tx
Today, we celebrate the incredible mothers who have shaped us into who we are today. Thank you for your guidance, love, and endless support. Happy Mother's Day! #mothersday
-
Moderna
@moderna_tx
We’re proud to be part of the global community working to preserve the health of children through the power of #mrna. Thanks to everyone who joined us at #espid2023.
-
Moderna
@moderna_tx
This past week our team was honored to sponsor the @RareDiseases Rare Impact Awards and Rare Family Forum. Thank you to everyone who attended and supported this important event for the rare disease community! #nord #livingrareforum
-
Moderna
@moderna_tx
Julia Lanouette, a nurse and director on our Pharmacovigilance operations team, shares her message for #nursesweek. To all the nurses, we thank you for all that you do! Your hard work and dedication to patient care is truly inspiring. 🩺❤️
-
Moderna
@moderna_tx
In Lisbon for #espid2023? Join us for two oral presentations from our seasonal respiratory portfolio in children and adolescents.
-
Moderna
@moderna_tx
The threat of infectious diseases is not limited to adults. Respiratory and latent viruses, including #rsv #covid19 and #cmv can have severe consequences for children and adolescents.
At #espid2023, we’re presenting data across several therapeutic areas of focus that reinforce the value of vaccination in the youngest populations and the potential impact of #mrna technology in preserving global public health.
Join us virtually or on-site in Lisbon to learn more. -
Moderna
@moderna_tx
Moderna is proud to announce our fill-finish agreement with Ontario-based Novocol Pharma.
Moderna
@moderna_tx
Fill-finish sterile manufacturing is the final step in the production cycle and includes transferring the vaccine into vials and packaging them for use.
Moderna
@moderna_tx
This partnership will secure end-to-end #mrna #vaccine production in Canada, and strengthen rapid response capabilities for future pandemic readiness.
-
Moderna
@moderna_tx
Today, we're reporting financial results and providing business updates for the first quarter of 2023. Read more: feeds.issuerdirect.com/news-release.html?newsid=554165572….
Moderna
@moderna_tx
We invite you to join our first quarter 2023 earnings presentation at 8:00 AM ET today. Tune in: investors.modernatx.com/events-and-presentations/events/e….
-
Moderna
@moderna_tx
Today, we announced that an abstract reporting on interim data from the Phase 1/2 trial of mRNA-3927, an investigational #mrna therapy for propionic acidemia (PA) has been accepted for presentation at the 2023 American Society of Gene + Cell Therapy (ASGCT) Annual Meeting being held May 16-20, 2023 in Los Angeles, CA. Read more: investors.modernatx.com/news/news-details/2023/Moderna-An…
#asgct23 -
Moderna
@moderna_tx
Dr. Jeffrey S. Weber will be presenting efficacy, toxicity, and biomarker results from the Phase 2b KEYNOTE-942/mRNA-4157-P201 trial at the New York Academy of Sciences’ 10th Annual Frontiers in Cancer Immunotherapy symposium. Join him at the NYU Langone Health Murphy Auditorium on May 4th!
Learn more: events.nyas.org/event/b42eef99-1a18-41dc-9322-17c52d483a4… -
Moderna
@moderna_tx
We're announcing plans to establish an Enterprise Solutions Hub in the Philippines. The Moderna Enterprise Solutions Hub will support business services across the Asia Pacific region, which currently comprises seven countries.
Alongside the formation of the Enterprise Solutions Hub, Moderna also plans to establish a commercial subsidiary in the Philippines.
Read more: investors.modernatx.com/news/news-details/2023/Moderna-An… -
Moderna
@moderna_tx
We are thrilled that our bivalent #covid19 booster #vaccine won gold in the Health, Medical & Biotech category at the prestigious 2023 Edison Awards. 🎉🏆
We are grateful for our exceptional team, and their relentless commitment to delivering the greatest possible impact to people through mRNA medicines.
edisonawards.com/2023-winners-dev/ -
Moderna
@moderna_tx
Since our founding, we have been relentlessly researching and developing mRNA #medicines to positively impact human health. We recently launched a new campaign to educate on the promise of #mrna science.
Read about the making of the #mrnage campaign: www.mmm-online.com/home/channel/welcome-to-the-mrnage-mod… -
Moderna
@moderna_tx
We are thrilled that our mRNA #covid19 #vaccine won a Vaccine Industry Excellence award at the 2023 The World Vaccine Congress. 🎉🏆
#wvcusa #wvc2023 #vieawards -
Moderna
@moderna_tx
What are latent #viruses? What kind of impact can they have long-term?
This #worldimmunizationweek, learn more about latent viruses, the #diseases caused by some of the more common ones, and how they affect the immunocompromised. -
Moderna
@moderna_tx
About 270 #viruses are known to infect humans and only about 25 have available #vaccines.
We can do better, and our hope is that countless diseases caused by viruses can someday be prevented through the use of vaccines.
#worldimmunizationweek -
Moderna
@moderna_tx
We are thrilled to announce that we’ve been certified as a Great Place to Work in the U.S.! Thank you to #teammoderna - the driving force behind our scientific progress and our culture. This recognizes your ability to change everything!
Learn more about what makes Moderna a great place to work: www.greatplacetowork.com/certified-company/7047683/
#gptwcertified -
Moderna
@moderna_tx
Today was a milestone moment for the Moderna UK team, as we hosted a ground-breaking event at @HarwellCampus in Oxfordshire to mark the official commencement of construction the Moderna Innovation and Technology Centre (MITC).
The event was attended by Moderna colleagues, CEO of the @UKHSA Professor Dame Jennifer Harries, local community leaders and representatives from the UK’s health resilience and life sciences community.
We’re looking forward to continuing our collaboration with the @GOVUK to establish the UK as a world-leading #mrna center of excellence.
Learn more: www.harwellcampus.com/moderna-groundbreaking-at-harwell/ -
Moderna
@moderna_tx
It's #worldimmunizationweek, and we're excited to spread awareness about the importance of #vaccines! Vaccines work to protect us from diseases by training our immune system to recognize and fight off infections - and not only do vaccines save lives, they also provide a significant return on healthcare dollars.
In fact, studies have shown that for every dollar spent on childhood vaccinations, there is a savings of up to $44 in healthcare costs!
Let's continue to protect ourselves and those around us by getting vaccinated. Together, we can help build a healthier and safer world. -
Moderna
@moderna_tx
We’re proud of our Chief Human Resources Officer, Tracey Franklin, for being named as one of Insider's Most Innovative HR Leaders for 2023.
She joins #hr leaders from around the country recognized for driving change within their industries, navigating the changing norms around workplace culture, and supporting belonging, inclusion, and #diversity. Congratulations, Tracey! 🤗
#chro #leadership
www.businessinsider.com/hr-leaders-helping-companies-and-… -
Moderna
@moderna_tx
Vaccination is a key #publichealth tool to combat infectious #diseases - and save millions of lives every year.
We've spent over a decade developing our #mrna platform, and we believe our technology has the potential to significantly impact the way we treat and prevent infectious diseases in years ahead.
This #worldimmunizationweek, learn more about how our platform enables us to work on priority #pathogens that have the potential to threaten global public health ⬇
Learn more: www.youtube.com/watch?v=GtbSIBqyDvY -
Moderna
@moderna_tx
We believe that human and planetary health are interconnected and that we have a responsibility to protect our planet. This #earthday, we're outlining some of the ways in which we are planning to minimize our impact on the environment:
1) We have set a goal to achieve net-zero carbon emissions from our global operations by 2030.
2) We have committed to defining a near-term science-based target and evaluating a long-term target, which will include targets related to our value chain.
3) We are incorporating #sustainability in our new sites and buildings. As an example, we have partnered with Alexandria Real Estate Equities, Inc. to make our new Moderna Science Center in Massachusetts the most sustainable lab building in Cambridge. This new building will harness geothermal energy using heat pumps that will reduce fossil fuel usage, targeting a 92% reduction. We will also seek #leed Platinum Core & Shell and LEED Zero energy certifications for this building. As we expand our global operations, we will incorporate similar sustainability design elements into our new facilities.
#earthdayeveryday #investinourplanet -
Moderna
@moderna_tx
Welcome to the #mrnage! One strand of mRNA could change how we stand up to multiple diseases – from the widespread to the extremely rare. It could even individualize how we approach cancer.
Watch our new mRNAge video that launched this week and learn what else #mrna could do: www.modernatx.com/power-of-mrna/science-of-mrna?tc=soc_kn….
#thischangeseverythingThis media couldn't be displayed. See it on the original post. -
Moderna
@moderna_tx
Moderna and @IBM today announced an agreement under which Moderna will explore next generation technologies including quantum computing and artificial intelligence to advance and accelerate #mrna research and science.
Read more: investors.modernatx.com/news/news-details/2023/Moderna-an… -
Moderna
@moderna_tx
That's a wrap! Thanks to @AACR for the opportunity to share detailed results from the Phase 2b trial evaluating mRNA-4157 (V940), and connect with the global cancer research community at #aacr23.
Moderna
@moderna_tx
Additional data from KEYNOTE-942/mRNA-4157-P201 will be shared at an upcoming medical meeting and published in a peer-reviewed publication.
-
Moderna
@moderna_tx
Today at #aaacr23, Dr. Ryan Sullivan of @MGHCancerCenter presented data from an exploratory subgroup analysis of KEYNOTE-942/mRNA-4157-P201 for recurrence-free survival with mRNA-4157 (V940) in combination with KEYTRUDA compared to KEYTRUDA alone regardless of #tumor mutational burden status.
Tumor mutational burden (TMB) represents the number of mutations found in the DNA of #cancer cells.
The association between TMB and mRNA-4157 (V940) treatment effect will be further explored in upcoming planned studies. -
Moderna
@moderna_tx
Meet us at @ESCMID's 33rd annual European Congress of Clinical Microbiology & Infectious Diseases in Copenhagen, Denmark!
We will be at booth # C3-10 - stop by and say hello!
#eccmid2023 -
Moderna
@moderna_tx
One therapy, for one patient. We, along with our partner @Merck, are pioneering a new frontier in the fight against #cancer by designing an mRNA-based investigational individualized #neoantigen therapy - that targets each patient’s unique cancer cells.
Learn more ⬇ -
Moderna reposted
AACR
@AACR
The first study in today’s press conference is presented by Jeffrey Weber, MD, PhD, from NYU Langone Perlmutter Cancer Center, and Ryan Sullivan, MD, from Mass General Cancer Center and Harvard Medical School. #aacr23 www.aacr.org/about-the-aacr/newsroom/news-releases/adding…
-
Moderna
@moderna_tx
Dr. Jeffrey S. Weber’s presentation starts shortly - join him at the Chapin Theatre!
www.abstractsonline.com/pp8/
#aacr23
Moderna
@moderna_tx
Today, Moderna and Merck announced the first presentation of detailed results from the Phase 2b KEYNOTE-942/mRNA-4157-P201 trial evaluating mRNA-4157 (V940), an investigational individualized neoantigen #therapy (INT), in combination with KEYTRUDA, Merck’s anti-PD-1 therapy, in patients with resected high-risk #melanoma (stage III/IV).
These findings will be presented during the 2023 @AACR Annual Meeting plenary session (Abstract #ct001).
Data from a subgroup analysis of KEYNOTE-942/mRNA-4157-P201 (Abstract #ct224) evaluating mRNA-4157 (V940) in combination with KEYTRUDA among patients based on tumor mutational burden (TMB) status will also be presented.
Learn more: investors.modernatx.com/news/news-details/2023/Moderna-an…
#aacr23 -
Moderna
@moderna_tx
Stéphane Bancel, our Chief Executive Officer, discusses the potential promise of mRNA-4157/V940, our investigational #mrna individualized neoantigen #therapy, and Phase 2b study data that will be presented at #aacr23. Read the full blog here: www.modernatx.com/media-center/all-media/blogs/one-medici…
-
Moderna
@moderna_tx
Today, Moderna and Merck announced the first presentation of detailed results from the Phase 2b KEYNOTE-942/mRNA-4157-P201 trial evaluating mRNA-4157 (V940), an investigational individualized neoantigen #therapy (INT), in combination with KEYTRUDA, Merck’s anti-PD-1 therapy, in patients with resected high-risk #melanoma (stage III/IV).
These findings will be presented during the 2023 @AACR Annual Meeting plenary session (Abstract #ct001).
Data from a subgroup analysis of KEYNOTE-942/mRNA-4157-P201 (Abstract #ct224) evaluating mRNA-4157 (V940) in combination with KEYTRUDA among patients based on tumor mutational burden (TMB) status will also be presented.
Learn more: investors.modernatx.com/news/news-details/2023/Moderna-an…
#aacr23 -
Moderna
@moderna_tx
#teammoderna will be at booth 2664 to discuss opportunities in #oncology research at Moderna!
We look forward to meeting you - stop by and say hello!
#aacr23
Moderna
@moderna_tx
At Moderna, our mission is to deliver the greatest possible impact to people through #mrna medicines. If you're looking to make an impact in #oncology research, stop by our booth at #aacr23 and chat with us about joining our growing team!
Learn more: modernatx.eightfold.ai/careers -
Moderna
@moderna_tx
We are implementing a multi-pronged approach that could ease the substantial global burden of respiratory infections through the power of #mrna.
Respiratory infections are a top cause of death globally and are particularly impactful to older adults who experience more severe illness and greater mortality than younger adults.
Meet us at @ESCMID’s 33rd annual European Congress of Clinical Microbiology & Infectious Diseases in Copenhagen, Denmark, as we present data across #covid19, #rsv and seasonal #influenza.
#eccmid2023 -
Moderna
@moderna_tx
This past year, #teammoderna worked relentlessly to make significant progress across our pipeline. Driven by our mission, we advanced potential #medicines across multiple therapeutic areas and our global public health strategy – all while caring deeply for our communities, patients and each other.
Read our 2022 Annual Report to learn more: investors.modernatx.com/financials/annual-reports/default… -
Moderna
@moderna_tx
At Moderna, our mission is to deliver the greatest possible impact to people through #mrna medicines. If you're looking to make an impact in #oncology research, stop by our booth at #aacr23 and chat with us about joining our growing team!
Learn more: modernatx.eightfold.ai/careers -
Moderna
@moderna_tx
From developing treatments at unprecedented speed, to addressing global health threats - we're here to fight the big, intimidating, impossible-to-change problems.
We're here to change #medicine.
#mrna #thischangeseverything -
Moderna
@moderna_tx
Looking ahead to #mrna based therapeutics for #cancer, rare diseases, cystic fibrosis, and #cardiovascular diseases ⏩
-
Moderna
@moderna_tx
In addition to sharing clinical updates from select programs, we're also introducing new development programs today!
#lyme #norovirus #vaccinesday -
Moderna
@moderna_tx
Our #mrna technology is well positioned with key attributes to address latent #viruses with unmet need.
#vaccinesday -
Moderna
@moderna_tx
Our infectious disease #vaccine portfolio has made substantial progress over the past two years.
#vaccinesday 2021 vs 2023 ⬇ -
Moderna
@moderna_tx
We announced today clinical and program updates for our fourth annual #vaccinesday. Some key updates:
- We expect to file for approval of our investigational #rsv #vaccine candidate, mRNA-1345, this quarter.
- We are announcing new development candidates against Lyme disease, our first #bacterial vaccine, and #norovirus, an enteric virus.
Read more: investors.modernatx.com/news/news-details/2023/Moderna-An…
Join us live for our Vaccines Day presentation here: moderna-vaccines-day-2023.open-exchange.net/welcome -
Moderna
@moderna_tx
Heading to #aacr23? Stop by our booth at the @AACR Annual Cancer and Biomedical Career Fair. Our team is excited to chat about opportunities to work in #oncology research at Moderna!
Learn more: modernatx.eightfold.ai/careers/ -
Moderna
@moderna_tx
Happy #worldhealthday! Today, and every day, Moderna continues to strive to transform the future of #medicine and pave the way for new public health successes. We are dedicated to our mission of delivering the greatest possible impact to people through #mrna medicines.
-
Moderna
@moderna_tx
Moderna and @Merck today announced that mRNA-4157/V940, an investigational personalized #mrna #cancer vaccine, in combination with KEYTRUDA, Merck's anti-PD-1 therapy, has been granted Priority Medicines (PRIME) scheme designation by the @EMA_News for the adjuvant treatment of patients with high-risk stage III/IV #melanoma following complete resection.
Read more: investors.modernatx.com/news/news-details/2023/MRNA-4157V… -
Moderna
@moderna_tx
For over a decade, we have been studying whether it is possible to instruct a patient’s own cells to produce #proteins that may have the potential to treat a wide range of conditions - and we believe our technology has the potential to significantly impact the way we treat and prevent #diseases in years ahead.
Learn more about out platform approach to delivering the greatest possible impact to people with #mrna: specials.verywellhealth.com/original-plus/a-platform-appr… -
Moderna
@moderna_tx
For day 3 of The World Vaccine Congress, five of our leaders will be discussing topics ranging from vaccine supply & logistics to mRNA based vaccines for RSV and cancer.
Join us today for the below sessions 👇🏽
#wvcusa #wvc2023 @vaccinenation -
Moderna
@moderna_tx
Join us today at the The World Vaccine Congress in Washington DC for the following sessions:
- Paul Burton, our Chief Medical Officer, will be presenting on 'What are the next COVID vaccines going to be?' in Hall D.
- David Martin, our Vice President of Medical Affairs, will be presenting on 'With RSV vaccines seemingly around the corner, what is the current status and what are the next steps?' at 3:30 pm in Hall D.
#wvcusa #wvc2023 @vaccinenation -
Moderna
@moderna_tx
We’re proud of Patricia Gauthier, our VP of Latent Viruses Global Franchise, for being recognized as one of the Top 10 Healthcare Innovators by @macleans magazine in its Power List 2023! 🏆
This ranking spotlights the 100 Canadians shaping the country in 2023, and whose ideas and inventions are forging new industries and reinventing old ones.
Congratulations, Patricia!
Maclean’s Magazine
@macleans
#9: When Patricia Gauthier became @Moderna_TX's first Canadian lead in 2020, she quickly got to work. Since then, she’s overseen a country-wide effort to establish Canada as an epicentre of vaccine production: macleans.ca/society/health/the-power-list-top-10-health-c…
-
Moderna
@moderna_tx
We will be kicking off our participation at The World Vaccine Congress in Washington DC with the following sessions:
- Hamilton Bennett, our Senior Director of Vaccine Access & Partnerships, will be presenting on 'The role of vaccines in preventing outbreaks, through natural causes or biothreats' at 10:40 am in room 202A.
- Jacqueline Miller, our Senior Vice President and Head of Development for Infectious Diseases, will be presenting on 'Addressing antimicrobial resistance through prevention' at 12:25 pm in room 207B.
Learn more: www.terrapinn.com/conference/world-vaccine-congress-washi…
@vaccinenation #wvcusa #wvc2023 -
Moderna
@moderna_tx
In 2023, we stand as a mature company with a broad pipeline that includes a diverse portfolio of #mrna #vaccines and therapeutics in clinical trials.
Ten of our leaders will be presenting their research and sharing their knowledge of design, development, safety, and manufacturing, of mRNA vaccines at The World Vaccine Congress 2023. We look forward to sharing our #science and expertise - come join us!
Learn more: www.terrapinn.com/conference/world-vaccine-congress-washi…
@vaccinenation #wvcusa #wvc2023 -
Moderna
@moderna_tx
Moderna and the Government of the Republic of Kenya have finalized an agreement to establish an #mrna manufacturing facility in the Republic of Kenya.
The state-of-the-art mRNA facility is expected to produce up to 500 million doses of #vaccines each year, and will enable drug substance and #drug product manufacturing for Kenya and the African continent.
Read more: investors.modernatx.com/news/news-details/2023/Moderna-Fi… -
Moderna
@moderna_tx
Our Chief Human Resources Officer @traceyrfranklin participated in a fireside chat at the Economist Business Innovation Summit in London, where she spoke with Andrew Palmer, Executive Editor at @TheEconomist, about responsible leadership in times of uncertainty and the importance of codifying company culture. #econbis
-
Moderna
@moderna_tx
Nearly 13 years ago, we set out to study whether it is possible to instruct a patient’s own #cells to produce #proteins that may have the potential to treat a wide range of conditions with #mrna.
We believe our mRNA platform could potentially solve some of the world’s greatest health challenges—from #diseases impacting millions to #medicines personalized down to the individual level.
Read on to learn how we are working relentlessly to maximize our impact on human health.
www.washingtonpost.com/creativegroup/moderna/working-rele… -
Moderna
@moderna_tx
Medical Science Liaisons are an integral part of scientific advancement and the development of therapies. This #internationalmslday, we recognize all the Medical Science Liaisons at Moderna for supporting our mission to deliver the greatest possible impact to people through #mrna #medicines. 🔬🧪
-
Moderna
@moderna_tx
Moderna and @generationbio announced today that the two companies have entered into a strategic collaboration to combine Moderna’s biological and technical expertise with core technologies of Generation Bio’s non-viral #genetic medicine platform. The collaboration aims to expand the application of each company’s platform by developing novel nucleic acid therapeutics, including those capable of reaching immune cells, to accelerate their respective pipelines of non-viral genetic #medicines.
Read more: investors.modernatx.com/news/news-details/2023/Moderna-an… -
Moderna reposted
Financial Times Live
@ftlive
On 22 March, join experts from @moderna_tx, @LonzaGroup, @Atarabio and @Cytiva as they discuss innovative ways to expedite and improve biomanufacturing and ensure the next generation of advanced therapies can reach patients affordably and at scale: manufacturingtherapies.live.ft.com
-
Moderna reposted
Economist Enterprise events
@EconomistEvents
Join us at the Business Innovation Summit on March 28th to hear from Tracey Franklin, chief human resources officer at @moderna_tx. Tracey will be exploring responsible leadership in times of uncertainty. Register now: events.economist.com/business-innovation-summit/registrat… #econbis #responsibleleadership
-
Moderna
@moderna_tx
We believe our strength comes from our #diversity, and we are committed to building a culture of #inclusion and belonging for all.
We're proud to be recognized on the @Forbes 2022 list of the World's Top Female-Friendly Companies, which identifies companies excelling in gender equality in career advancement opportunities, advancing female representation at the executive levels, and using their platforms and marketing messaging to promote gender #equity.
Learn more: modernatx.eightfold.ai/careers/ -
Moderna
@moderna_tx
Yesterday at @TheDohertyInst we announced our inaugural Australian Fellowships Program. We invite Australian researchers working on the advancement of #mrna to apply - applications close June 30th, 2023. For more information, and to apply: www.modernatx.com/en-AU/fellowships
-
Moderna
@moderna_tx
Jerh Collins, our Chief Technical Operations and Quality Officer, will join other senior industry leaders at @ftlive's 'Biopharma Manufacturing for Advanced Therapies' event to discuss innovative ways to expedite and improve #biomanufacturing and ensure the next generation of advanced #therapies can reach patients affordably and at scale.
Tune in virtually to the event on March 22nd: manufacturingtherapies.live.ft.com?reference=speaker -
Moderna
@moderna_tx
Today we announced that Phase 2 data on mRNA-4156/V940, our investigational personalized #mrna #cancer vaccine, will be presented at the 2023 American Association of Cancer Research Annual Meeting being held April 14-19 in Orlando, FL.
mRNA-4157/V940 is being jointly developed by Moderna and @Merck, known as MSD outside of the United States and Canada. Read more: investors.modernatx.com/news/news-details/2023/Moderna-An…
#aacr23 -
Moderna
@moderna_tx
“We do experiments, we measure things, we run clinical studies, and the more and more data and richness of that data that we can get, the better we can predict what’s going to happen, the better the AI models we can develop, the better we can understand the performance of our drugs".
In this video from @CES 2023, Dave Johnson, our Chief Data and AI Officer, discusses how #data is an important component of #healthcare, and how better data—and the transparent communication of that data—became the standard at Moderna.
#ces2023This media couldn't be displayed. See it on the original post. -
Moderna
@moderna_tx
Today we announced plans to establish a corporate presence on the West Coast with new offices in South San Francisco, California, and Seattle, Washington.
Our West Coast presence joins additional U.S. locations in Cambridge, MA; Norwood, MA; Atlanta, GA; Bethesda, MD; and Princeton, NJ. We also plan to hire approximately 2,000 new employees globally by the end of 2023.
Read more: news.modernatx.com/news/news-details/2023/Moderna-Outline… -
Moderna
@moderna_tx
Kate Cronin, our Chief Brand Officer, will take the stage with Jacqueline Jones and Kathryn Finney at #sxsw 2023 to discuss what it takes to become a #changemaker, how companies can use their platforms for good, and how to build an effective and engaging approach to drive action.
Join them on March 12th: schedule.sxsw.com/2023/events/PP131813 -
Moderna
@moderna_tx
Happy International @womensday! Today and throughout the year, we celebrate the achievements of women and allies at Moderna who work relentlessly to make a positive impact on human health.
We are proud to #embraceequity and believe in creating an inclusive workplace that fosters belonging. Our Women's Employee Resource Group, Women in Science Driving Moderna (WISDM), empowers women and allies through career development, leadership opportunities and connections across the organization.
#iwd2023 -
Moderna
@moderna_tx
Dr. Michelle Brown, our Oncology Program Leader, will be a part of the panel on “How mRNA technology is changing approaches to diseases” at @AHCJ’s Health Journalism 2023. Join her on Friday, March 10th! #hj23
whova.com/embedded/session/VlUvVl5du0LWWCluLwoHy8tAoWtdwp… -
Moderna
@moderna_tx
The last few years have amplified the responsibility of both private and public sectors to address health inequities that were exacerbated by the global #pandemic. When we reflect about what #healthequity means to Moderna – it's making sure people of all backgrounds have access to the promising #medicines of tomorrow.
Read more about our commitment to removing barriers to representation in clinical research: www.modernatx.com/media-center/all-media/blogs/our-commit… -
Moderna
@moderna_tx
Heading to @sxsw 2023? Stop by the Creative Industries Expo on March 12th starting 9 am local time for your morning coffee, and discuss exciting opportunities in #tech, #ai, and personalized #cancer vaccine research at Moderna! #sxsw23
schedule.sxsw.com/2023/events/OE43078 -
Moderna
@moderna_tx
We’re proud to announce @HarwellCampus in Oxfordshire as the location of our new Moderna Innovation and Technology Centre (MITC) in the UK. This exciting milestone follows finalization of Moderna’s ten-year strategic partnership with the UK government in December 2022.
Moderna
@moderna_tx
Once operational, the facility will aim to provide the UK public with access to #mrna vaccines for a wide range of respiratory diseases, pending independent regulatory assessment and licensure.
Moderna
@moderna_tx
The MITC will include an adjoining biomarker laboratory, constructed in Northumberland and shipped to site by our specialist construction partner @WeAreTeamMerit.
Moderna
@moderna_tx
This investment will create hundreds of jobs during construction and operation. Construction will begin in 2023 and the facility is expected to become operational in 2025.
-
Moderna
@moderna_tx
“What I love about Moderna is that from its inception…a really big piece was how our leadership and our CEO thought about the world: how do we help ensure that every single individual, patient, family who needs access to our therapy can get it—and get the same as the rest of the world.”
Globalization is core to how we think about delivering the greatest impact to people through #mrna #medicines. In this video from @CES 2023, Barbara Salami, our VP of Digital for Commercial, describes the criticality of health equity and explains how building support for everyone from the very beginning made it easier for Moderna to serve a global population.
#ces2023This media couldn't be displayed. See it on the original post. -
Moderna
@moderna_tx
Our leadership team spent the final day of Black History Month visiting The Legacy Museum in Montgomery, Alabama.
The team also spent time with Bryan Stevenson, founder of the Equal Justice Initiative, who shared his inspiration behind the museum and memorial, which provides a comprehensive history of the U.S. with a focus on the legacy of slavery.
Learn more about important work being done by the museum: museumandmemorial.eji.org/visit
#bhm2023 -
Moderna
@moderna_tx
Today marks the annual celebration of Rare Disease Day - and our HQ in Cambridge, MA, is illuminated in #rarediseaseday colors to show support for over 300 million people worldwide impacted by over 7,000 #rarediseases.
#shareyourcolours #lightupforrare -
Moderna
@moderna_tx
On #rarediseaseday, we are sharing our colors and showing our stripes in honor of the more than 300 million people worldwide living with #rarediseases. We are committed to advancing #mrna therapeutic candidates to address diseases – whether they affect one person or a million.
-
Moderna
@moderna_tx
Jordan has Glycogen Storage Disease Type 1a (GSD-1a) - which is a rare inherited metabolic disease that affects just 1 in 1.25 million people. It is caused by an #enzyme deficiency where the liver fails to break down glycogen into #glucose, causing the body’s blood sugar levels to drop.
Moderna is committed to advancing #mrna research for patients living with #rarediseases like GSD-1a.
#rarediseasedayThis media couldn't be displayed. See it on the original post. -
Moderna
@moderna_tx
On @rarediseaseday, Kyle Holen, MD, our SVP and Head of Development, Therapeutics and Oncology shares his motivation and commitment to the #raredisease community. Read more: www.modernatx.com/media-center/all-media/blogs/our-commit…
-
Moderna
@moderna_tx
We're heading south to @sxsw'23! Come join us on March 12th at the Austin Convention Center as we discuss the future of #healthcare and what it takes to be a changemaker in our industry and beyond.
Post not available here, view on X
Moderna
@moderna_tx
You can also join us at the Creative Industries Expo on March 12th to hear Moderna’s Chief Brand Officer Kate Cronin discuss #changemakers. schedule.sxsw.com/2023/events/PP131813
Moderna
@moderna_tx
Head to Room 6AB later in the day to hear our Senior Director of Vaccine Access & Partnerships Hamilton Bennett discuss the potential prevention, detection and response to future #pandemics.
#sxsw23 #modernaxsxsw
schedule.sxsw.com/2023/events/PP129989 -
Moderna
@moderna_tx
In the fourth video in our #voiceofthepatient series, @KathyStagni shares how #newbornscreening is giving the world a better picture of the true impact of rare metabolic disorders like methylmalonic acidemia (MMA) and propionic acidemia, allowing a larger group of families to come together.
Our mission is to deliver the greatest possible impact to people through #mrna #medicines, and we are exploring several #rarediseases with the hope that mRNA technology could help patients and families in the future. -
Moderna
@moderna_tx
Ahead of @rarediseaseday 2023, Patrick Finn, our Vice President of Rare Disease Research and Preclinical Development, shares what inspires him to work towards our goal of bringing transformative #therapies to patients.
-
Moderna
@moderna_tx
That's a wrap! Thanks to @RESVINET for organizing #rsvvw23, allowing us to share topline results from our Phase 3 respiratory syncytial virus (#rsv) #mrna vaccine trial, and connect with other researchers and stakeholders worldwide.
As we advance a broad respiratory portfolio, with five ongoing RSV trials, we look forward to sharing progress on our RSV research at upcoming medical conferences. -
Moderna
@moderna_tx
Today, we're reporting financial results and providing business updates for the fourth quarter and fiscal year 2022. Read more: investors.modernatx.com/news/news-details/2023/Moderna-Re…
Moderna
@moderna_tx
We invite you to join our fourth quarter and fiscal year 2022 earnings presentation at 8:00 AM EDT today. Tune in: investors.modernatx.com/events-and-presentations/events/e…
-
Moderna
@moderna_tx
We announced today that mRNA-4157/V940, an investigational personalized #mrna #cancer vaccine, in combination with KEYTRUDA, @Merck's anti-PD-1 therapy, has been granted Breakthrough Therapy Designation by the U.S. FDA for the adjuvant treatment of patients with high-risk #melanoma following complete resection.
The FDA granted Breakthrough Therapy Designation based on positive data from the Phase 2b KEYNOTE-942/mRNA-4157-P201 trial.
The FDA’s Breakthrough Therapy Designation is granted to expedite the development and review of drugs that are intended to treat a serious condition, and when preliminary clinical evidence indicates that the product may demonstrate substantial improvement over available therapies on at least one clinically significant endpoint.
Read more: investors.modernatx.com/news/news-details/2023/Moderna-an… -
Moderna
@moderna_tx
Today we announced a strategic research and development collaboration with @LifeEditTx, an @elevatebio company, to discover and develop in vivo #mrna gene editing therapies.
The partnership will combine Life Edit’s suite of proprietary #gene editing technologies, including base editing, with our mRNA platform to advance in vivo gene editing therapies against a select set of therapeutic targets.
Read more: investors.modernatx.com/news/news-details/2023/Moderna-An… -
Moderna
@moderna_tx
Respiratory syncytial virus, or #rsv, poses a significant burden each year, leading to approximately 58,000 #hospitalizations among children younger than 5 years old and 177,000 among adults 65 years and older.
Moderna
@moderna_tx
We will be presenting topline safety and efficacy data from the Phase 3 trial of our investigational #mrna #vaccine for RSV at the 7th @RESVINET #rsvvw conference in Lisbon, Portugal. Join us in session III on 23rd Feb!
www.resvinet.org/rsvvw23-home.html -
Moderna
@moderna_tx
In the third video in our #voiceofthepatient series, @KathyStagni, Executive Director of @OrganicAcidemia Association and mom to Melissa, who lives with Propionic Acidemia, shares her passion to connecting families with rare #metabolic disorders.
#raredisease
Moderna
@moderna_tx
@OrganicAcidemia Association is a parent-led non-profit organization that binds together thousands of people affected with rare metabolic disorders - and we thank them for their commitment to empowering patients and their families with support, knowledge and resources.
-
Moderna
@moderna_tx
The immunogenicity and safety results of two randomized, placebo-controlled, dose-ranging, Phase 1 clinical trials of our #zika virus #mrna vaccine candidates has been published in @TheLancetInfDis. The findings support the continued development of mRNA-1893 against Zika #virus.
Read the full study here: www.thelancet.com/journals/laninf/article/PIIS1473-3099(2… -
Moderna
@moderna_tx
Health Canada (@GovCanHealth) has authorized the use of our Omicron-targeting #bivalent #covid19 vaccine, mRNA-1273.214, in children and adolescents 6 to 17 years of age. Read more: investors.modernatx.com/news/news-details/2023/Health-Can…
The authorizations are based on a 25 μg booster dose for children ages 6 to 11 years old and a 50 μg booster dose for adolescents 12 to 17 years old, each following a completed primary series of any of the authorized COVID-19 #vaccines or a previous booster. -
Moderna
@moderna_tx
Meet us at the 7th @RESVINET #rsvvw conference in Lisbon, Portugal from 22-24 February!
In session III on 23rd Feb, for the first time ever we will be presenting topline safety and efficacy data from the Phase 3 trial of mRNA-1345, an #mrna respiratory syncytial virus #vaccine (RSV) candidate, in adults 60 years and older.
Our representatives will also be at table 7 to answer your queries about our #rsv research. We look forward to meeting you - stop by and say hello!
Learn more: www.resvinet.org/rsvvw23-home.html -
Moderna
@moderna_tx
We announced today interim results from our pivotal Phase 3 safety and immunogenicity trial of mRNA-1010 (P301), an #mrna based seasonal #influenza (flu) #vaccine candidate, in adults.
Read more: investors.modernatx.com/news/news-details/2023/Moderna-An…
The Phase 3 randomized trial was designed to evaluate the safety and #immunogenicity of mRNA-1010 in adults 18 years and older in the Southern Hemisphere. -
Moderna
@moderna_tx
Ahead of Rare Disease Day 2023, Kayla Klein, our Associate Director of Patient Advocacy, shares why she is passionate about working in rare diseases and building partnerships with rare disease patient groups.
-
Moderna
@moderna_tx
In the second video in our #voiceofthepatient series, Honey Stecken, mom to Maren, shares her experience of raising a child with Propionic Acidemia (#pa) during #covid19, and how some parents actually felt safer during the pandemic..(1/2)
Moderna
@moderna_tx
...because others were required to take the same precautions that they had to be mindful of every day.
#rarediseases #rarediseaseday
(2/2) -
Moderna
@moderna_tx
This International Day of Women & Girls in Science, we congratulate our Chief Development Officer, @MelanieIvarsson OBE, for receiving an OBE (Officer of the Most Excellent Order of the British Empire) for her services to public health during #covid19.
www.independent.co.uk/news/science/obe-moderna-windsor-ca…
Moderna
@moderna_tx
“I would be very proud if the fact that I received an OBE today inspires women and girls to consider careers in vaccine research,” said Dr. Ivarsson.
Moderna
@moderna_tx
Dr. Ivarsson hopes to set an example for future female scientists around the world, and hope that women and girls consider going into #science, technology, engineering or math when they’re thinking about their future careers.
@WomenInScience #bringingeveryoneforward #idwgs -
Moderna
@moderna_tx
Ahead of @rarediseaseday 2023, Heather Knowles, our Executive Director of Clinical Operations, Therapeutics and Oncology, shares what inspires her to make a difference for #raredisease patients and their families.
-
Moderna
@moderna_tx
Patient needs are at the center of our work every day, and listening to and learning from the patient community is a top priority for us. In honor of #rarediseaseday, we're kicking off #voiceofthepatient - a series capturing the voice of parents of kids with propionic acidemia.
Moderna
@moderna_tx
Propionic acidemia (PA) is a #raredisease in which the body is unable to process certain parts of #proteins and #lipids properly, which can cause serious health problems.
Moderna
@moderna_tx
For parents of kids with PA, the condition consumes their lives. In this first video, hear from Honey Stecken, who recently shared with us her story of caring for her daughter, Maren, with PA.
-
Moderna
@moderna_tx
One characteristic that makes #cancer hard to treat is that each person’s cancer is different. On #worldcancerday, learn more about how we, along with our partner @Merck, are researching #medicines that are designed specifically to each patient's individual cancer.
-
Moderna
@moderna_tx
It's National #wearredday! We are proud to join @American_Heart and @GoRedForWomen and rock our red to raise awareness of cardiovascular diseases, the leading cause of death in women.
#goredforwomen #heartmonth 🫶❤️🫶 -
Moderna
@moderna_tx
The start of February marks our countdown to #rarediseaseday on February 28th! Join us to raise awareness for the 300 million people living with a rare disease worldwide, as we share stories about individuals, families, and those who care for people living with rare diseases. 🦓
Moderna
@moderna_tx
Visit @rarediseaseday to learn how you can get involved: www.rarediseaseday.org
-
Moderna
@moderna_tx
We announced today that mRNA-1345, an investigational #vaccine candidate for respiratory syncytial virus (RSV), has been granted Breakthrough Therapy Designation by the U.S. FDA for the prevention of RSV-associated lower respiratory tract disease in adults aged 60 years or older.
Moderna
@moderna_tx
The designation was based on positive topline data from the ConquerRSV Phase 3 pivotal efficacy trial.
Read more: investors.modernatx.com/news/news-details/2023/Moderna-Gr… -
Moderna
@moderna_tx
At Moderna, we are changing how #medicines are created and delivered –and giving you the opportunity to change more than just your career. Find your new opportunity at Moderna: modernatx.eightfold.ai/careers/
#wearehiring -
Moderna reposted
News from Science
@NewsfromScience
A study from last year that strongly links multiple sclerosis with Epstein-Barr virus may help spur the development of a vaccine against #ebv. #sciencemagarchives scim.ag/1gI
-
Moderna
@moderna_tx
In the US, every 30 min a baby is born with Cytomegalovirus (CMV) - which is a leading cause of childhood deafness, and the #1 infectious cause of #birthdefects in the US.
This #birthdefectsawarenessmonth, learn more about the long-term impacts of CMV, and how to prevent it ⬇ -
Moderna
@moderna_tx
Moderna is a proud sponsor of @EmbraceBOS, whose mission is to dismantle structural racism through their work at the intersection of arts and #culture, #community, and research and policy.
Moderna
@moderna_tx
As part of our sponsorship, we were excited to support the Embrace Memorial that was unveiled over the #mlkday weekend. The Memorial commemorates the Kings’ efforts for racial and social #equity, and will serve as a reminder to foster a community of love, belonging and hope.
-
Moderna
@moderna_tx
Our CEO Stéphane Bancel joins colleagues at @FlagshipPioneer to discuss digital first, growing R&D budget, #cancer breakthroughs, Moderna's progress in addressing respiratory illnesses, and a growing leadership in #genomics. #flagshipjpm #jpm23
This media couldn't be displayed. See it on the original post. -
Moderna
@moderna_tx
Chisom Udengwu, a Senior Research Associate on Moderna’s technical development team, attributes his love for research to his innate curiosity as a child growing up in Nigeria. Learn more about Chisom's professional journey! #peoplebehindthescience
This media couldn't be displayed. See it on the original post.
Moderna
@moderna_tx
We are looking for individuals who bring their personal passions to our pursuit to deliver the greatest possible impact to people through mRNA medicines. Join us! #wearehiring #modernacareers
www.modernatx.com/careers/life-at-moderna -
Moderna
@moderna_tx
Respiratory syncytial virus, or #rsv, is a common seasonal #virus that can cause serious illness in certain groups like infants and older adults. Learn more about our investigational #mrna #vaccine that may help prevent RSV disease, and help your body fight RSV in the future.
-
Moderna
@moderna_tx
Our Chief Executive Officer Stéphane Bancel speaks about mRNA-1345, our investigational #vaccine candidate against respiratory syncytial virus (RSV) in older adults, and results from our pivotal Phase 3 study, in his latest blog post. Read the blog here: www.modernatx.com/media-center/all-media/blogs/Vaccines-R…
-
Moderna
@moderna_tx
Today, we announced positive topline data from its ConquerRSV Phase 3 pivotal efficacy trial of mRNA-1345, an investigational #mrna #vaccine targeting respiratory syncytial virus (RSV) in older adults.
Moderna
@moderna_tx
mRNA-1345 demonstrated vaccine efficacy (VE) of 83.7% against RSV lower respiratory tract #disease, defined by 2 or more symptoms in older adults. It was generally well-tolerated, with no safety concerns identified by the Data and Safety Monitoring Board.
Moderna
@moderna_tx
Based on these results, we intend to submit mRNA-1345 for regulatory approval in the first half of 2023.
-
Moderna
@moderna_tx
Caring deeply about and #givingback to the communities where we live and work is an integral part of who we are and what we do. With our 4th Annual Volunteer Week, Moderna teams across 6 countries helped to make an impact for more than a dozen #nonprofits globally.
Moderna
@moderna_tx
Volunteering for #mlkday of Service in honor of the work and legacy of Dr. King is a great way to give back. Need inspiration? Find volunteer activities here: americorps.gov/join/find-volunteer-opportunity
-
Moderna reposted
NBC10 Boston
@NBC10Boston
Welcome the Embrace.
#nbc10boston #worthyofyou #embraceboston @embracebos -
Moderna
@moderna_tx
We’re delighted to be joining @ABPI_UK – this alliance is an important part of our long-term commitment to the UK!
ABPI
@ABPI_UK
We’re delighted to welcome our latest member @moderna_tx, a company investing heavily in the 🇬🇧 www.abpi.org.uk/media/news/2023/january/moderna-joins-the…
-
Moderna
@moderna_tx
At Moderna, we are dedicated to researching and developing innovative mRNA vaccines and therapies for a wide range of diseases that impact people’s lives, but we can’t do it alone.
Moderna
@moderna_tx
We invite you to partner with us on our journey to bring a new generation of transformative medicines to the world. Join the online Moderna Community today: www.modernacommunity.com
-
Moderna
@moderna_tx
Cytomegalovirus (CMV) is the #1 infectious cause of #birthdefects in the US - yet 91% of women have never heard of CMV.
This #birthdefectsawarenessmonth, learn about the long-term impact of a CMV infection, and how to prevent it.
#acrossthelifespan
www.mother.ly/health-wellness/childrens-health/cmv-infect… -
Moderna
@moderna_tx
Our CEO Stéphane Bancel will present an update on Moderna and its pipeline of #mrna development programs on Monday, January 9, 2023, at 2:15 p.m. PT at the 41st Annual @JPMorgan Healthcare Conference. #jpm23
investors.modernatx.com/news/news-details/2023/Moderna-An…
Moderna
@moderna_tx
Tune into the live webcast of both the presentation and question and answer session - investors.modernatx.com/events-and-presentations/events/e…
-
Moderna reposted
Rahmi Oklu MD, PhD
@rahmioklu
CEO of Moderna talking about mRNA technology and cancer. Fascinating… @CES
-
Moderna reposted
CES
@CES
Happening now at #ces2023 : www.ces.tech/conference/55907/999722.aspx
Moderna
@moderna_tx
2 days to go! Join our CEO Stéphane Bancel at @CES 2023 on Jan 7th as he discusses #mrna technology, personalized medicine, and the potential future of #cancer treatment. #ces2023
www.ces.tech/conference/55907/999722.aspx -
Moderna
@moderna_tx
Congrats to Lavina Talukdar, our Senior Vice President & Head of Investor Relations, who was named the #3 IR professional in the #biotechnology industry as part of the @iimag's 2023 All-America Executive Team!
www.institutionalinvestor.com/article/b20kkr1pmy6bfl/How-… -
Moderna
@moderna_tx
Moderna and @CytomXInc announce a Strategic Research Collaboration to generate and develop #therapeutics for #oncology and non-oncology conditions. Read more: investors.modernatx.com/news/news-details/2023/Moderna-an…
Moderna
@moderna_tx
The research collaboration will leverage our #mrna technology, and @CytomXInc's Probody® technology that enables #proteins to be activated locally in diseased tissue, while remaining masked in systemic circulation.
-
Moderna
@moderna_tx
2 days to go! Join our CEO Stéphane Bancel at @CES 2023 on Jan 7th as he discusses #mrna technology, personalized medicine, and the potential future of #cancer treatment. #ces2023
www.ces.tech/conference/55907/999722.aspx
Moderna
@moderna_tx
We are #hiring for our personalized cancer vaccine program! Explore open opportunities, and apply at www.modernatx.com/careers/life-at-moderna.
-
Moderna
@moderna_tx
Moderna and OriCiro Genomics announce that they have entered into a definitive agreement through which Moderna will acquire OriCiro. Read more: investors.modernatx.com/news/news-details/2023/Moderna-to…
Moderna
@moderna_tx
OriCiro Genomics is a pioneer in cell-free #dna synthesis and amplification technologies, and its synthetic biology and #enzyme technologies will bolster Moderna’s suite of platform technologies, and support its expanding portfolio of therapeutics and #vaccines.
-
Moderna reposted
CES
@CES
#ces2023 featured studios to learn about tech innovation include:
💡C Space studio sponsored by @salesforce
💡Digital Health Studio presented by @EmergencyDocs + sponsored by @moderna_tx & @VitalsHub
💡Web3 Studio presented by @CoinDesk
Visit: www.ces.tech/sessions-events/c-space-studio.aspx?sf262990… -
Moderna
@moderna_tx
2022 was a pivotal year for Moderna. After 12 years of hard work on the #science, we reached the most important pivot point in our company’s history.
Read our CEO Stéphane Bancel’s annual letter to shareholders to learn more about our journey: www.modernatx.com/media-center/all-media/blogs/moderna-20… -
Moderna
@moderna_tx
#teammoderna wishes you a safe and festive holiday season, and hope that 2023 brings you health and happiness! 🎉 🎊 #happyholidays #happynewyear
-
Moderna reposted
Department of Health and Social Care
@DHSCgovuk
🤝 We've finalised our partnership with @moderna_tx to protect the UK against potential global health threats.
It includes:
✅ investment in research & development
✅ a state-of-the-art vaccine manufacturing centre
✅ more than 150 jobs
www.gov.uk/government/news/uk-cements-10-year-partnership…
@UKHSA -
Moderna
@moderna_tx
We’re proud to announce the finalization of a 10 year strategic partnership with the UK government to build a state-of-the-art #mrna R&D and manufacturing center in the UK, providing direct access to #pandemic response capabilities #vaccines.
Read more: investors.modernatx.com/news/news-details/2022/Moderna-Fi…Post not available here, view on X
Moderna
@moderna_tx
Darius Hughes, Moderna UK GM met with Rt Hon @SteveBarclay, Secretary of State for Health and Social Care to finalize the strategic partnership with the UK government @DHSCgovuk @10DowningStreet.
📸: Lauren Hurley / Department of Health and Social Care
Moderna
@moderna_tx
Today's announcement will see Moderna continue its collaboration with the UK government and @UKHSA to establish the UK as a world-leading mRNA center of excellence. As part of the 10yr deal, Moderna will also support the UK’s mRNA health and science ecosystem @UK_Life_Science.
-
Moderna
@moderna_tx
This landmark occasion at @MonashUni in Victoria Australia captures the official groundbreaking ceremony of our new #mrna #vaccine manufacturing facility with Michael Azrak, @TimPallas, @Mark_Butler_MP, @GardmarM and our distinguished guests.
This media couldn't be displayed. See it on the original post.
Moderna
@moderna_tx
We’re bringing the future of mRNA to Australia with a world class local scientific and medical community.
#modernaaustralia #victoria #australia #mrnavictoria -
Moderna
@moderna_tx
2022 marked our most impactful year of #givingback to our communities, both locally and globally. This year’s 4th Annual Volunteer Week included participants in six countries. Learn more about our commitment to giving back: www.modernatx.com/en-US/media-center/all-media/blogs/volu…
#modernagivesback #volunteering -
Moderna
@moderna_tx
One characteristic that makes #cancer hard to treat is that each person’s cancer is different. Learn more about how we, along with our partner @Merck, are researching medicines like personalized cancer #vaccines, that are designed specifically to each patients individual cancer.
Moderna
@moderna_tx
To learn more about our investigational personalized #cancer #vaccine program, join our CEO Stéphane Bancel's session on Jan 7th at #ces2023, where he will discuss will discuss the potential of individualized cancer treatments for patients. www.ces.tech/conference/55907/999722.aspx
-
Moderna
@moderna_tx
The @EMA_News’s Committee for Medicinal Products for Human Use (CHMP) recommends the use of mRNA-1273.214, our Omicron BA.1 targeting bivalent #covid19 #booster in children (6-11 years) in the European Union. Read more: investors.modernatx.com/news/news-details/2022/EMA-Commit…
Moderna
@moderna_tx
Our #bivalent Omicron-targeting COVID-19 vaccines (mRNA.1273.214 (BA.1) & mRNA.1273.222 (BA.4-5)) are approved for use in individuals 12 years of age and older in the European Union.
Moderna
@moderna_tx
Both bivalents have been shown to trigger a superior #antibody response compared to a booster dose of mRNA-1273 against Omicron (BA.4-5) in Phase 2/3 clinical trials.
-
Moderna
@moderna_tx
At Moderna, our commitment to serve the communities where we live and work has always been part of our identity. Read more about how we helped make a difference for more than a dozen organizations around the world as part of our 4th Annual Volunteer Week: www.csrwire.com/press_releases/762366-giving-back-moderna…
-
Moderna reposted
Invest in Canada
@invest_canada
Access to Canada's flourishing #lifesciences ecosystem, its large pool of #stem talent, and its commitment to #sustainability are just some of the reasons why #biotechnology company @moderna_tx has chosen to #investincanada. #fdi 🧪🔬 Learn more: sponsorcontent.cnn.com/edition/2022/invest-in-canada/why-…
-
Moderna
@moderna_tx
“We will begin additional studies in melanoma and other forms of cancer with the goal of bringing truly individualized cancer treatments to patients.” - Stéphane Bancel, our CEO.
-
Moderna
@moderna_tx
Results from KEYNOTE-942/mRNA-4157-P201 are the first demonstration of efficacy for an investigational #mrna #cancer treatment in a randomized clinical trial.
-
Moderna
@moderna_tx
mRNA-4157/V940 is an investigational personalized #cancer #vaccine consisting of a single #mrna coding for up to 34 neoantigens that is designed to stimulate an immune response by generating specific T cell responses based on the unique mutational signature of a patient’s #tumor.
-
Moderna
@moderna_tx
One medicine, for one patient. We, along with our partner @Merck, are pioneering a new frontier in the fight against #cancer by designing an mRNA-based investigational personalized cancer #vaccine - that targets each patient’s unique cancer cells. Learn more about how it works ⬇
This media couldn't be displayed. See it on the original post. -
Moderna
@moderna_tx
Stéphane Bancel, our Chief Executive Officer, speaks about mRNA-4157/V940, our investigational personalized #mrna #cancer #vaccine, and Phase 2b trial results in his latest blog post. Read the full blog here: www.modernatx.com/media-center/all-media/blogs/fight-agai…
-
Moderna
@moderna_tx
Moderna and @Merck announce that that the Phase 2b KEYNOTE-942/mRNA-4157-P201 trial of mRNA-4157/V940, an investigational personalized #mrna #cancer #vaccine, in combination with KEYTRUDA®, Merck’s anti-PD-1 therapy, demonstrated a statistically significant and clinically..(1/2)
Moderna
@moderna_tx
meaningful improvement in the primary endpoint of recurrence-free survival (RFS) versus KEYTRUDA alone for the adjuvant treatment of patients with stage III/IV #melanoma following complete resection.
investors.modernatx.com/news/news-details/2022/Moderna-an… -
Moderna
@moderna_tx
The U.S. FDA has cleared an Investigational New Drug application by @VertexPharma for VX-522, an #mrna therapy targeted at treating the underlying cause of #cysticfibrosis, for people who cannot benefit from a cystic fibrosis transmembrane conductance regulator (CFTR) modulator.
Moderna
@moderna_tx
VX-522 is the result of an exclusive research collaboration between Vertex and Moderna. VX-522 is delivered to the lung through inhalation of a CFTR mRNA encapsulated by a lipid nanoparticle, and the mRNA is designed to produce functional copies of the CFTR protein.
Moderna
@moderna_tx
Vertex plans to initiate a single ascending dose clinical trial for VX-522 in people with CF in the coming weeks. Read more: news.vrtx.com/news-releases/news-release-details/vertex-a…
-
Moderna
@moderna_tx
#didyouknow that every year in the US, the #flu causes anywhere from 140k-710k hospitalizations, and 12k-52k deaths? Flu #vaccines decrease the risk of serious illness, and offer the best protection against flu.
Moderna
@moderna_tx
Check out cdc.gov/flu for information on how to keep your loved ones safe and #fightflu this winter.
-
Moderna
@moderna_tx
That’s a wrap on our 4th Annual Volunteer Week! Being part of #teammoderna isn’t only about developing a new generation of transformative medicines -- it also means caring deeply about the communities where we live and work.
Moderna
@moderna_tx
This year, teams from six countries helped to make an impact for over a dozen #nonprofits around the globe. We’re grateful for our colleagues who passionately work to make a difference for others.
www.modernatx.com/responsibility/our-commitment
#modernagivesback #volunteering -
Moderna
@moderna_tx
We announced today that we have received emergency use authorization (EUA) from the U.S. FDA for our BA.4/BA.5 Omicron-targeting #bivalent #covid19 booster #vaccine, mRNA-1273.222, in children 6 months through 5 years of age.
Read more: investors.modernatx.com/news/news-details/2022/Moderna-Re…
Moderna
@moderna_tx
The authorization is based on a 10 μg #booster dose following a completed primary series of our original vaccine. mRNA-1273.222 has also received FDA EUA for children and adolescents aged 6 through 17 years old, as well as adults over the age of 18.
-
Moderna
@moderna_tx
We're pleased to announce that Brad Miller will be joining us as Chief Information Officer, beginning January 3, 2023. He will serve on our Executive Committee and report to Chief Executive Officer Stéphane Bancel.
Read more: investors.modernatx.com/news/news-details/2022/Brad-Mille…
Moderna
@moderna_tx
Marcello Damiani, who is currently serving as Chief Digital Officer, will be retiring from the company after seven years.
Prior to joining the Company, Mr. Miller served as Executive Vice President and Chief Information Officer of Enterprise Products and Platforms at Capital One.
Moderna
@moderna_tx
At Capital One, he was responsible for building and operating critical enterprise services and digital experiences across all lines of business.
Welcome, Brad. -
Moderna
@moderna_tx
#nationalinfluenzavaccinationweek is here! Worldwide, there are 290-650K influenza-related respiratory deaths annually - and flu vaccines are the best way to protect yourself. If you haven’t received your flu shot yet, now is a good time! Together, we can #fightflu💪
-
Moderna
@moderna_tx
We’re walking in a winter wonderland! As part of our 4th Annual Volunteer Week, our team had the chance to decorate and bring some #holiday spirit to a @headinghomeinc shelter. 🎄✨
Moderna
@moderna_tx
Heading Home, a Moderna Charitable Foundation nonprofit partner, is one of Boston's leading providers of #emergency shelter, transitional, and permanent #housing for extremely low-income #families and individuals currently or formerly experiencing homelessness.
-
Moderna
@moderna_tx
Vaccination saves millions of lives every year - and it is a key #publichealth tool to combat infectious #diseases.
We've spent over a decade developing our #mrna platform, and the characteristics of this platform that make it scalable are well suited for public health #vaccines.
Moderna
@moderna_tx
Learn more about how our platform enables us to work on priority #pathogens that have the potential to threaten global public health, in this documentary produced in partnership with @EuropeVaccine: www.youtube.com/watch?v=GtbSIBqyDvY
-
Moderna
@moderna_tx
Congrats to all who made the @iimag 2023 All-America Executive Team! We're proud of our CEO Stéphane Bancel, previous CFO David Meline, SVP of Investor Relations Lavina Talukdar, and our Investor Relations team for being ranked in top 3 of the #biotechnology industry!
Institutional Investor
@iimag
How America’s Top CEOs Tackled 2022’s Biggest Challenges
www.institutionalinvestor.com/article/2bstnzx1bc4tp6jvc42… -
Moderna
@moderna_tx
At the heart of our 4th Annual Volunteer week are our employees working together to #giveback in the community.
Our team in Basel, Switzerland spent the afternoon at Thanksgiver Schweiz helping to sort, organize and distribute food to those in need. 🍠🥕🥖
Moderna
@moderna_tx
ThanksGiver is a local food bank in Basel, Switzerland that provides high-quality food to those in need, and whose mission is to eliminate hunger and prevent food waste.
#modernagivesback #volunteering
www.modernatx.com/responsibility/our-commitment -
Moderna
@moderna_tx
Brett Leav, our Head of Clinical Development for Public Health Vaccines, shares a message for #worldaidsday.
We are grateful for all the scientific research that has happened on HIV vaccines, and hopeful for the potential role mRNA technology can play in the fight against #hiv. -
Moderna reposted
Reuters
@Reuters
Moderna exec says COVID trials improved diversity recruiting www.reuters.com/business/healthcare-pharmaceuticals/moder…
-
Moderna
@moderna_tx
This #worldaidsday, we recognize our partner organizations that work to address inequalities and help #endtheepidemic.
Moderna
@moderna_tx
We continue to be a proud supporter of @FenwayHealth, a leader in providing equitable healthcare to underserved communities. We’re committed to their mission of enabling our local, national, and global neighbors to have the tools they need to flourish.
fenwayhealth.org/give/fenway-health-sponsors/
Moderna
@moderna_tx
We're also pleased to be a 'Hope Partner' of @aids_memorial's World AIDS Day events, including a national observance in the National AIDS Memorial Grove, which brings leaders together for conversations on the ongoing efforts to end the epidemic.
www.aidsmemorial.org/wad2022 -
Moderna reposted
Reuters Press Team
@ReutersPR
LIVE: @moderna_tx Chief Medical Officer Paul Burton and @MayoClinic President of International @antondecker discuss transforming healthcare by placing equity and sustainability first with @Reuters @CarolineHumer. #reutersnext x.com/i/broadcasts/1YpJkgDrmENJj
-
Moderna
@moderna_tx
We are excited to be ranked #6 on @Deloitte's Technology Fast 500 list, which honors the most innovative, fastest-growing public and private companies from all over North America.
#fast500
www2.deloitte.com/us/en/pages/technology-media-and-teleco…
Moderna
@moderna_tx
Congratulations to all the industry disruptors across the technology, media, telecommunications, life sciences, fintech, and energy tech sectors!
-
Moderna
@moderna_tx
Each year during our Volunteer Week, our teams around the world come together to #giveback in our local communities - and this #givingtuesday, we’re excited to kick off our 4th Annual Volunteer Week!
www.modernatx.com/responsibility/our-commitment
Moderna
@moderna_tx
From decorating a shelter in Boston with @HeadingHomeInc, to helping families in need in Warsaw with @szlachetnapaczk, we’re proud to be #volunteering with charitable organizations around the world like @YearUp, Thanksgiver Schweiz, and Aktion Pinguin, to support those in need.
-
Moderna
@moderna_tx
ANNOUNCEMENT 📢: We are proud to announce that the first participant has been dosed in the Phase 1 study of mRNA-1574, our experimental human immunodeficiency virus (#hiv) trimer #mrna #vaccine candidate.
investors.modernatx.com/news/news-details/2022/Moderna-An… -
Moderna
@moderna_tx
We're excited to partner with The University of Queensland (@UQ_News) to research and develop #vaccines to tackle the world’s greatest global public health threats. 🤝🔬🧪
UQ News
@UQ_News
#uq partners with Moderna to use mRNA technology to target global public health threats.
news.uq.edu.au
#uq @moderna_tx #mrnaaccess @ProfPaulYoung @UQscience @UQ_SCMB #profmarkwalker -
Moderna
@moderna_tx
ANNOUNCEMENT 📢: We are proud to announce that the first participant has been dosed in the Phase 1 study of mRNA-1644, our experimental #hiv #mrna #vaccine candidate. Learn more about this exciting venture with @IAVI: investors.modernatx.com/news/news-details/2022/IAVI-and-M…
-
Moderna
@moderna_tx
Today, we shared positive pre-clinical data demonstrating our ability to combine 6 mRNAs against 3 different respiratory viruses in 1 vaccine: COVID-19 booster + Flu booster + RSV booster. #mrna
-
Moderna
@moderna_tx
We just announced that we have submitted an authorization application to Swissmedic for the use of our COVID-19 vaccine in adolescents. Read more: investors.modernatx.com/news-releases/news-release-detail…
-
Moderna
@moderna_tx
After carefully reviewing the available safety data to date for Moderna COVID-19 Vaccine for cases of myocarditis and/or pericarditis, we have not established a causal association with our vaccine. Read our full statement here: investors.modernatx.com/news-releases/news-release-detail…
-
Moderna
@moderna_tx
We announced a new supply agreement with Australia for 25 million doses of our COVID-19 vaccine, including 10 million doses of our vaccine against the ancestral strain for in 2021 & 15 million doses of our variant booster candidate for delivery in 2022: investors.modernatx.com/news-releases/news-release-detail…
-
Moderna
@moderna_tx
The @WHO has issued Emergency Use Listing (EUL) for our COVID-19 vaccine to prevent COVID-19 in individuals 18 years of age and older. Read more: investors.modernatx.com/news-releases/news-release-detail…
-
Moderna
@moderna_tx
Moderna's statement on CVST or thrombotic events.
-
Moderna
@moderna_tx
We just announced that the Philippines has secured 7 million additional doses of our COVID-19 vaccine through a new supply agreement & partnership with the private sector, bringing its confirmed order commitment to 20 million doses. Read more: investors.modernatx.com/news-releases/news-release-detail…
-
Moderna
@moderna_tx
We just announced that the Moderna COVID-19 Vaccine retains neutralizing activity against emerging variants first identified in the U.K. and the Republic of South Africa. Read more: investors.modernatx.com/news-releases/news-release-detail…
-
Moderna
@moderna_tx
We just confirmed that the @US_FDA VRBPAC recommended that the FDA grant an Emergency Use Authorization for our COVID-19 vaccine candidate, mRNA-1273. 20 VRBPAC members recommended for EUA, 0 members voted against, and 1 abstained. Read more: investors.modernatx.com/news-releases/news-release-detail…
-
Moderna
@moderna_tx
We just announced that mRNA-1273, our COVID-19 vaccine candidate, has met its primary efficacy endpoint in the first interim analysis of the Phase 3 COVE study.
Read more: investors.modernatx.com/news-releases/news-release-detail… -
Moderna
@moderna_tx
While the pandemic continues, Moderna will not enforce our COVID-19 related patents against those making vaccines intended to combat the pandemic. Read our statement here: investors.modernatx.com/news-releases/news-release-detail…
-
Moderna
@moderna_tx
We are proud to participate in this pledge to uphold the integrity of the scientific process in the research and development of a #covid19 vaccine. #westandwithscience, and @BioNTech_Group, we invite you to stand with us.
-
Moderna
@moderna_tx
We just announced that the first participants in each age cohort have been dosed in the Phase 2 study of our mRNA vaccine (mRNA-1273) against novel coronavirus. Read more: investors.modernatx.com/news-releases/news-release-detail… #mrna
-
Moderna
@moderna_tx
Summary of our SARS-CoV-2 #vaccine (mRNA-1273) interim Phase 1 data. Read more: investors.modernatx.com/news-releases/news-release-detail… #mrna
-
Moderna
@moderna_tx
We just announced positive interim Phase 1 data for our mRNA vaccine (mRNA-1273) against novel coronavirus. Read more: investors.modernatx.com/news-releases/news-release-detail…
-
Moderna
@moderna_tx
We’re thrilled to welcome Moncef Slaoui, former Chairman of Global Vaccines at @GSK, to our Board. www.modernatx.com/newsroom/press-releases/moncef-slaoui-j…
-
Moderna
@moderna_tx
Great talks by @AstraZeneca (Kenny Hansson) & @karolinskainst (Nevin Witman); impt work by our partners to advance #mrna tx. #mrna2016

































































































































































































































































































































































































































































































































